An investigation into sex-differences in the regulation and function of Toll-like receptors in leukocyte trafficking in vivo by Kay, Emma
An investigation into sex-differences in the regulation and function of Toll-
like receptors in leukocyte trafficking in vivo
Kay, Emma
 
 
 
 
 
The copyright of this thesis rests with the author and no quotation from it or information
derived from it may be published without the prior written consent of the author
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/jspui/handle/123456789/8441
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
1 
 
 
 
 
An investigation into sex-differences in the 
regulation and function of Toll-like 
receptors in leukocyte trafficking in vivo 
 
 
A thesis submitted for the degree of 
 
Doctor of Philosophy 
University of London 
 
By 
 
Emma Kay 
 
Centre for Microvascular Research 
William Harvey Research Institute 
Barts & The London School of Medicine and Dentistry 
Queen Mary University of London 
Charterhouse Square 
London EC1M 6BQ 
UK  
2 
 
Acknowledgements 
I would first and foremost like to express my utmost thanks to Dr Ramona Scotland for giving 
me the opportunity to carry out this PhD. I must also express my gratitude to Dr James 
Whiteford for agreeing to supervise me for the last 18 months, and for his support, 
encouragement, dedication, and optimism for the project. I must also thank Prof Sussan 
Nourshargh for acting as my second supervisor and allowing me to undertake this project in 
the Centre for Microvascular Research, and the British Heart Foundation for the funds to 
support this work.  
I wish to thank all the members of Microvascular Research, past and present, for their 
welcome, support, advice, comments and expertise during the past 3 years. I am also grateful 
to Dr Guglielmo Rosignoli for all the help during the hundreds of hours spent in the FACS room, 
Dr Lorena Gomez for her help with the bone marrow work, and Arif Mustafa for his time and 
assistance in the BSU. I express my thanks to Andrew Leese, with whom I have shared the ‘PhD 
rollercoaster’ with from the beginning, who has always been there to make me smile, and with 
whom I hope to stay friends for life. My thanks also go to the other students Chris, Michi, 
Krishma, Suborno, Thomas and Giulia for the laughs, encouragement, and friendship.     
A special thank you goes to Matt for the motivation, the listening, the patience, the positivity, 
the flexibility, and most of all the fun times.  
Most importantly, I am eternally grateful to my amazing parents for their love, support, and of 
course the roof over my head, not just in the last 3 years. To them I dedicate this thesis.  
3 
 
Abstract 
Sexual dimorphisms exist in the incidence and severity of many diseases, with females 
demonstrating relative protection from inflammatory conditions. The extent and mechanisms 
by which excessive leukocyte recruitment underlies these differences are not well established, 
and better understanding is essential for the development of targeted therapies. Evidence 
suggests that variances in pathogen-sensing Toll-like receptors (TLRs) underlie sex-differences 
in leukocyte recruitment. This thesis aimed to investigate sex-differences in trafficking of 
leukocytes in the zymosan peritonitis murine model of acute inflammation and furthermore 
evaluate if these differences were accompanied by changes in TLR2 or TLR4 expression. 
This work shows that female mice recruit fewer classical monocytes and neutrophils during 
zymosan induced peritonitis. It demonstrates female murine peritoneal macrophages are more 
numerous, whilst the peritoneal cytokine environments and zymosan-sensing receptors are 
similar between the sexes. Sex-differences were evident in the circulation as female mice 
showed reduced neutrophilia and monocytosis versus male counterparts, despite having 
similar mobilisation from bone marrow (BM) stores. The work further revealed that storage 
and trafficking of splenic leukocytes during acute inflammation is distinct between the sexes. 
Male mice have greater splenic stores of neutrophils, classical- and non-classical- monocytes, 
despite similar spleen sizes, signifying another source of potential pathogenic leukocytes. 
Furthermore, males but not females mobilise splenic classical monocytes in response to 
peritonitis. Conversely, neutrophils appear to traffic to the spleen in females, but not males, in 
this model. Whilst BM neutrophils from males displayed more TLR2 and TLR4 than females, no 
major differences under basal or inflamed conditions in TLR2 or TLR4 expression were evident 
on leukocyte subsets.  
This work demonstrates that males and females have distinct leukocyte trafficking profiles in 
acute inflammation, and suggests that the spleen, not the BM, plays a role in determining sex-
differences in the available pool of immune cells. Such dimorphisms demonstrate the 
importance of considering gender in assay development, drug design and clinical trials.  
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 General Introduction  Chapter 1:
 Inflammation 1.1.
Inflammation is an essential biological response to infection or injury. Abnormalities in this 
process, however, can be harmful and ultimately result in disease. An inflammatory aetiology 
can underlie both immune disorders, such as rheumatoid arthritis (RA), and non-immune 
diseases like stroke, and together can account for a huge proportion of human diseases 
worldwide. The financial repercussions place a huge burden on both health systems and the 
workforce and therefore the need for new, more efficacious therapies to target aberrant 
inflammation must be addressed.  
Manifested in the form of heat, pain, redness and swelling, inflammation represents the 
critical process the body adopts to restore homeostasis after infection or injury. Such changes 
are governed by inflammatory mediators released from activated leukocytes and endothelial 
cells (ECs) in response to the infection. Consequently, chemokine and cell adhesion molecules 
are upregulated, attracting circulating leukocytes towards the infected area and blood vessel 
wall, and aiding their migration into the inflamed tissue. These changes represent acute 
inflammation. It remains, however, a fine balance between eliminating the harmful pathogens 
or damaged tissue and causing harm to the host. If control over leukocyte influx or leukocyte 
effector functions is lost, the consequence can be chronic inflammation and damage to healthy 
tissues. 
 Leukocytes 1.2.
Leukocytes are pivotal to the inflammatory response. They are required for immune 
surveillance, immune suppression, and detection and clearance of damaged tissues or invading 
pathogens. An array of leukocyte subsets exists, each with specific functions essential for the 
restoration and maintenance of tissue homeostasis. 
 Macrophages 1.2.1.
First described by Ilya Mechnikov over 100 years ago, macrophages are resident cells found in 
all resting tissues at low levels (Tauber, 2003). Primarily the first sensors of pathogens or tissue 
damage, they are therefore considered inducers of the inflammatory response (Cailhier et al., 
Chapter 1 
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2005). Detection by macrophages causes intracellular signalling which results in the activation 
of the cell, release of pro-inflammatory cytokines such as interleukin 1 (IL-1) and tumour 
necrosis factor (TNF), and the phagocytosis of pathogens or tissue debris.  
Macrophages are thought to be derived from the differentiation of circulating monocytes that 
enter the tissue, and in doing so adopt either the ‘M1’ or ‘M2’ phenotype. M1 macrophages 
exhibit more ‘killer’ characteristics, being more pro-inflammatory, highly microbicidal, and 
promoting TH1-type responses (Geissmann et al., 2010). M2 macrophages on the other hand 
display ‘repair’ features and participate in wound healing, angiogenesis, resolution of 
inflammation, and more TH2-type responses (Martinez et al., 2009; Geissmann et al., 2010; 
Randolph, 2011). Recent studies have suggested that whilst M1 macrophages derive from 
circulating monocyte precursors, M2 macrophages result from local proliferation of 
macrophages in vivo (Jenkins et al., 2011). This topic remains controversial with other groups 
postulating monocyte-derived macrophages can shuttle between phenotypes depending on 
the cytokine environment, or arguing that terminally differentiated M1 or M2 macrophages 
derive from different subsets of circulating monocytes (Auffray et al., 2007). Macrophages 
abundantly produce pro-inflammatory cytokines, growth factors and pro-angiogenic factors 
and their persistent presence at high levels and continual activation can be detrimental in 
chronic diseases such as asthma, atherosclerosis and cancer.  
 Neutrophils 1.2.2.
Neutrophils arise from a common myeloid progenitor in the bone marrow (BM) and comprise 
between 40-75% of all leukocytes in mammals. There is a small but continual release into the 
circulation to retain the 10-25% present in murine blood under physiological conditions 
(Mestas et al., 2004). In humans, 50-70% of circulating leukocytes are neutrophils. Mature 
neutrophils are also referred to as polymorphonuclear cells (PMNs) due to the multi-lobed 
nature of the nucleus and in mice are identifiable by the expression of Ly6G (recognised by the 
Gr1 antibody). In the circulation, these cells are between 7-10µm in diameter, and are highly 
granular. The lifespan of a circulating neutrophil is debated but has been reported to be 
between 1.5 and 12h (Kolaczkowska et al., 2013). Numbers of circulating neutrophils are 
therefore regulated by rate of precursor proliferation, egress from the BM to the circulation, 
and clearance in the spleen, liver, and BM (Sadik et al., 2011).  
Neutrophils are innate immune cells recruited from the circulation to the tissue shortly after 
recognition of pathogens or tissue damage. They contain 3 main types of granules in the 
cellular cytoplasm that keep damaging or unstable molecules contained but ready for quick 
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release when required. Primary, secondary, and tertiary granules contain varying combinations 
of proteases and antimicrobial peptides to address the infection (Faurschou et al., 2003). As 
professional phagocytes, neutrophils rapidly ingest bacteria or cell debris, removing them from 
the body and thereby limiting further damage (Phillipson et al., 2011). The contents of the 
resulting phagosomes are degraded by reactive oxygen species (ROS) and enzymes using 
granule stores of NAPDH oxidase, and antibacterial proteins (e.g. cathepsins, defensins, 
lysozyme), respectively (Kolaczkowska et al., 2013). Antibacterial proteins can also be released 
from the cell, thereby promoting killing of bacteria residing in the tissue. Finally, highly 
activated neutrophils can also expel neutrophil extracellular traps (NETs), consisting of core 
DNA elements, histones, proteins, and enzymes, which immobilise pathogens to prevent 
spreading and aid digestion (Brinkmann et al., 2004). Despite the short half-life of circulating 
neutrophils, once activated and in the tissue during inflammation their lifespan extends, 
ensuring primed neutrophils are present at the infected site long enough to clear the pathogen 
and mount a sufficient inflammatory response. 
 Classical monocytes 1.2.3.
Monocytes originate in the BM from hematopoietic stem cells via a common monocyte-
macrophage-dendritic cell (DC) precursor (MDP) (Fogg et al., 2006). Development of mature 
monocytes is dependent on macrophage colony stimulating factor (M-CSF) (Cecchini et al., 
1994). Although traditionally considered a BM-specific process, it has recently been 
demonstrated that BM-derived hematopoietic stem and progenitor cells (HSPCs) can circulate 
and relocate to the splenic red pulp in a murine model of atherosclerosis (Robbins et al., 2012). 
Here, in a process termed ‘extramedullary haematopoiesis’, they proliferate and differentiate 
into classical monocytes in a manner dependent upon GM-CSF and IL-3. Peripheral 
proliferation of monocytes is not however believed to occur under resting conditions. 
In mice approximately 4% of peripheral blood leukocytes are monocytes (Doeing et al., 2003). 
In the blood these are mononuclear cells identifiable by a bean-shaped nucleus. Classical 
monocytes are defined by their expression of cell surface markers and as such are CD14++CD16- 
in humans and CD115+Ly6C+CCR2highCX3CR1
dim in mice (Figure 1.1A) (Ziegler-Heitbrock et al., 
2010). Of note, the Gr1 antibody that recognises both the Ly6G and Ly6C epitopes is often 
used to describe these monocytes as Gr1+. In response to infection or tissue damage, classical 
monocytes exhibit innate effector function, killing pathogens by phagocytosis, producing ROS 
and myeloperoxidase (MPO), and propagating the inflammatory response by cytokine 
production (Saha et al., 2011). The exact response however is dependent on the nature and 
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location of the inflammatory stimulus. Unlike neutrophils, monocytes do not store cytokines 
and so produce them de novo.  
Classical monocytes are recruited en masse to the site of infection or injury. They are able to 
produce high amounts of TNF, IL-1, ROS, and NO during infection and have been referred to as 
‘inflammatory’. Recruited classical monocytes later give rise to inflammatory DCs, or TNF/ 
iNOS-producing DCs (TipDCs) which upregulate MHC class II antigens, uptake antigen and 
migrate to the lymphoid organs (Geissmann et al., 2008; Shi et al., 2011a). Furthermore, they 
have the potential to differentiate into ‘classically-activated’, or ‘M1’, macrophages, associated 
with pro-inflammatory and TH1-type responses (Figure 1.2) (Geissmann et al., 2010). In 
addition to roles in propagating inflammation and repopulating tissues, classical monocytes 
provide a small contribution to myeloid-derived suppressor cells which promote the tumour 
microenvironment by suppressing T cell function and thereby preventing immune cell attack 
(Movahedi et al., 2008).   
 Non-classical monocytes 1.2.4.
Also called ‘resident’ due to their longer half-life, non-classical monocytes are defined as 
CD14+CD16++ in humans (Ziegler-Heitbrock, 2007) and CD115+Ly6C(Gr1)-CX3CR1
highLFA-1high in 
mice (Figure 1.1B) (Ingersoll et al., 2010). The development of these cells is however unclear 
with some suggestions they differentiate from the classical subset, upregulating CX3CR1 and 
downregulating Ly6C, whilst others suggest they develop within the BM independently of 
classical monocytes (Figure 1.2) (Geissmann et al., 2010).  Their function was originally 
Figure 1.1. Phenotype of monocyte subsets. Presence of cell surface markers to distinguish (A) 
classical monocytes and (B) non-classical monocytes.  
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considered one of resident macrophage and DC repopulation due to their presence in both 
inflamed and resting tissues (Geissmann et al., 2003). More recently however, the function of 
murine non-classical monocytes has been elucidated in immune surveillance. These monocytes 
exhibit ‘patrolling’ behaviour, undertaking long-range crawling along the luminal side of the 
endothelium under resting conditions (Auffray et al., 2007). Not only does this behaviour allow 
Figure 1.2. Development and fate of monocyte subsets. Hematopoietic stem cells give rise to 
monocyte-macrophage-DC precursors (MDPs) in the bone marrow. MDPs give rise to classical 
monocytes which are then able to differentiate into non-classical monocytes in the bone 
marrow. It is unclear if MDPs can directly give rise to non-classical monocytes. Mature 
monocytes can then enter the blood and under naïve conditions non-classical monocytes in 
the circulation patrol the endothelium. In inflamed conditions both classical and non-classical 
monocytes enter the tissue and differentiate, with classical monocytes giving rise to ‘M1’ 
inflammatory macrophages and TNF and iNOS-producing DCs (TipDCs), and non-classical 
monocytes giving rise to alternatively activated ‘M2’ macrophages.  
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detection of pathogens or tissue damage, or subsequently released cytokines, it is also 
suggestive of oxidized lipid and dead cell scavenging, although this has yet to be demonstrated 
in vivo (Auffray et al., 2009a). Non-classical monocytes differentiate into ‘alternatively 
activated’ or ‘M2’ macrophages, associated with TH2-type responses such as tissue 
remodelling, wound repair, and immunomodulation. In the myocardium after infarction, non-
classical monocytes are involved in collagen deposition, express growth factors indicative of 
angiogenesis and are thought to promote myofibroblast accumulation, all suggestive of their 
function in wound healing (Nahrendorf et al., 2007).  
 Lymphocytes 1.2.5.
Derived from the common lymphoid progenitor in the BM, T cells, B cells, and natural killer 
(NK) cells, are the three major types of lymphocyte. T cells, defined by the presence of the T 
cell receptor (TCR), have their name due to their maturation in the thymus (Alberts et al., 
2002). A highly heterogeneous leukocyte with diverse subtypes, T cells play a key role in cell-
mediated immunity with T helper (TH) cells involved in B cell maturation, differentiating into a 
number of subtypes including TH1, TH2, and TH17 cells. Cytotoxic T cells are also involved in 
cytokine and granule production that result in the killing of infected cells whilst regulatory T 
cells (Treg) have important immune suppressive functions. B cells are defined by the presence 
of a B cell receptor (BCR) and are primarily involved in the production of antibodies, otherwise 
called the humoral response (Alberts et al., 2002). Both cell types are components of the 
adaptive immune system and participate later in the inflammatory response. NK cells, named 
due to their response to stressed cells in the absence of opsonisation, are located in the BM, 
blood, lymphoid, and non-lymphoid tissues. After activation by interferons and macrophage-
derived cytokines, NK cells participate in immune responses to viral infections and tumours 
with both cytotoxic and cytokine-producing responses, thereby limiting spread and tissue 
damage (Vivier et al., 2008). The characterisations of these lymphocytes are, however, vastly 
oversimplified as the exact function and phenotype of lymphocytes is outside the scope of this 
thesis. 
 Inflammatory cell recruitment 1.3.
One of the key pro-inflammatory strategies the body adopts in response to infection or injury 
is the recruitment of circulating immune cells into tissues. Recognition of pathogens or 
damaged tissue by macrophages enables recruitment of neutrophils and monocytes from their 
sites of storage to the circulation and the tissue. This process involves a plethora of 
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inflammatory molecules operating in a highly regulated and sequential manor which together 
act to eliminate the infection, remove damaged tissue, and restore homeostasis.  
 Chemokines 1.3.1.
The process by which inflammatory cells are recruited to the tissue involves cellular activation 
and subsequent secretion of cytokines that provide a gradient for immune cells towards the 
site of infection. This gradient is achieved by specific chemotactic cytokines, or ‘chemokines’. 
Chemokines are distributed into families depending on the number and location of cysteine 
residues at the amino terminus: C, CC, CXC, and CX3C, whereby a succeeding ‘L’ indicates 
ligand, and ‘R’ indicated receptor (Luster, 1998). As a generalisation, CC-chemokines attract 
mononuclear cells, whilst CXC-chemokines attract granulocytes (Charo et al., 2006). Once 
released, chemokines bind to glycosaminoglycans on the luminal side of ECs, anchoring them 
in a gradient and preventing removal in the bloodstream or potential proteolytic cleavage 
(Mantovani et al., 2006). Chemokines are bound by chemokine receptors; G-protein coupled 
receptors (GPCRs) that are differentially expressed amongst leukocyte subsets. Binding allows 
activation of complex intracellular signalling events that trigger cellular activation, and thereby 
orchestration of the inflammatory response to recruit specific cell types to the site of infection 
at the correct time. 
 Neutrophil recruitment 1.3.2.
Neutrophils are considered the cells that extravasate most rapidly out of the circulation into 
the tissue. They respond from remote locations to a plethora of chemotactic agents, acting on 
only a handful of cell surface receptors (Table 1.1). Interestingly, neutrophils have been shown 
to traffic to the site of inflammation not by the shortest route through the tissue, but via the 
vasculature, ensuring a quick and close delivery (McDonald et al., 2010). Sentinel cell-derived 
inflammatory mediators such as IL-1β, TNF, LTB4, and C5a, activate nearby vascular ECs, 
inducing expression of adhesion molecules and vascular permeability, thereby promoting 
adhesion and transmigration of neutrophils, respectively (Soehnlein et al., 2010). Activated ECs 
can propagate the inflammatory signal, also producing pro-inflammatory mediators. 
Movement along the endothelium exposes neutrophils to increasing concentrations of 
chemokines acting on CXCR2, which in turn induces cell activation and migration. CXCR2 
ligands, including CXCL1 (Bozic et al., 1995), CXCL2 (Wuyts et al., 1998) and CXCL5 (Soehnlein 
et al., 2010), are highly important for neutrophil chemoattraction and activation. 
Neutralisation of CXCL1 and CXCL2 resulted in a 4-fold reduction in infiltrating neutrophils in a 
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peritonitis model (Wengner et al., 2008). The activities of CXCL1 and CXCL2 are increased by 
exposure to MMP-9 and MMP-8, respectively, released from activated neutrophil granules to 
elevate the inflammatory response. The actions of both chemokines are reportedly terminated 
by MMP12 cleavage, an important step in preventing excess cytokine storm and neutrophil 
influx (Soehnlein et al., 2010). CXCL8 is the human analogue to the murine CXCR2 ligands, 
acting via CXCR2 to induce the same potent neutrophil recruitment (Baggiolini et al., 1989). As 
with ECs, activation of neutrophils triggers adhesion molecule upregulation promoting 
stronger cell-to-cell contact.  
Table 1.1. Chemokines involved in murine neutrophil migration. 
 
Interestingly chemoattractants released from, or located at, intermediate sites such as the 
endothelium (i.e. CXCL2, LTB4), are reportedly overridden by more localised ‘end-target’ 
chemoattractants such as fMLP and C5a located close to the pathogen to which the 
neutrophils preferentially respond to (Kolaczkowska et al., 2013). It has also been proposed 
that in order for neutrophils to be fully activated, they must first be primed by cytokines such 
as TNF or IL-1β, or by contact with activated ECs, and then once in the tissue their activation 
heightens by exposure to bacteria or damaged tissues (Summers et al., 2010). Whether this is 
a method of rapidly recruiting close-by neutrophils, or a method for better homing precision is 
unknown. In addition to recruitment of already circulating neutrophils, chemokines also 
promote mobilisation of the BM store, another method to ensure a sufficient supply of 
circulating neutrophils (Martin et al., 2003a). Taken together, these mechanisms ensure arrival 
Chemokine 
Alternative 
Name 
Receptor Species Source Reference 
CXCL1 KC CXCR2 human, mouse macrophages (Bozic et al., 1995) 
CXCL2 MIP-2α CXCR2 human, mouse macrophages (Wuyts et al., 1998) 
CXCL5 ENA-78 CXCR2 human, mouse 
macrophages, 
eosinophils, 
epithelial cells 
(Soehnlein et al., 
2010) 
CXCL7 NAP-2 CXCR2 human, mouse platelets (Brandt et al., 1991) 
CXCL8 IL-8 CXCR1 human 
macrophages 
neutrophils 
(Baggiolini et al., 
1989) 
CXCL12 SDF-1 CXCR4 human, mouse 
stromal cells 
(BM) 
(Martin et al., 
2003a) 
Chapter 1 
 
29 
 
of neutrophils en masse to rapidly eliminate the bacteria or damaged tissue by phagocytosis, 
ROS, and protease production. It is worth noting however, many of the neutrophil functions 
can potentially also be detrimental to the host and thus have a potential causative role in 
disease (Sadik et al., 2011).   
 Monocyte recruitment 1.3.3.
Like neutrophils, monocytes respond to specific sets of chemokines that are sensed by 
receptors on their cell surface and as a result are recruited towards the site of inflammation. 
CCL2 is a key monocyte chemokine produced primarily by macrophages and ECs, which exerts 
its chemotactic effect via the CCR2 receptor highly expressed on the classical monocyte subset. 
CCL7 also acts on CCR2 to induce monocyte recruitment. The importance of CCR2 activation by 
CCL2 and CCL7 has been demonstrated in mice as knockout of either chemokine almost halves 
the number of monocytes recruited in response to bacteria (Jia et al., 2008). There are 
however, many other chemokines involved in the chemotaxis of monocytes from various 
stores during inflammation (Table 1.2). 
Infiltration of classical monocytes typically begins around the height of neutrophil 
accumulation at 3h and peaks at approximately 12h after bacterial infection (Auffray et al., 
2009a). Once recruited, classical monocytes participate in inflammatory ‘M1-type’ responses 
including phagocytosis, inflammatory cytokine release, and production of bacterial killing tools 
such as ROS and iNOS (Auffray et al., 2009a). Non-classical monocyte infiltration peaks later, 
approximately 18h post infection, and ‘M2-type’ responses including tissue remodelling and 
wound healing are employed (Auffray et al., 2009a).  
Classical monocyte recruitment is considered to be neutrophil-dependent. The extent of 
dependency on neutrophils is not however clear. Both during and after transmigration, 
activated neutrophils release a series of granules containing proteins able to stimulate 
subsequent classical monocyte influx (Soehnlein et al., 2010). Granule proteins such as 
azurocidin are released from secretory vesicles of transmigrating neutrophils and deposited on 
the endothelium. This interaction causes further activation of ECs, inducing expression of 
adhesion molecules vascular cell adhesion molecule 1 (VCAM-1) and E-selectin that aid 
monocyte activation and migration (Soehnlein et al., 2009b). Activated transmigrated 
neutrophils also shed their surface IL-6 receptor, forming a soluble sIL-6R that binds to IL-6 
present at the site of inflammation. The IL-6/sIL-6R complex is then able to interact with 
endothelial gp130 co-receptor resulting in enhanced CCL2 and adhesion molecule expression 
and further promotion of monocyte recruitment (Hurst et al., 2001). Such signalling also turns 
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off neutrophil recruitment due to the loss of the IL-6R and is therefore referred to as a ‘switch’ 
in leukocyte recruitment.  
Granule proteins act to induce and enhance chemokine release and potency. Proteinase 3, 
alongside its ability to produce antimicrobial peptides by cleavage, induces EC CCL2 production 
(Sugawara, 2005). Azurocidin on the other hand induces the production of monocyte-
expressing CCR1 ligand, CCL3 from monocytes and macrophages (Soehnlein et al., 2010). 
Interestingly, the other CCR1 ligands (CCL6, CCL9, CCL15, and CCL23) are also released by 
Chemokine 
Alternative 
Name 
Receptor Species Source Target 
CCL1 I-309 CCR8 
human, 
mouse 
T cells 
classical monocytes        
(Qu et al., 2004) 
CCL2 MCP-1 CCR2 
human, 
mouse 
macrophages, 
ECs, MSCs, 
CAR cells 
classical monocytes 
(Boring et al., 1997) 
CCL3 MIP-1α CCR1 CCR5 
human, 
mouse 
macrophages, 
ECs, 
monocytes 
classical monocytes 
(Soehnlein et al., 2010) 
CCL4 MIP-1β CCR1 
human, 
mouse 
neutrophils 
classical monocytes 
(Soehnlein et al., 2009a) 
CCL5 RANTES 
CCR1 CCR3 
CCR5 
human, 
mouse 
macrophages 
classical monocytes (Shi et 
al., 2011a), neutrophils 
(Soehnlein et al., 2010) 
CCL6 C10 CCR1 mouse 
macrophages 
neutrophils 
classical monocytes 
(Berahovich et al., 2005) 
CCL7 MCP-3 
CCR1 CCR2 
CCR3 
human, 
mouse 
macrophages 
classical monocytes     
(Tsou et al., 2007) 
CCL12 MCP-5 CCR2 mouse macrophages 
classical monocytes   
(Sarafi et al., 1997) 
CCL20 MIP-3A CCR6 
human, 
mouse 
macrophages 
neutrophils 
lymphocytes 
classical monocytes         
(Le Borgne et al., 2006) 
CX3CL1 fractalkine CX3CR1 
human, 
mouse 
ECs 
macrophages 
mainly non-classical, also 
classical monocytes 
(Ingersoll et al., 2011) 
Table 1.2. Chemokines involved in the migration of monocytes 
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macrophages but have only weak chemotactic capabilities. The action of neutrophil-derived 
serine proteases can however increase the potency of these CCR1 ligands by up to 1000-fold in 
vitro (Berahovich et al., 2005). Therefore, the release of specific granule contents by 
neutrophils has the potential to modulate the extent and strength of monocyte infiltration by 
proteolytic cleavage of certain chemokines (Soehnlein et al., 2009b). Furthermore, certain 
granule contents such as bactericidal/permeability-increasing protein (BPI) or heparin-binding 
protein (HBP) are capable of promoting vessel permeability, additionally aiding the 
extravasation of monocytes (Borregaard et al., 2007).  
The classical multistep paradigm of macrophage activation, neutrophil migration, and classical 
monocyte recruitment followed later by non-classical monocyte recruitment has however 
recently been challenged. Non-classical monocytes reportedly continually patrol the 
endothelium in a CX3CR1-dependent manner, rapidly extravasating within 1h in response to a 
range of inflammatory stimuli (Auffray et al., 2007). CX3CR1 expression differs between the 
monocyte subsets with non-classical monocytes CX3CR1
high (Geissmann et al., 2003). Its ligand, 
CX3CL1 is found in both soluble and membrane-anchored forms, contributing to potent non-
classical monocyte chemoattractive and adhesive abilities, respectively. Non-classical 
monocyte recruitment therefore precedes that of neutrophils in certain situations, suggesting 
both monocyte and macrophage activation is able to induce neutrophil recruitment.  
 Leukocyte adhesion cascade  1.3.4.
Additional factors besides chemokine gradients are required to recruit immune cells to the 
tissue. Leukocytes must cross the blood vessel wall, a process requiring induction of machinery 
to physically aid the extravasation process. In addition to leukocyte-targeted chemokines, 
activated tissue macrophages also release inflammatory mediators that activate and alter the 
phenotype of the endothelium. Mediators such as TNF and IL-1β induce such changes to aid 
leukocyte extravasation (Nourshargh et al., 2010). The exact mechanism by which 
inflammatory cells migrate from the circulation, through the endothelium, into the tissue is a 
well characterised phenomenon comprising 4 main stages: rolling, adhesion, crawling, and 
transmigration (Figure 1.3) (Ley et al., 2007). Collectively, these processes are termed the 
‘leukocyte adhesion cascade’. Circulating leukocytes are captured and begin rolling along the 
wall of the blood vessel by interaction of leukocyte L-selectin and activated endothelial E- and 
P-selectin, with the P-selectin glycoprotein ligand 1 (PSGL1) (Ley et al., 2007). As rolling slows, 
integrins take over, resulting in subsequent arrest and firm adhesion. This can occur via 
leukocyte lymphocyte function-associated antigen 1 (LFA-1, αLβ2 integrin) – endothelial 
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intracellular adhesion molecule 1 (ICAM-1) interaction in the case of neutrophils, or very late 
antigen 4 (VLA-4, α4β1 integrin) – VCAM-1 interaction in the case of monocytes and 
lymphocytes (Ley et al., 2007). Firmly adhered leukocytes begin intraluminal crawling, a 
process of membrane protrusion and filopodia formation that interact with activated 
adhesion-molecule expressing ECs, thus seeking permissive sites for transendothelial migration 
(TEM). Neutrophils use Mac-1 (αMβ2 integrin) expressing filopodia to crawl, interacting with 
endothelial ICAM-1 whilst lymphocytes use those expressing LFA-1 (Nourshargh et al., 2010). 
Luminal endothelial chemokines activate leukocytes, inducing conformational changes that 
allow adhesion, whilst chemotactic gradients along the endothelium provide direction for 
crawling and TEM. TEM, the final step in the adhesion cascade, involves additional adhesion 
molecules including platelet/endothelial cell adhesion molecule 1 (PECAM1), and junctional 
adhesion molecules (JAMs) (Nourshargh et al., 2010). TEM can occur either by the paracellular 
route (between ECs), or the transcellular route (through individual cells), allowing the 
subsequently extravasated leukocyte to contribute to the inflammatory response within the 
tissue (Kolaczkowska et al., 2013). 
Figure 1.3. The leukocyte adhesion cascade. In response to inflammatory stimuli, circulating 
leukocytes migrate into the tissue in response to released cytokines and chemokines. 
Leukocytes are first captured onto the endothelium, and begin rolling, a process mediated by 
selectins. Chemokines drive activation of rolling and leukocyte activation, which allows arrest 
and adhesion to the endothelium with subsequent crawling. The leukocyte finally 
transmigrates by either the transcellular or paracellular route. (Figure adapted from 
Nourshargh et al., 2010).  
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 Leukocyte recruitment in disease 1.3.5.
Leukocyte recruitment to the site of infection or injury is essential for clearance of the 
pathogen or damaged tissue and the subsequent restoration of tissue homeostasis. Immune 
cells involved in the response clearly have powerful functions that if not tightly regulated can 
be highly damaging to the host. Not only must the functions of these cells be controlled, the 
number recruited must be tightly regulated to ensure adequate clearance of the stimuli, thus 
maintaining control of the inflammatory response. Whilst the pathogenesis of many diseases is 
highly complex and not well characterised, there is increasing evidence that dysregulation of 
immune cell infiltration and response is in fact the underlying cause of many diseases. 
Understanding the exact context of dangers versus importance of leukocyte infiltration may 
provide potential new targets for treating inflammatory disorders. 
1.3.5.1. Reperfusion Injury 
Ischaemia reperfusion (I/R) injuries are an example of leukocyte recruitment being causative in 
tissue damage. Ischemic insult such as during myocardial infarction (MI), stroke, or organ 
transplantation is followed by the essential reperfusion phase, whereby the tissue is once 
again exposed to oxygen. Without oxygenation, tissue death would result. This restoration of 
blood flow however is accompanied by release of cytokines and chemokines, activation of the 
endothelium, upregulation of adhesion molecules, and accumulation of activated neutrophils 
(Eltzschig et al., 2011; Timmers et al., 2012). The presence of activated neutrophils 
consequently causes ROS generation and a subsequent imbalance of superoxide (O2
-•) and 
nitric oxide (NO). This imbalance promotes accumulation of highly toxic oxygen products such 
as peroxynitrite (OONO-), hydrogen peroxide (H2O2), and hypochlorus acid (HOCl) that have the 
ability to oxidise DNA, proteins and lipids, inevitably destroying the cell (Thannickal et al., 
2000). It is suggested that disruption of the cell membrane by oxidation may also result in 
more ROS and cytokine release, propagating the potential for tissue damage. Release of 
reperfusion-induced inflammatory mediators and activated leukocytes in the blood results in 
remote organ damage via the circulation, and is a serious problem after ischaemic insult 
potentially causing multi organ dysfunction (Carden et al., 2000). The key role for leukocyte 
infiltration accelerating disease progression has been demonstrated using neutrophil-
depletion protocols that effectively suppressed neutrophil recruitment, ROS generation, 
phagocytosis, and degranulation in rat myocardial I/R (Kohtani et al., 2002).  Further evidence 
for association of neutrophils with the injuries obtained during reperfusion is seen in kidney 
(Klausner et al., 1989), cerebral (Matsuo et al., 1995), liver (Jaeschke et al., 1990), and skeletal 
Chapter 1 
 
34 
 
muscle I/R injuries (Carden et al., 1990) where depletion of neutrophils has further proved 
suppressive. 
1.3.5.2. Atherosclerosis 
Unlike the acute nature of I/R injury, atherosclerosis is a chronic condition involving gradual 
lesion formation and thickening of the arterial wall as a consequence of immune cell and lipid 
infiltration. Comparable to I/R however, leukocyte recruitment underlies the pathology. 
Primarily monocyte-driven, these cells accumulate and differentiate into macrophages once in 
the vessel wall, appearing as fatty streaks. An atheroma develops when macrophages take up 
lipid droplets to become foam cells and the plaque matures. A smooth muscle cell and 
collagen matrix ‘fibrous cap’ covers a plethora of infiltrated immune cells (DCs, mast cells, T 
cells, monocytes), and a core of cholesterol and cell debris (Hansson et al., 2006). Lesions can 
grow so large as to limit the blood flow however the real danger arises when the plaque 
ruptures and a sudden thrombotic event is triggered, resulting in a blood clot, occlusion of the 
artery and often the formation of an unstable new atheroma. In the heart this causes MI, and 
in the brain, stroke. The importance of monocyte recruitment in atherosclerosis is 
demonstrated by the positive correlation of lesion size and numbers of circulating monocytes 
(Combadiere et al., 2008). Furthermore, combined deletion of key monocyte chemokines and 
receptors, CCL2, CX3CR1, and CCR5 limited numbers of circulating monocytes and markedly 
reduced lesion progression in atherosclerosis-prone mice.  
1.3.5.3. Sepsis 
Acute infection leads to the activation of sentinel cells, release of cytokines and chemokines 
and infiltration of immune cells in order to restore homeostasis of the tissue. In some cases 
the host response becomes dysregulated and cell, tissue, and organ damage can result. The 
clinical hallmark of sepsis is multi-organ failure, an indication the immune response has lost 
control, entered the bloodstream, and is injuring organs it reaches. The pathogenesis of sepsis 
is not clear, but in most cases is initiated from gram-negative bacterial infection of the lungs, 
abdomen, urinary tract or blood (Cohen, 2002). Activation of leukocytes and the endothelium 
by bacteria results in activation of complement, imbalance of coagulation pathways, and 
production of cytokines and subsequent oxygen and lipid intermediates. These cause a 
combination of vascular instability and occlusion that produce the classical signs of shock 
(fever, vasodilation, capillary leakage), and culminate in sepsis and multi organ failure (Angus 
et al., 2013). It is therefore clear that dysregulation of neutrophil and monocyte responses can 
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result in excessive respiratory burst, cytokine release, and promotion of further immune cell 
recruitment, however exactly how these responses become both aberrant and systemic to 
culminate in sepsis is considered a complex web of events that are not fully clear. 
I/R injuries, atherosclerosis, and sepsis are three diverse examples of inflammatory conditions 
where leukocyte infiltration and function no longer become helpful, but instead turn against 
the host. They are the result of lost regulation and therefore subsequent amplification of 
response. These examples only scratch the surface but demonstrate the importance of 
understanding mechanisms of leukocyte recruitment in the clearance of infection and 
damaged tissue, and the restoration of the surrounding environment homeostasis. 
 Bone marrow leukocyte mobilisation 1.4.
The BM is both a large storage pool for mature neutrophils, and the site of neutrophil 
production: in mice the neutrophil BM reserve is thought to be in the region of 1.2x108 cells 
(Furze et al., 2008). Cells are continually released into the circulation and upon inflammatory 
insult the BM reserve rapidly mobilises, amplifying neutrophil release. The molecular 
mechanism of sequestration and release is thought to be via cytokine and chemokine actions. 
Mature neutrophils are retained in the BM via the CXCL12/CXCR4 chemokine axis (Ma et al., 
1999; Furze et al., 2008). Low levels of CXCR4 on BM neutrophils are unlikely to support 
chemotaxis, however blockade of CXCR4 by small molecule antagonist AMD3100, or 
repopulation of irradiated WT mouse BM with CXCR4-/- cells, resulted in relocation of 
neutrophils from the BM to the circulation (Ma et al., 1999; Martin et al., 2003a). These 
observations, combined with high levels of CXCL12 in the resting BM, suggest CXCL12 functions 
via CXCR4 as a retention factor for the BM reserve neutrophils.  
Whilst CXCR4 blockade leads to the release of neutrophils from the BM, the mechanism by 
which this occurs is not passive and is reported to be via CXCR2. Chemokines CXCL1 and CXCL2 
are produced both remotely and locally and act on neutrophil CXCR2 to promote mobilisation 
(Eash et al., 2010). Thus whilst CXCL12/CXCR4 acts as a retention axis for BM neutrophils, the 
CXCL1-CXCL2/CXCR2 axis acts antagonistically to regulate neutrophil release (Figure 1.4). The 
CXCR4 axis is however dominant, thus granulocyte colony stimulating factor (G-CSF) also acts 
similarly to CXC chemokines and down regulates BM neutrophil CXCR4 and CXCL12 so that the 
CXCR2 axis can predominate (Semerad et al., 2002; Kim et al., 2006; Eash et al., 2010). 
Combined, the actions of CXCL1, CXCL2, and G-CSF disrupt the CXCL12/CXCR4 retention axis 
and facilitate neutrophil mobilisation. Whilst high CXCR4 is indicative of BM sequestration, and 
low expression is suggestive of mobilisation, it is worth noting that under homeostatic 
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conditions neutrophil CXCR2 is down regulated and CXCR4 is again upregulated in senescence 
representing an indicator for old circulating neutrophils to return back to the BM to die 
(Martin et al., 2003a; Rankin, 2010).  
The CXCL12/CXCR4 BM retention axis has also been described in the context of murine 
classical monocytes. As with neutrophils, BM classical monocytes reportedly express CXCR4 
(Wang et al., 2009). With the use of small molecule inhibitors, monocyte CXCR4 is shown to 
play a role in sequestration in the BM during CCR2 blockade, however the physiological 
relevance of such a mechanism is not clear. Mobilisation of classical monocytes on the other 
hand involves the CCL2-CCL7/CCR2 axis (Serbina et al., 2006; Wang et al., 2009). CCR2 null 
Figure 1.4. Changes in neutrophil chemokine receptors in inflammation. (A) Neutrophils are 
produced and stored in the bone marrow (BM) via the CXCL12-CXCR4 interaction. Mature BM 
neutrophils upregulate CXCR2 and are mobilised in response to CXCL1 and CXCL2 produced 
during inflammatory conditions. G-CSF also produced in inflammation aids this process by 
inhibiting the CXCL12/CXCR4 axis. (B) Neutrophils with high CXCR2 enter the circulation from 
the BM during inflammation. (C) Aging neutrophils downregulate CXCR2 and upregulate 
CXCR4. (D) High CXCR4 causes homing of senescent neutrophils back to the BM via a CXCL12 
chemotactic gradient.   
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mice display accumulation of monocytes in the BM, with fewer cells in the circulation and 
peripheral organs (Serbina et al., 2006). In response to bacteria, monocytes already present in 
the blood were able to traffic to the site of infection suggesting the importance of CCR2 in BM 
egress but not recruitment.  
Classical monocyte mobilisation under both homeostatic and inflammatory conditions is 
thought to be dependent on the constitutively produced CCR2 ligands CCL2 and CCL7, as mice 
deficient in either chemokine displayed elevated BM monocytes and reduced circulating 
monocytes, whilst pharmacological blockade of CCR2 led to elevated blood CCL2 and CCL7 
levels (Tsou et al., 2007; Wang et al., 2009). The mechanism of CCR2-dependent classical 
monocyte egress is reportedly governed by BM mesenchymal stem cells (MSCs) and their 
CXCL12-abundant reticular (CAR) cell progeny. These cells rapidly express CCL2 in response to 
circulating TLR ligands, inducing monocyte mobilisation into the bloodstream (Shi et al., 
2011b). CCR2 is clearly important for mobilisation, however CCL2 deficiency does not affect 
monocyte egress from the BM in a model of atherosclerosis suggesting that whilst CCR2 is of 
utmost importance, CCL2 action can be compensated for by other chemokines (Combadiere et 
al., 2008). The importance of CCR2 in classical monocyte egress for both homeostasis and 
inflammation is becoming clear; the mechanisms for the non-classical subset however are not 
so well documented. Whilst some groups refer to non-classical monocytes as CCR2-, others 
have demonstrated that although this is characteristic for human monocytes, mice indeed 
express low levels of CCR2 and are therefore considered CCR2low (Ingersoll et al., 2010). As a 
result, it would be fair to speculate that mobilisation of non-classical monocytes may also 
occur via the CCL2/CCR2 axis, however unlike the classical subset, non-classical monocytes are 
not reduced in the circulation of CCR2-/- mice (Qu et al., 2004), and the differing role of each 
subset suggests an alternative mechanism may be more likely.  
Monocyte subsets are also distinguished by expression of CX3CR1, with classical and non-
classical monocytes CX3CR1
low and CX3CR1
high, respectively. In the absence of CX3CR1, classical 
monocytes were reduced in the BM and accumulated in the circulation of mice exposed to 
chemotherapy agent cyclophosphamide (Jacquelin et al., 2013). This indicates CX3CR1 acts in 
an opposing manner to CCR2 to retain classical monocytes in the BM. More specifically, 
CX3CR1 reduces monocyte movement within the BM parenchyma, and adherence to the 
endothelium. In contrast, CX3CR1 deficiency did not affect mobilisation of BM monocytes after 
thioglycollate treatment, suggesting the CCL2/CCR2 axis is dominant over that of 
CX3CL1/CX3CR1 (Jacquelin et al., 2013). The role of CX3CR1 in the fate of BM CX3CR1
high non-
classical monocytes has not however been explored. Indeed, the very existence of BM non-
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classical monocytes is a disputed topic. Some believe only Ly6Chigh classical monocytes exist in 
the BM and once in the periphery differentiate in Ly6Clow non-classical monocytes 
(Sunderkotter et al., 2004). Whether MDPs directly give rise to either subset, or whether non-
classical Ly6Clow cells are precursors of classical Ly6Chigh cells is unclear. However generally 
accepted is that both subsets exist in the BM and exit to the circulation, with classical 
monocytes considered to shuttle back and forth from the BM to the circulation (Yona et al., 
2010).  
 Spleen leukocyte reservoir 1.5.
The spleen consists of white and red pulp, and functions as a filter of the blood, removing old 
erythrocytes, recycling iron, and metabolising haemoglobin of senescent cells (Mebius et al., 
2005). As a lymphoid organ, it also synthesises antibodies in the white pulp and disposes of 
antibody-coated pathogens or cells via the blood and lymphatic circulations. In mice, the 
spleen has a further role as a leukocyte reservoir holding half of the body’s monocytes within 
the red pulp, a store that far outnumbers circulating counterparts (Swirski et al., 2009). This 
splenic reservoir was shown to hold mature but undifferentiated monocytes indistinguishable 
and at the same subset ratio as those in the blood. The relative contribution of splenic 
leukocytes to disease is poorly characterised, however in response to myocardial ischemic 
injury in mice, monocytes reportedly exit the spleen, not the BM, and accumulate in the 
injured myocardium (Swirski et al., 2009). The spleen did not however contribute neutrophils 
to the extent of monocytes, leaving the BM as the primary site of mature neutrophil storage. 
This indicates a role for the spleen as another store of readily available inflammatory cells, and 
the same phenomenon has also been documented in human acute MI patients (van der Laan 
et al., 2014). In non-inflamed conditions, both monocyte subsets have been shown to 
accumulate in the spleen after adoptive transfer (Geissmann et al., 2003). Whilst the non-
classical subset also accumulated in the lung, circulation and liver, classical monocytes homed 
solely to the spleen, suggesting that while the non-classical cells are likely to be involved in 
tissue homeostasis, classical monocytes are awaiting deployment in response to infection.  
More recently the spleen has been shown to supplement the haematopoietic function of the 
BM by producing classical monocytes that are released into the circulation and intrude lesions 
in atherosclerosis-prone mice (Robbins et al., 2012). Interestingly, despite splenectomy not 
being lethal, it is reported to enhance both ischaemic heart disease and risk of infection, and 
human patients are required to be on lifelong antibiotics (Robinette et al., 1977). Considering 
the physical properties of the spleen, i.e. location, high vascularisation, and the plethora of 
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adhesive ligands suggestive of cell retention, these reports add increasing evidence towards 
the spleen as an ideal store of inflammatory cells (Mebius et al., 2005). Whilst it is known that 
B cells are retained in the follicles by CXCL13/CXCR5 interaction, and T cells to the T-cell zone 
by the CCL19-CCL21/CCR7 axis, the nature by which monocytes and neutrophils are arranged 
in the spleen is not well documented (Mebius et al., 2005). CX3CR1 is reportedly required for 
classical monocyte recruitment to the murine spleen after infection and irradiation: Evidence is 
provided by increased circulating classical monocytes and reduced spleen recruitment in 
CX3CR1-deficient mice after splenic L.monocytogenes infection compared to WT counterparts 
(Auffray et al., 2009b). Although its ligand CX3CL1 has indeed been identified in the spleen, a 
possible involvement of the CX3CL1/CX3CR1 axis in the naïve state has been refuted (Auffray et 
al., 2009b; Jacquelin et al., 2013).  
Although CCR2 has been implicated as important for monocyte mobilisation from the BM, its 
role in the spleen is not yet defined. After cardiac ischaemia monocytes were mobilised from 
the spleen to the circulation in WT and CCR2-/- mice despite a defect in accumulation of cells 
in the CCR2-/- myocardium (Swirski et al., 2009). This indicated a redundant role for the 
CCL2/CCR2 axis in splenic monocyte mobilisation. In contrast, angiotensin II (ang II), acting via 
the angiotensin type I receptor (AT-1) on monocytes is reported to control the egress of these 
cells from the spleen. Evidence for this is provided by the failure of AT-1 receptor null mice 
(Atrgr1a-/-) to both mobilise and recruit splenic monocytes in the ischaemia model, whilst 
naïve WT mice infused with ang II are able to promote egress from the spleen (Swirski et al., 
2009). The splenic reserve pool of monocytes are therefore mobilised during MI via an ang II-
dependent, CCR2-independent mechanism (Kintscher et al., 2001; Swirski et al., 2009; Shi et 
al., 2011a). The exact mechanism of ang II-mediated classical monocyte release is currently 
unknown however effects on the cytoskeletal arrangement and on vasoconstriction have been 
proposed. Whether ang II is pivotal to classical monocyte recruitment in other diseases or non-
sterile inflammatory models however is as yet unknown. Monocytes also express CCR1, CCR5, 
CCR6, CCR7, CCR8, and CXCR2 however any contribution of the chemokines acting via these 
receptors has yet to be described in the context of the spleen. 
Unlike the lung, liver, and BM, under physiological conditions the spleen was not thought to 
contain any neutrophils (Peters et al., 1985). Conversely, it is reported as a site of neutrophil 
clearance in addition the BM and liver, suggesting basal splenic neutrophils are indeed there to 
die (Furze et al., 2008). Under basal and inflammatory conditions the action of so-called splenic 
reticular endothelial macrophages clears these neutrophils (Mebius et al., 2005). The 
mechanisms of senescent neutrophil homing to the spleen are poorly characterised, however 
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it could be speculated that a CXCL12/CXCR4 axis may be exploited as it is required for homing 
to the BM. More recently, neutrophils have been identified for the first time in the marginal 
zone of the resting spleen, increasing the controversy over their presence or absence (Puga et 
al., 2012). The presence of so-called B cell-helper neutrophils in this area specifically enhanced 
production of B cell immunoglobulin production and class switching in inflammatory 
conditions, providing one of the first detailed demonstrations of the involvement of 
neutrophils in adaptive immunity. 
 Pattern Recognition 1.6.
Sections 1.6, 1.7 and 1.8 have also been published as a review (Kay et al., (2013) BioFactors vol. 
40, (3) 284-294).  
The complex series of events that culminate in the inflammatory response must first be 
initiated. Objects foreign or damaging to the body contain unique highly conserved sequences 
detectable by innate immune receptors, which alert the immune system to mount a rapid 
inflammatory response. Such sequences on invading pathogens are termed pathogen-
associated molecular patterns (PAMPs) and allow discrimination between self and non-self, 
harmful and non-harmful (Medzhitov et al., 2000). Tissue damage also requires the 
inflammatory response, and stressed, dying or injured cells expose self-patterns, termed 
damage-associated molecular patterns (DAMPs). The pattern recognition receptor (PRR) family 
function to detect PAMPs and DAMPs and instruct the immune system to respond accordingly. 
The concept of pattern recognition does not however account for the highly varied responses 
to the diverse number of stimuli, whilst remaining ‘self’-tolerant, and thus has been deemed 
overgeneralised by some. Alternative theories have therefore been proposed opposing the 
idea the immune system works to discriminate between ‘self’ and ‘non-self’, protecting the 
body from the ‘non-self’. The Danger Theory suggested the immune response was not 
orchestrated as classically thought, and instead is driven by the need to detect the difference 
between what is dangerous, such as tissue and cell damage, independent of how it arose, and 
what is not, consequently protecting the body against the danger. Controversially, as part of 
the danger theory, Matzinger proposed PRRs did not evolve to recognise pathogenic PAMPs, 
instead the pathogens evolved to activate PRRs (Medzhitov, 2009). Despite initial popularity, 
danger theory was not widely accepted as microbial cells can be detected whether they cause 
damage or not.    
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 Toll-like receptors 1.6.1.
1.6.1.1. Structure 
One family of PRRs termed Toll-like receptors (TLRs) function to recognise PAMPs and DAMPs. 
First identified as the human homologue to drosophila Toll, 10 human and 12 murine 
functional TLRs have since been discovered (Kawai et al., 2010). TLRs demonstrate stark 
similarities to the mammalian IL-1 pathway, both in terms of receptor structure and signalling. 
Both receptors consist of a single membrane-spanning glycoprotein, and a highly conserved 
region of around 200 amino acids in their C-terminal, termed the Toll/IL-1R (TIR) domain 
(Figure 1.5) (Akira et al., 2004). Markedly distinct from the three immunoglobulin-like domains 
the IL-1R family exhibits in its extracellular region, TLRs contain leucine-rich repeat (LRR) 
motifs, 19-25 in tandem. The LRRs have been described as forming a ‘horseshoe’ structure 
with speculation this surface forms the basis for ligand binding.  
The first mammalian family member to be discovered was TLR4, identified as the receptor for 
lipopolysaccharide (LPS), a component of Gram-negative bacterial outer membranes, however 
Figure 1.5. Structural homology of Toll-like receptors and the interleukin-1 receptor. (A) The 
IL-1 receptor (IL-1R) and (B) TLR families exhibit a conserved cytoplasmic domain termed the 
Toll/IL-1R (TIR) domain. The TIR domain contains highly homologous regions. Both receptors 
have a single membrane-spanning domain, however differ in their extracellular portion with 
TLRs containing leucine-rich region repeats (LRRs), compared to IL-1Rs that have three 
repeating immunoglobulin (Ig)-like domains. (Figure adapted from Akira et al., 2004). 
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subsequently each TLR has been described to recognise specific sets of PAMPs. The TLR family 
is divided into two groups based on subcellular localisation (Figure 1.6): TLR1, TLR2, TLR4, TLR5 
and TLR6 are cell surface receptors, principally focused on detecting bacterial PAMPs. 
Conversely, TLR3, TLR7, TLR8, TLR9 and murine TLR11 are located intracellularly in endosomal 
compartments, primarily sensing viral PAMPs and DNA, and uropathogenic bacteria in the case 
of TLR11 (Broz et al., 2013). TLR2 is considered the most promiscuous, recognising a range of 
patterns from peptidoglycan and lipoteichoic acid from Gram-positive bacteria, to lipoproteins 
and lipopeptides from various pathogens (Takeda et al., 2003). Certain TLRs also identify 
DAMPs. In addition to its role as the LPS receptor, TLR4 recognises a number of DAMPs 
including heat shock proteins (HSP60, HSP70), high-mobility group protein B1 (HMGB1), and 
components of the extracellular matrix such as hyaluronic acid, heparan sulphate, fibronectin, 
and tenascin-C (Takeda et al., 2003; Midwood et al., 2009; Bauer et al., 2013). TLR7, TLR8 and 
TLR9 detect RNA immune complexes, and chromatin and DNA complexes, respectively. TLR2 
and TLR4 together are the most widely characterised of the TLR family.  
Greater research into pattern recognition, particularly TLR4, found the PAMP-DAMP/receptor 
interaction to be oversimplified. Cells with TLR4 only were unresponsive to LPS, leading to the 
Figure 1.6. Subcellular localisation of Toll-like receptors. TLRs are located either at the cell 
surface, as is the case for TLR2, TLR4, TLR5, and TLR6, or intracellularly, for TLR3, TLR7, TLR8, 
TLR9. Intracellular TLRs reside in endosomes, where they detect both foreign and host-derived 
nucleic acids. Uniquely, TLR4 is found both at the cell surface and intracellularly. To function, 
TLRs dimerise which allows recruitment of adaptor proteins crucial for the TLR signalling 
pathways. (From Kay et al., 2013). 
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discovery of MD-2, a glycosylated soluble protein required to bind extracellularly to TLR4 and 
link receptor and ligand (Akira et al., 2006). LPS-binding protein (LBP) is also an important 
cofactor in ligand delivery to surface TLRs. By binding LPS, lipoteichoic acid, peptidoglycan and 
lipopeptides, amongst others, LBP transfers TLR ligands to CD14, another cofactor of several 
TLRs with the ability to bind multiple TLR ligands and enhance their activation of the receptor 
(Stewart et al., 2010). It is emerging that TLR signalling requires a plethora of accessory 
molecules which may prove important in the development of novel therapeutics that target 
initiation of innate immune signalling in inflammatory disorders.   
1.6.1.2. Signalling  
Despite existing at the plasma membrane as monomers, TLR dimerisation is required for 
signalling, and both homo- and hetero- dimerisations occur. TLR2 acts only as a heterodimer 
with either TLR1 or TLR6, whilst the remaining TLRs are traditionally considered to function as 
homodimers (Kawai et al., 2010). TLR4 has also been reported to form heterodimers with TLR6 
and as so act as a receptor for both oxidised low-density lipoproteins (oxLDL), and amyloid-β 
(Shimazu et al., 1999). More recently, TLR11 has been shown to dimerise with TLR12 for 
recognition of profilin (Broz et al., 2013). TLR ligation and dimerisation activates signalling 
cascades and subsequent production of pro-inflammatory cytokines, interferons, ROS, and 
proteases. Signalling is dependent on recruitment of adaptor proteins MyD88, MAL, TRIF or 
TRAM (Figure 1.7), differential recruitment of which is thought to confer some discrimination 
of the ligand (Lee et al., 2012). The MyD88-dependent pathway is required for all TLRs except 
TLR3, and signalling constitutes a serine kinase IL-1R-associated kinase (IRAK), TNFR-associated 
factor 6 (TRAF6), TGFβ-activated kinase 1 (TAK-1) sequence followed by activation of nuclear 
factor (NF)κB and activator protein 1 (AP-1) transcription factors via the IKK and MAPK 
pathways, respectively (Akira et al., 2006). Translocation of NFκB to the nucleus results in 
expression of proinflammatory cytokines such as TNF, IL-1β and IL-6. The MyD88-independent 
signalling pathway is activated with TLR3 ligation, and is also an alternative pathway for TLR7, 
TLR8, TLR9, in addition to endocytosed TLR4, with recruitment of TRIF and subsequent type II 
interferon (IFN) production via translocation of nuclear factors IRF3 and 7 to the nucleus.   
1.6.1.3. Expression: Immune cells, non-immune cells, vasculature, disease 
Immune Cells TLRs are widely accepted to be present on immune cells and vast numbers of 
studies report the presence of TLR message in leukocytes. Despite all TLRs being present on 
specific leukocyte subsets, most widely investigated are TLR2 and TLR4, therefore from 
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hereon, only these will be discussed. High TLR mRNA is present in human monocytes, 
particularly TLR2, followed by TLR4, whilst T cells, B cells, and NK cells have low mRNA levels 
(Muzio et al., 2000; Hornung et al., 2002; Zarember et al., 2002). Human neutrophils and mast 
cells also express TLR2 and TLR4 mRNA (Muzio et al., 2000; Supajatura et al., 2001). Human 
Figure 1.7. TLR signalling pathways. Ligation of TLRs leads to recruitment of adaptor proteins 
MAL and MyD88, or TRAM and TRIF. The MyD88-dependent pathway involves an IRAK- TRAF6- 
TAK-1 cascade with subsequent activation and translocation to the nucleus of NFκB via IKK, 
and AP-1 via MAPK pathways. Translocation results in inflammatory gene expression. MyD88-
independent/ TRIF-dependent signalling results in IRF-3 translocation to the nucleus via TBK1 
activation and type I interferon production. IRAK, IL-1R-associated kinase; TRAF, TNFR-
associated factor;  TAK1, TGFβ-activated kinase; IKK, inhibitor kB kinase; MAPK, mitogen active 
protein kinase; NFκB, nuclear factor kB; AP-1, activator protein 1; TRAM,  TRIF-related adaptor 
molecule; TRIF, TIR-domain-containing adaptor protein-inducing IFN-β; IRF, interferon 
regulatory factor. (Figure adapted from Akira et al., 2006). 
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blood DCs express various TLRs depending on the subset, however only myeloid DCs express 
TLR2 and TLR4 (Kadowaki et al., 2001). TLR protein has also been demonstrated on leukocytes 
by flow cytometry. Monocytes and macrophages are reported to express high levels of TLR2 
and TLR4 protein on their cell surface, compared to low levels on neutrophils, and no 
expression on eosinophils (Sabroe et al., 2002; Henning et al., 2008). A handful of studies 
confirm leukocyte TLR expression by immunofluorescence microscopy. Both flow cytometry 
and immunohistochemistry were used to show RAW264.7 macrophages express TLR4 (Jiang et 
al., 2005), whilst human alveolar macrophages were shown to express TLR4 by confocal 
microscopy (Thorley et al., 2011), and monocyte-like THP-1 cells express TLR2 also by 
immunofluorescence (Faure et al., 2000). Neutrophil TLRs have yet to be demonstrated by 
immunofluorescence, and unlike PCR and flow cytometry data, the extent of immune cell 
imaging of TLR2 and TLR4 is very limited. Moreover, despite the vast amount of literature into 
immune cell TLR expression, a comprehensive study into the expression of protein on 
leukocytes subsets has yet to be carried out. 
Non-Immune Cells In comparison to leukocytes, little is known about expression of TLRs on 
non-immune cells. TLR mRNA in healthy human tissues was comprehensively investigated in 
one study, demonstrating out of 15 different tissues all express at least one isoform, with the 
spleen expressing all 10 (Zarember et al., 2002). Other studies focus on a specific tissue or cell 
type, for example functional TLR4 is reportedly expressed intracellularly in the Golgi of the m-
ICc12 mouse epithelial cell line (Hornef et al., 2002). Similarly, human pulmonary epithelial cells 
exhibit intracellular, LPS-responsive TLR4, although LPS concentrations required for activation 
(i.e. inflammatory cytokine secretion) (0.1-1µg/ml) do not compare to phagocytic leukocytes 
(1-10ng/ml) (Guillot et al., 2004). TLR4 is also expressed on epithelial cells of the lung. Both 
mRNA and protein has been shown to be present in human alveolar (A549) and 
tracheobronchial (BEAS-2B and 16-HBE) epithelial cell lines. Alongside the aforementioned cell 
types, gastric epithelial cells, intestinal enteroendocrine cells, cystic fibrosis bronchial epithelial 
cells, tubular kidney cells, and lymphatic ECs have been shown to express TLR4 (Schmausser et 
al., 2004; Palazzo et al., 2007; Sawa et al., 2008; John et al., 2010; Chen et al., 2011). TLR2 is 
also reportedly expressed on non-immune cells including isolated small airway epithelial cells, 
astrocytes, hepatocytes and cultured keratinocytes (Mempel et al., 2003; Ritter et al., 2005; 
Visvanathan et al., 2007; Stridh et al., 2011). These lists suggest examples of the diverse 
localisation and the cell types that TLR2 and TLR4 protein have been identified in, however this 
is in no way comprehensive, and in many cases, highly disputed.     
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Vasculature There remains much debate as to the expression profile of TLRs in the 
vasculature. As yet, there is little evidence for TLR2 or TLR4 protein on ECs or associated 
vascular structures like pericytes or basement membrane. PCR and Western blot revealed no 
TLR4 was present in unstimulated human umbilical vein ECs (HUVECs) and human aortic ECs 
(HAECs), however both mRNA and protein were induced when treated with LPS (Wang et al., 
2011). Another study further shows TLR4 protein by immunoblotting in HAECs and human 
dermal microvascular ECs (Lu et al., 2012). A more comprehensive study reported TLR1-9 
mRNA expression in primary human vascular cells, showing TLR4 was expressed in HUVECs, 
HAECs, human coronary artery ECs (HCAECs) and human arterial smooth muscle cells 
(HASMCs), whilst TLR2 was only expressed in HCAECs (Erridge et al., 2008). Amongst the only 
studies to demonstrate TLR4 on ECs directly by fluorescence microscopy showed LPS-
responsive TLR4, but not TLR2, to be located intracellularly in HCAECs (Dunzendorfer et al., 
2004). Likewise, it has been shown by en face confocal microscopy of atherosclerosis-prone 
Ldlr-/- mouse aortas that TLR2 expression co-localised with ECs, specifically those in regions of 
disturbed blood flow (Mullick et al., 2008). This aligns with previous reports of reduced TLR2 
expression in ECs subjected to chronic laminar flow (Dunzendorfer et al., 2004).   
Functional data provides the majority of evidence for the expression of TLRs in the vasculature. 
Leukocyte transmigration was significantly reduced in TLR2-/- mice subjected to cremaster 
ischaemia-reperfusion injury. In addition, post-ischaemic vascular leakage was significantly 
attenuated in both the TLR2-/- and TLR4 mutant mice in the same model indicating a role for 
TLR2 and TLR4 in post-ischemic EC integrity, and for TLR2 in recruitment (Khandoga et al., 
2009). Despite this, adhesion, motility and polarisation of TLR2-/- and TLR4 mutant migrating 
leukocytes displayed no difference to wild-type mice. TLR4 has however been shown to be 
involved in maintaining endothelial function as TLR4-/- mice reportedly have reduced 
endothelium-dependent dilator responses in mesenteric resistance arteries, despite a normal 
appearance (Harrington et al., 2007). A major factor contributing to sepsis-related death is 
neutrophil accumulation in the lung leading to pulmonary failure. Using chimeric mice in a 
systemic LPS model of sepsis, it was shown that endothelium TLR4-/- mice show largely 
attenuated neutrophil sequestration in the lung compared that of leukocyte TLR4-/- mice, 
suggesting the importance of endothelial TLR4 (Andonegui et al., 2003). Evidence of TLR4 
expression in the endothelium further stems from in vitro studies of response to PAMPs and 
DAMPs, with cultured human lung microvascular ECs producing IL-8 on treatment with LPS 
(Gatheral et al., 2012), and cultured human pulmonary artery EC migration inhibited by 
HMGB1, however not when treated with siRNA to TLR4 (Bauer et al., 2013) 
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Therefore, despite mounting functional evidence for TLR2 and TLR4 expression in the 
vasculature, few groups have produced robust studies displaying the expression of TLR protein 
associated with vascular structures such as ECs or pericytes, and no studies show a detailed 
analysis of TLR expression and localisation in different kinds of blood vessels, information 
which would be highly beneficial when studying vascular diseases. 
Disease Many of the pathophysiological processes involved in cardiovascular, autoimmune, 
and other inflammatory conditions involve TLR activation, and there is increasing evidence for 
modulation of TLR expression in such diseases. Many TLR isoforms have been implicated in a 
wide variety of diseases however an extensive list of these is beyond the scope of this thesis 
(for a more detailed review see (Cook et al., 2004)), therefore focus will be kept to TLR2 and 
TLR4. Hypoxia is a characteristic of multiple cardiovascular diseases (CVD) such as MI and 
stroke, and is a known modulator of TLR expression. RAW264.7 macrophages upregulate TLR4 
message and protein in response to <1% O2, and this occurs via hypoxia-inducible factor 1 (HIF-
1) (Kim et al., 2010). In patients with acute MI, there are multiple reports of modulation of TLR 
expression, with one study showing leukocyte TLR4 mRNA and protein expression is increased 
versus healthy controls, and another exploring further to specifically show elevated monocyte 
TLR4 (Ishikawa et al., 2008; Kashiwagi et al., 2012). PBMCs from patients with both unstable 
and stable angina had higher TLR4 than those from healthy controls, whilst TLR2 was highest in 
those with unstable angina (Ashida et al., 2005). In patients undergoing cardiopulmonary 
bypass, blood monocyte TLR2 and TLR4 was significantly elevated at 20h post-surgery in 
comparison to pre-surgery (Hadley et al., 2007). Furthermore, both monocytes and neutrophils 
from patients with sepsis exhibited significantly more TLR2 and TLR4 than those from healthy 
controls (Härter et al., 2004). Contrary to the majority of studies detailing upregulation of TLRs 
in disease, patients with acute anterior uveitis, a common but dangerous intraocular 
inflammatory condition, had reduced monocyte and neutrophil TLR2 protein (Chang et al., 
2007). 
Much less is known however regarding regulation of TLR expression on non-immune cells. 
TLR2 and TLR4 are present in the tubules, loop of Henle and collecting ducts and expression is 
upregulated in all areas in a mouse model of renal I/R injury (Wolfs et al., 2002). Similarly, in a 
study of human kidney transplants, TLR4 expression was significantly higher on organs from 
deceased donors versus living donors. Elevated TLR4 correlated with increased TNF, CCL2, 
haem oxygenase 1, and lower rate of immediate graft function (Kruger et al., 2009). TLR2 
expression is also elevated on aortic ECs in areas of disturbed blood flow in Ldlr-/- 
atherosclerosis-prone mice fed a high fat diet versus chow (Mullick et al., 2008), however 
Chapter 1 
 
48 
 
whether human aorta exhibit such a phenotype is still unknown, likely due to difficulties in 
obtaining tissue samples. TLR2 and TLR4 have also been shown to traffic in response to LPS or 
peptidoglycan from the apical membrane to the cytoplasmic compartments of intestinal 
epithelium, indicating that TLRs can be regulated both in terms of expression and subcellular 
localisation (Cario et al., 2002).    
TLRs are also considered to play a role orchestrating the tumour microenvironment via 
regulation of both pro- and anti-tumorigenic agents. The inflammatory and hypoxic nature of 
the tumour microenvironment produces DAMPs that act both on immune cell and tumour cell 
TLRs to induce recruitment of immunosuppressive cells such as TRegs, TH17, and myeloid 
derived suppressor cells (for a detailed review see (Ridnour et al., 2013)). Multiple studies have 
both directly and indirectly linked alteration in TLR expression to tumour outcome. Directly, 
TLR4 was overexpressed on tumours from 67% of oesophageal, and 69% of pancreatic cancer 
patients (Ridnour et al., 2013), whilst TLR4 was also upregulated on tumour-infiltrating 
monocytes from patients. Similarly, knockdown of TLR2 reduced metastases in a mouse 
pulmonary tumour model (Yang et al., 2009). Downstream of receptor upregulation, 
consequent enhanced TLR signalling is reported to increase NOS2 and COX2 production with 
subsequent IL-10, TGFβ and VEGF that further promote tumour progression via suppression of 
immune cell action and consequently chemoresistance.   
 Leukocyte TLRs and the deleterious effects of inflammation 1.7.
Activation of TLR signalling, proinflammatory mediators and adhesion molecule upregulation, 
and subsequent infiltration of leukocytes into the tissue is essential for clearance of 
pathogens, however if this process becomes aberrant, damage to the host can result. Although 
TLRs are considered to be present on both immune and non-immune cells, several lines of 
evidence suggest leukocyte TLRs are the main contributor in the pathogenesis of vascular 
diseases. Atherosclerosis is one such disease, characterised by accumulation of lipids leading 
to thickening of the arterial wall, a process largely macrophage-mediated. Knockout of TLR4 
and to a lesser degree TLR2 was protective in early intimal foam cell accumulation and 
chemokine (CCL2) production in the aorta of ApoE-/- atherosclerosis-prone mice (Higashimori 
et al., 2011). In another model of atherosclerosis, Ldlr-/- mice on a high fat diet demonstrated 
reduced aortic lesions when also deficient in TLR2 (Mullick et al., 2005). Whether deletion of 
leukocyte or tissue TLR provided protection against atherosclerosis is unknown, however many 
would postulate leukocytes as the main culprits in pathogenic inflammation associated with 
such diseases. Indeed, a distinct TLR expression profile is observed in diseased human arteries, 
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fundamentally due to population of the tissue with TLR-expressing immune cells (i.e. DCs), 
providing additional fire for such inflammatory vascular conditions (Pryshchep et al., 2008). 
Ischaemia-reperfusion injury is a common problem with solid organ transplantation and is the 
major event in trauma, stroke, septic shock and MI (Arslan et al., 2010a). Ischemia deprives 
cells of oxygen, therefore exposes them to periods of hypoxia, causing accumulation of 
metabolic products. However, when blood flow is restored, the tissue is reperfused and a 
series of inflammatory events occur including complement deposition, adhesion molecule 
upregulation, and inflammatory cell accumulation. This can cause substantial damage to the 
vasculature and surrounding tissue, predominantly via proinflammatory cytokine, ROS, and 
chemokine release from infiltrated leukocytes. TLR2 and TLR4 are being increasingly linked to 
the detrimental inflammatory effects of these conditions, and their involvement has been 
reported in I/R injury in the kidney, liver, brain, heart, and intestine (Zhai et al., 2004; Arslan et 
al., 2010b; Hyakkoku et al., 2010; Rusai et al., 2010; Victoni et al., 2010). Beneficial effects of 
TLR-blocking antibodies prior to ischaemia provide further evidence to cement this theory. 
Whether TLRs are specifically involved in facilitating leukocyte transmigration any more so 
than simply sensing DAMPs and PAMPs and activating immune cells in not known. The process 
of leukocyte recruitment is significantly attenuated in TLR2 knockout mice subjected to I/R 
injury, but no effect on adhesion was observed (Khandoga et al., 2009). Decreased 
permeability was observed in both TLR2 and TLR4 knockouts, indicating a potential role in 
regulation of junctional molecules. This area of TLR function is little explored however a 
handful of studies investigate the link, for example showing TLR3 agonist poly(I:C), but not 
other TLR ligands, reduces JAM-A expression in nasal epithelial cells (Ohkuni et al., 2011), 
whilst TLR2 activation induces calcium-dependent proteases that cleave E-cadherin and 
occludin in airway epithelial cells (Chun et al., 2009). 
 TLRs as therapeutic targets 1.8.
Based on the fundamental role TLRs play in the innate immune response, plus evidence for 
modulation of their expression in disease, there have been numerous therapeutics designed to 
target these receptors. Much research is being carried out on TLRs as therapeutic targets, yet 
to date only one compound is in the clinic: Imiquimod is a TLR7 agonist used to treat 
papillomavirus infection (Hennessy et al., 2010). A large number of other compounds are 
however in clinical trials each targeting various members of the TLR family (for detailed list see 
review (Connolly et al., 2012)), however the majority target the intracellular TLRs and are 
indicated primarily for viral infections and as adjuvants and therefore will not be discussed in 
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this thesis. Few successful compounds have emerged targeting the surface TLRs. One such 
example is TLR4 antagonist Eritoran, a synthetic lipodisaccharide that has proved beneficial in 
animal models of inflammation. Mice treated with Eritoran were protected at least partially 
from lethal influenza challenge (Shirey et al., 2013), endotoxemia (Ehrentraut et al., 2011b) 
and cardiac hypertrophy after organ injury (Ehrentraut et al., 2011a). Eritoran blockade of TLR4 
improved the course of rat kidney I/R injury (Liu et al., 2010). Based on success in rodents, 
Eritoran also proved beneficial in Phase II trials, showing a trend in two trials of lower mortality 
in severely septic patients, and in a trial of patients with sepsis, shock or respiratory failure 
(Tidswell et al., 2010; Opal et al., 2013). Neither trial however showed significance in mortality 
rate or in any suppression of the cytokine storm and the compound has therefore been unable 
to progress through to phase III trials. Other TLR4-targetting therapeutics includes AV411, a 
TLR4 antagonist in Phase II trials for chronic pain and withdrawal, and NI0101, a TLR4 
antagonistic biologic in the preclinical phase indicated for acute and chronic inflammation 
(Connolly et al., 2012).        
Data from animal studies using anti-human/mouse TLR2 antibodies demonstrated the 
protection achieved from TLR2 blockade. OPN-301 treated mice have a functional graft and 
preserved renal function and structure in a model of renal transplantation I/R injury (Farrar et 
al., 2012). In addition, antagonising TLR2 with OPN-301 only 5 minutes before reperfusion 
decreases infarct size and preserves cardiac structure and function in a murine model of 
cardiac I/R injury (Arslan et al., 2010b). The cardiac protection obtained was attributed to 
reduced leukocyte infiltration, and therefore reduced associated cytokine production and 
proapoptotic signalling. This strong evidence linking TLR2 as detrimental in I/R injuries led to 
the development of a fully humanised monoclonal anti-TLR2 antibody, OPN-305, that blocks 
both TLR2/1 and TLR2/6 signalling. In a porcine myocardial I/R model, OPN-305 given during 
the period of ischemia reduced infarct size by up to 50% at the highest dose, and significantly 
preserved cardiac function (Arslan et al., 2012). Promising results from both rodent and 
porcine studies led to movement into Phase I trials that showed infusion of OPN-305 was well 
tolerated in healthy subjects with no adverse effects (Reilly et al., 2013). Phase II clinical trials 
are therefore due to commence imminently in renal transplant patients at high risk of delayed 
graft function. 
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 Sex-differences 1.9.
 Disease 1.9.1.
The prevalence of numerous autoimmune diseases (Sjogren’s syndrome, systemic lupus 
erythematosus (SLE), autoimmune thyroid diseases and scleroderma) is remarkably sex-biased 
with female patients accounting for over 80% of disease presentation (Whitacre, 2001). More 
common autoimmune diseases such as multiple sclerosis (MS) and RA exhibit a 3:1 female: 
male ratio. Despite sex-bias in disease incidence, the severity of human autoimmune 
conditions is considered similar between males and females (Lockshin, 2006). Conversely, 
innate immune conditions have higher incidence in aged-matched men. After trauma, male 
patients show higher frequency of pneumonia and multi organ failure (Kher et al., 2005). 
Males also demonstrate around 25% higher incidence of sepsis than females, however whilst 
men are more likely to gain bacterial infections, the mortality outcomes among sepsis patients 
are highly debated. In multiple studies including the largest cohort to date, mortality rates 
were not different between male and female sepsis patients (Angus et al., 2001; Martin et al., 
2003b; Berkowitz et al., 2007). Yet in other reports of severe septic shock, male patients had 
far greater rates of mortality after hospitalisation versus matched females (Schroder et al., 
1998; Adrie et al., 2007). It therefore continues to remain unclear whether sex underlies 
mortality outcome of sepsis patients. Sex is also shown to affect innate disease severity: of 
patients with severe sepsis, a lower risk of hospital mortality is observed in postmenopausal 
women than age-matched men (Adrie et al., 2007). Furthermore, male MI patients show poor 
life expectancy pre-hospitalisation but equal survival rates after 1 month suggesting women 
show early, but not late, protection (Kher et al., 2005).   
Premenopausal women are considered at less risk of CVD than aged-matched men. Women 
develop CVD 7-10 years later than males (Maas et al., 2010) and demonstrate better cardiac 
contractility and wall thickness compared to disease-matched men (Leinwand, 2003). 39% 
more males than females die from heart disease between the ages of 45-64 whilst after 65 
women outnumber men (Leinwand, 2003). Females continue to have a lower death rate due 
to CVD, coronary heart disease (CHD), stroke and heart failure when adjusted for age than 
males, and at the age of 40 have a 1 in 2 remaining lifetime risk versus 2 in 3 for males (Mosca 
et al., 2011). In 2007, the total age-adjusted CVD death rate was nearly 50% greater in males 
than females. Prevalence of atherosclerotic lesions and associated risk factors were moreover 
consistently lower in females independent of age, despite a rise post-menopause (Kroger et 
al., 1999). Sex-bias in CVD have frequently been attributed to variances in risk factors including 
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lower blood pressure, acute MI, hypercholesterolaemia and atherosclerosis, however it is also 
thought disease presentation may vary between males and females (Reckelhoff, 2001; Maas et 
al., 2010).  
The protection that women appear to demonstrate in the context of innate immune 
conditions is not constrained to sepsis and CVD, these purely provide examples and others are 
demonstrated in Table 1.3. In humans this protection is commonly contested, nevertheless the 
majority of studies are suggestive towards female protection in acute injury. Further 
investigation using animal studies is clearer, with female animals consistently demonstrating 
better outcomes than aged-matched males in inflammatory models (Kher et al., 2005). Male 
mice for example exhibit poorer survival rates after LPS induced sepsis as well as that induced 
by cecal ligation, puncture and trauma-haemorrhage (Marriott et al., 2006a). Clear differences 
in both the incidence and severance of human and animal immune disease therefore suggest 
an influence of inherent differences most likely stemming from both sex hormones and X 
chromosome genes. The effects of other factors such as the environmental, socio-economic 
status and race are also however likely to have a role in shaping the responses of males and 
females in inflammation.  
More prevalent in males  More prevalent in females                             
Coronary heart disease Sjogren syndrome  
Stroke SLE 
Sepsis Thyroid disease 
Trauma Dementia 
Heart failure Myasthenia gravis 
Atherosclerosis Rheumatoid arthritis 
Bacterial infection Multiple Sclerosis 
Table 1.3. Differences in disease prevalence in males and females. 
 Sex-differences in the inflammatory response 1.9.2.
Sexual dimorphism in the severity and incidence of diseases are likely to stem, at least in part, 
from inherent differences in the immune system and the inflammatory response. In humans, 
females have more CD4+ T cells (Amadori et al., 1995), and are shown to have more circulating 
IgM and IgG than aged-matched men although the latter is debated (Bouman et al., 2005). 
Similarly, in mice and rats more tissue-resident leukocytes, namely macrophages, T- and B-
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lymphocytes, are present in the peritoneal and pleural cavities of females (Scotland et al., 
2011). In addition to being more numerous, resident macrophages of the mouse female 
peritoneum exhibited higher surface TLR2 and TLR4, and had greater NADPH oxidase and 
phagocytosis activity when stimulated compared to male macrophages (Scotland et al., 2011). 
Male neutrophils have also been shown to express more TLR4 under basal conditions than 
female equivalents, a difference exaggerated during IFNγ stimulation (Aomatsu et al., 2013). 
Differences in PPRs have been linked both to oestrogen increasing- and testosterone reducing-
expression (D'Agostino et al., 1999; Scotland et al., 2011).  
In addition to inherent differences in the cellular make-up and phenotype of the immune 
system, sex-differences have also been described with respect to cytokines. In a study of X-
linked genes in healthy adults, males were found to have more monocytes and greater TNF 
production than females (Lefevre et al., 2012). Indeed, of genes present on the human X 
chromosome, over 60 have the potential to directly influence immunity including immune 
receptors, immune-response related proteins, and transcriptional and translational effectors 
(Fish, 2008). Female sepsis patients produced higher immunosuppressive IL-10 and lower pro-
inflammatory TNF levels than males (Schroder et al., 1998), whilst hearts from female rats had 
reduced expression of TNF, IL-1β, and IL-6 after acute I/R compared to males (Wang et al., 
2005). The translations of such observations were lower mortality and improved post-
ischaemic myocardial functions, respectively. Furthermore, despite no difference in severity of 
the condition, male trauma patients had higher plasma IL-1β than females following 
haemorrhage (Ertan et al., 2007). In vitro studies mimic such in vivo observations as post LPS 
challenge adult male peripheral immune cells produce higher levels of TNF whilst similarly 
treated male rat neutrophils produce more CXCL1 than matched females (Marriott et al., 
2006a; Aomatsu et al., 2013). Likewise, isolated macrophages from male mice are shown to 
produce more IL-1β and IL-6, and lower amounts of immunosuppressive prostaglandin E2 
following LPS challenge than those from females, further suggestive of reduced pro-
inflammatory responses coupled with stronger immunosuppressive responses in females 
(Kahlke et al., 2000; Marriott et al., 2006b; Marriott et al., 2006a). Reports of lower cytokines 
are however mixed as low dose LPS induced a greater proinflammatory response in the form 
of TNF and IFNγ in female versus male volunteers (van Eijk et al., 2007). Females were also 
shown to produce more neutrophil attracting IL-8 per cell, possibly explaining the higher 
neutrophil count in girls with acute inflammatory disorders.  
Sexual dimorphisms in the immune system do not end at initiation of the inflammatory 
response and production of cytokines, but continue to chemokine production and importantly, 
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leukocyte recruitment. In a model of hepatic I/R, female mice had rapid accumulation of serum 
CXCL1, CXCL2, and IL-6, with male responses generally peaking later, and being slightly greater 
in TNF production versus females (Crockett et al., 2006). In addition, male rats exhibited 
significantly more CC chemokines (CCL3, CCL5, CCL24 and CCL28), and more neutrophil 
accumulation than females during the development of abdominal aortic aneurysms (Hannawa 
et al., 2006). The presented examples of greater chemokine production in males is not always 
the case however, as macrophages produced equal levels of CCL2 upon stimulation with LPS, 
despite male derived cells producing more CXCL10 than those derived from females (Marriott 
et al., 2006b). It may be fair to speculate that sex-difference in cytokine and chemokine 
responses connect the earlier addressed topics of the role of aberrant leukocyte recruitment 
and sex-differences in disease. 
 Sex hormones  1.9.3.
Sex-hormones including progestins, androgens and oestrogens are capable of mediating many 
aspects of the immune response (Pennell et al., 2012). Oestrogens are primarily produced in 
the ovaries and exert their effects via activation of intracellular nuclear oestrogen receptors 
(ERs) ERα and ERβ (Garcia-Gomez et al., 2013). High expression of ERs in the female 
reproductive tract is indicative of their role in reproduction and development, however ERs are 
also expressed in immune cells, including neutrophils, DCs, macrophages, and lymphocytes, 
suggestive of a further role of sex hormones in regulation of the inflammatory response (Fish, 
2008). Although no comprehensive studies of sex-differences in leukocyte hormone receptor 
expression exist, ER expression in human granulocytes is reported to be the same in men and 
women (Wolf et al., 2012). In addition to higher CD4+ T cells numbers in females, effects of 
17β-oestradiol on leukocyte populations are exemplified with the increase in TReg cell number 
during the follicular phase of the menstrual cycle, the phase whereby oestrogen levels are 
highest (Arruvito et al., 2007). Alteration of TRegs consequentially effects the regulation of the 
peripheral T cell pool, immune response, and immune suppression. In addition to its effects on 
TRegs, 17β-oestradiol increases neutrophil anti-inflammatory nitric oxide (NO) production whilst 
reducing chemotactic activity, and reduces IL-1β, IL-6, IL-8 and TNF production by monocytes 
(Kramer et al., 2004; Pioli et al., 2007; Fish, 2008). Effects on other leukocyte populations 
include reduced NK cell cytotoxicity, decreased T cell CCL1 and CCL5 production, and increased 
differentiation and cytokine production from DCs (Fish, 2008). Adhesion molecules are also 
affected as 17β-oestradiol inhibits IL-1-mediated EC E-selectin and VCAM-1 induction (Caulin-
Glaser et al., 1996), and LPS-mediated ICAM-1 and VCAM-1 expression (Simoncini et al., 2000; 
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Thor et al., 2010). Such changes thereby influence activation of leukocytes and ECs themselves, 
in addition to numbers of circulating and recruited cells. For example, numbers of both 
monocytes and neutrophils in the circulation during different phases of the oestrous cycle are 
altered, suggestive of alterations in mobilisation and recruitment mechanisms (Pennell et al., 
2012).  
ERs have been described to influence the phenotype and activity of leukocytes, and variations 
in ER expression have been observed in SLE and RA patients (Pennell et al., 2012). The greater 
resistance to CVD in pre-menopausal women compared to men is commonly attributed to 
17β-oestradiol, the principle oestrogen during the female reproductive years. Challenging this 
hypothesis however, is the finding in one study that oestrogen replacement in 
postmenopausal women increased heart disease (Leinwand, 2003). Similarly, females are 
considered at lower risk of sepsis than males, yet experimental sepsis severity was found to be 
increased with 17β-oestradiol treatment (Rettew et al., 2009). Despite the association of 
oestrogen in the protection that females are considered to have in CVD and sepsis, 17β-
oestradiol reportedly enhances production of proinflammatory cytokines (IL-1, IL-6 and TNF) 
whilst inhibiting immune suppressive cytokines (IL-4, IL-10 and TGFβ) (Garcia-Gomez et al., 
2013). Furthermore, in an experimental autoimmune encephalomyelitis (EAE) mouse model of 
MS, treatment with either 17β-oestradiol or ERα ligands provided both anti-inflammatory and 
delayed EAE onset effects (Tiwari-Woodruff et al., 2007). Therefore although females are 
generally accepted to be more resistant to infection and CVD, and more prone to autoimmune 
diseases, it is unclear how exactly sex hormones play a role in this.  
Testosterone is part of the androgen family and is present at around 7 times greater levels in 
males than females. It is produced predominantly in the testes and acts via the androgen 
receptor (AR), another nuclear receptor with transcription factor properties similar to ERs 
(Garcia-Gomez et al., 2013). The role of testosterone, like oestrogens, is considered to extend 
beyond reproduction and development into immune regulation. Testosterone reportedly 
reduces TNF whilst increasing IL-10 synthesis in murine macrophages, shifting towards an anti-
inflammatory response (D'Agostino et al., 1999), whilst its metabolites have similarly been 
shown to decrease cytokine and immunoglobulin production by lymphocytes (Bouman et al., 
2005). Testosterone treatment also demonstrated potential protective effects in men with MS, 
in line with males being more protected in autoimmune conditions (Sicotte et al., 2007). ARs 
are expressed on lymphocytes but not macrophages, unlike ERs, suggesting a more dominant 
role in the adaptive rather than innate immune response (Marriott et al., 2006a). The 
numerous reports of the influence of 17β-oestradiol and testosterone on leukocyte responses 
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therefore demonstrate the important role sex hormones play, either directly or indirectly, on 
the inflammatory response. Klein fully reviews both agreeing and conflicting reports of the 
effects of sex hormones (Klein, 2004), nevertheless it is possible that libraries of contradictory 
results are the consequence of the diverse function and sites of action of oestrogens, which in 
addition alter with age and disease. 
Pattern recognition is also influenced by sex hormones as demonstrated by reduced murine 
macrophage TLR4 expression after endogenous oestrogen removal by ovariectomy (Rettew et 
al., 2008; Rettew et al., 2009). Removal of oestrogens also decreased levels of circulating PRR 
accessory molecules namely LBP levels, which was rescued alongside TLR4 after 17β-oestradiol 
administration (Rettew et al., 2009). Similarly, in response to LPS, male mice had increased LBP 
levels compared to females (Marriott et al., 2006b). In the same study, male-derived 
macrophages expressed greater levels of TLR4 both pre- and post-LPS stimulation compared to 
those derived from females. Conversely, testosterone is shown to reduce macrophage TLR4 
(Rettew et al., 2008). Expression of ERs on immune cells, influence on pattern recognition 
receptor expression, and regulation of EC adhesion molecules are all suggestive of a role for 
oestrogens in leukocyte recruitment in inflammation. Reports of sex hormones regulating the 
immune response are not however limited to oestrogens. The influences of progesterone, 
testosterone and prolactin have also been reported, however mainly with reference to T cell 
responses and adaptive immunity.  
 Anti-inflammatory treatment 1.9.4.
Sexual dimorphism is not constrained to the inflammatory response and disease. More 
recently, questions have been raised with regard to anti-inflammatory drug dynamics. Due to 
inherent difference between males and females including metabolism, body composition, 
cardiac output and tidal volume, both pharmacokinetic and pharmacodynamic differences 
exist in response to drug treatment (Soldin et al., 2011). Some indications however suggest 
there are sex differences over and above this, and specifically in responses anti-inflammatory 
treatments due to the described differences in the immune systems and inflammatory 
responses. For example, statins reduced the risk of mortality and stroke in males, however lack 
of efficacy in females meant no such protection was observed (Dale et al., 2007). Similarly, low 
dose aspirin reduced the risk of first MI in males but not in females, whilst contrastingly 
lowering the risk of stroke in females but not in males (Ridker et al., 2005). This evidence again 
highlights the distinct differences in the male and female response, something that is 
consistently overlooked both in basic research with male animals most commonly used, and in 
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drug development whereby females are vastly underrepresented in clinical trials. It is 
imperative that sex-differences are fully understood and properly considered in future 
approaches to targeting the immune system in the treatment of inflammatory diseases both in 
terms of drug development and study design. 
 Aims  1.10.
The incidence and severity of inflammatory conditions that are characterised by excessive 
leukocyte recruitment are more prominent in males. However at present little is known about 
the mechanisms behind this difference. It was hypothesised that male mice recruit more 
leukocytes to the site of inflammation due to sex-differences in the expression and regulation 
of leukocyte TLRs in acute inflammation. The overall aim of this study was therefore to 
comprehensively investigate leukocyte subset trafficking in male and female mice and evaluate 
a possible role for differential TLR expression and modulation in this dimorphism. Therefore, 
the specific aims were to: 
Characterise sex-differences in the numbers of murine leukocyte subsets and their TLR2 and 
TLR4 expression.  
Female mice are reported to have greater numbers of peritoneal and pleural resident 
macrophages. Furthermore, peritoneal macrophages were also higher in TLR2 and TLR4 
expression in female versus male mice. To date no study has characterised such sex-
differences further. Therefore, leukocyte subsets from various leukocyte-containing pools 
were compared in naïve male and female mice for dimorphisms in their number and TLR2 and 
TLR4 expression.    
Investigate sex-differences in leukocyte subset trafficking in the murine zymosan peritonitis 
model of acute inflammation. 
To elucidate the extent of differential inflammatory responses in males and females in vivo, 
trafficking responses of leukocyte subsets were investigated using the well-established murine 
zymosan peritonitis model of acute inflammation. Numbers of leukocyte subsets in the 
circulation, peritoneum, BM and spleen were investigated throughout the time course of the 
inflammation. 
Study the influence of inflammation on leukocyte TLR2 and TLR4 expression and examine 
the potential of temporal receptor modulation to influence differential leukocyte 
recruitment in male and female mice.   
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The expression of TLR2 and TLR4 are differentially expressed on male and female peritoneal 
macrophages and modulated in certain inflammatory diseases. In addition, therapies targeting 
both receptors are currently in clinical trials for treatment of inflammatory conditions. 
Whether sex-differences in the expression of TLR2 or TLR4 in inflammation influence 
dimorphic leukocyte recruitment responses is unclear, therefore a temporal expression profile 
of both receptors on the different leukocyte subsets in the zymosan peritonitis model of acute 
inflammation will be carried out. 
Using this experimental approach this project will also elucidate new information relating to 
sex-differences in the way in which leukocytes are stored and mobilised in males and females. 
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 Materials & Methods Chapter 2:
 Animals  2.1.
All animal procedures were subject to Queen Mary ethical approval (Animal Welfare Ethical 
Review Body) and carried out in agreement with the United Kingdom Home Office Animals 
Scientific Procedures Act 1986 under project licence 70/7884 and personal licence 70/24053. 
Both wild type (WT) and genetically modified strains used were on a C57BL/6 background. 
Mice were age-matched (8-12 weeks) and 22-30g (males) and 18-25g (females) in weight. 
Those from the same litter were equally distributed between experimental groups and male 
and females were treated at the same time. Mice were housed in individually ventilated cages 
with a controlled 12h light/dark cycle (lights on 0700-1900h), and constant temperature 
(21±2°C). Animals were killed humanely by cervical dislocation in accordance with Home Office 
regulations 
 Strains 2.1.1.
C57BL/6  Male and female WT C57BL/6 mice were purchased from Charles River 
Laboratories (Margate, UK) 
CX3CR1
+/gfp  Mice heterozygote for targeted replacement of the CX3CR1 fractalkine gene 
with cDNA encoding eGFP (CX3CR1
+/gfp) (Jung et al., 2000), resulting in the expression of eGFP 
in all monocytes, and certain natural killer and T cells, were used for certain peritonitis 
experiments. Mice were bred in house by crossing CX3CR1
gfp/gfp homozygotes with WT 
C57BL/6s resulting in heterozygote CX3CR1
+/gfp offspring. No differences in leukocyte 
transmigration have been shown in these heterozygotes as compared with WT (Jung et al., 
2000), and this was confirmed in this thesis also (Appendix 1). 
 Anaesthetics 2.1.2.
Ketamine 
Ketaset® solution, 100mg/ml, Cat #SH4401C, Fort Dodge Animal Health Ltd 
(Southampton, UK) 
Xylazine Rompun® 2% w/v, 20mg/ml, Cat #79769161, Bayer plc (Berkshire, UK) 
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In experiments where blood was taken, mice were anaesthetised by intramuscular (i.m.) 
injection of 1ml/kg anaesthetic (40mg/kg ketamine and 3mg/kg xylazine in saline) in order to 
preserve the integrity of the carotid vessels after Schedule 1 killing by cervical dislocation.  
 Reagents 2.2.
 Antibodies 2.2.1.
Primary antibodies:  
B220 
Rat monoclonal anti-mouse CD45R (B220) PE/Cy7, clone RA3-6B2, 
0.2mg/ml, used at 0.25µg/ml, BioLegend (San Diego, USA) 
C5aR 
Rat monoclonal anti-mouse C5aR (CD88) PE, clone 20/70, 0.2mg/ml, used at 
1.0µg/ml, BioLegend (San Diego, USA) 
CD3 
Rat monoclonal anti-mouse CD3 PerCP/Cy5.5, clone 17A2, 0.2mg/ml, used 
at 0.67µg/ml, BioLegend (San Diego, USA) 
CCR1 
Rat monoclonal anti-mouse CCR1 PE, clone 643854, 25µg/ml, used at 
1.0µg/ml, R&D Systems (Minneapolis, USA) 
CCR2 
Rat monoclonal anti-mouse/rat CCR2 PE, clone 475301, 25µg/ml, used at 
1.0µg/ml, R&D Systems (Minneapolis, USA) 
CCR3 
Rat monoclonal anti-mouse CCR3 (CD193) PE, clone J073E5, 0.2mg/ml, used 
at 0.5µg/ml, BioLegend (San Diego, USA) 
CCR5 
Hamster monoclonal anti-mouse CD195 PE, clone HM-CCR5, 0.2mg/ml, 
used at 1.0µg/ml, BioLegend (San Diego, USA) 
CD115 
Rat monoclonal anti-mouse CD115 (CSF-1R) PE, clone AFS98, 0.2mg/ml, 
used at 0.67µg/ml, eBioscience (Hatfield, UK) 
CXCR2 
Rat monoclonal anti-mouse CXCR2 (CD182) Alexa Fluor® 647, clone TG11, 
0.5mg/ml, used at 1.0µg/ml, BioLegend (San Diego, USA) 
CXCR4 
Rat monoclonal anti-mouse CXCR4 (Fusin/CD184) PerCP-eFluor®710, clone 
2B11, 0.2mg/ml, used at 1.0µg/ml, eBioscience (Hatfield, UK) 
Dectin1 
Rat monoclonal anti-mouse Dectin-1 PerCP-eFluor®710, clone bg1fpj, 
0.2mg/ml, 2.0µg/ml, eBioscience (Hatfield, UK) 
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Fc Block™ 
Purified monoclonal rat anti-mouse CD16/CD32 (FcγIII/II receptor), clone 
2.4G2, 0.5mg/ml, used at 5µg/ml, BD Pharmingen (Oxford, UK) 
F4/80 
Rat monoclonal anti-mouse F4/80 PE/Cy7, Alexa Fluor® 700 or PE, clone 
BM8, 0.2mg/ml, used at 0.67µg/ml, eBioscience (Hatfield, UK) 
Gr1 
Rat monoclonal anti-mouse Ly-6G/Ly-6C (Gr1) Alexa Fluor® 647, clone RB6-
8C5, 0.2mg/ml, used at 0.1µg/ml, BioLegend (San Diego, USA) 
TLR2 
Mouse monoclonal anti-human/mouse TLR2 PE, clone T2.5, 0.2mg/ml. 
Selected for study, used at 1µg/ml, BioLegend (San Diego, USA) 
TLR2 
Rat monoclonal anti-mouse TLR2 PE, clone 6C2, 0.2mg/ml, eBioscience 
(Hatfield, UK) 
TLR4 
Rat monoclonal anti-mouse TLR4/MD2 PE, clone MTS510, 0.2mg/ml. 
Selected for study, used at 1.0µg/ml, eBioscience (Hatfield, UK) 
TLR4 
Rat monoclonal anti-mouse TLR4 PE, clone UT41, 0.2mg/ml, eBioscience 
(Hatfield, UK) 
TLR6 
Rat monoclonal anti-mouse TLR6 PE, clone 4186-1, 25µg/ml, used at 
0.5µg/ml, R&D Systems (Minneapolis, USA) 
Isotype controls: 
Hamster IgG 
Armenian hamster immunoglobulin IgG PE isotype control antibody, clone 
HTK888, 0.2mg/ml, BioLegend (San Diego, USA)  
Mouse IgG1 
Mouse immunoglobulin IgG1, κ PE isotype control antibody, clone MOPC-
21, 0.2mg/ml, BioLegend (San Diego, USA) 
Rat IgG2a 
Rat immunoglobulin IgG2a, κ PE or PerCP-eFluor®710 isotype control 
antibody, 0.2mg/ml, clone eBR2a, eBioscience (Hatfield, UK) 
Rat IgG2b 
Rat immunoglobulin IgG2b, κ PE isotype control antibody, clone 
eB149/10H5, 0.2mg/ml, eBioscience (Hatfield, UK) 
 Fluorescent cell markers 2.2.2.
7-AAD 7-aminoactinomycin D, 5mg/ml, Cat#A9400, Sigma (St Louis, USA) 
DAPI 4’,6-diamidino-2-phenylindole dihydrochloride, 1mg, Cat #D9542, Sigma (St 
Louis, USA) 
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 Inflammatory stimuli, cytokines, chemoattractants 2.2.3.
Zymosan 
Zymosan A from Saccharomyces cerevisiae, Cat #Z4250, lot #BCBF4506V used 
at 1mg, Sigma (St Louis, USA) 
 Kits 2.2.4.
Proteome Profiler™ Mouse 
Chemokine Array 
Cat ARY020, R&D Systems (Minneapolis, USA) 
Proteome Profiler™ Mouse 
Cytokine Array 
Panel A, Cat ARY006, R&D Systems (Minneapolis, USA) 
BCA™ Protein Assay Kit Cat #23227, Thermo Scientific (Rockford, USA) 
 Buffers 2.2.5.
ACK lysis buffer  150mM NH4Cl, 10mM KHCO3, 0.1mM EDTA, pH 7.3 in H2O  
FACS buffer PBS supplemented with 1% heat-inactivated goat’s serum 
Lavage buffer PBS with 0.25% BSA and 2mM EDTA 
Spleen lysis buffer 
PBS with 1% triton X-100 and 1% protease and phosphate 
inhibitor cocktail 
 Other reagents 2.2.6.
Bovine serum albumin 
(BSA) 
Cohn fraction V, 95% standard powder pH7.0, Cat #BPE9701, 
Fisher Scientific (Leicestershire, UK) 
BD™ CompBeads 
Anti-Rat Ig, κ / Negative control compensation particles set, 
Cat #552844, BD Biosciences (San Diego, USA) 
EDTA 
Ethylenediaminetetraaceticacid disodium salt dehydrate, Cat 
#E5134, Sigma (St Louis, USA) 
Halt™ protease inhibitor 
cocktail 
Halt protease and phosphatase inhibitor cocktail (100X), Cat 
#78440 (Thermo Scientific, Rockford, USA) 
Normal goat serum (NGS) Goat serum, Cat #G6767, Sigma (St Louis, USA) 
Phosphate buffered saline 
(PBS) 
Dulbecco A tablets, 1 tablet dissolved in 100ml distilled water 
pH7.2, Cat #BR0014G, Oxoid (Hampshire, UK) 
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Saline 
Sodium chloride 0.9%w/v pH5.5, Cat #FKE1323, Baxter 
healthcare (Norfolk, UK) 
Triton™ X-100 Laboratory grade, Cat #X100, Sigma (St Louis, USA) 
Trypan blue 0.4% trypan blue solution, Cat #T8154, Sigma (St Louis, USA) 
 
 Characterisation of male and female leukocyte subset numbers and 2.3.
TLR expression 
 Leukocyte isolation 2.3.1.
Leukocytes were isolated from various compartments of male and female mice post-schedule 
1 killing by cervical dislocation. Circulating cells were obtained by cardiac puncture using a 27 
gauge needle and 1ml syringe filled with 50µl 0.5M EDTA. 0.5-1ml of blood was obtained per 
mouse. Peritoneal cells were collected by lavage of the peritoneum with 6ml PBS 
supplemented with 0.25% BSA and 2mM EDTA (lavage buffer) injected with a 27 gauge needle, 
followed by 10 seconds shaking of the mouse by its tail and subsequent withdrawal of lavage 
fluid with a 19 gauge needle and 6ml syringe. At least 5.8ml was recovered per mouse. Splenic 
leukocytes were obtained by organ dissection followed by mechanical dissociation in PBS with 
1% goat’s serum (FACS-buffer) with the end of a 5ml syringe, through a 40µm cell strainer to 
obtain a single cell suspension. Bone marrow cells were isolated from the right femur by 
flushing with 4ml cold FACS-buffer. Cells were passed through a 40µm cell strainer for a single-
cell suspension. Blood and spleen samples were centrifuged at 300g for 5mins at 4°C, serum 
supernatant discarded, and erythrocytes were removed by incubation (7min, room 
temperature) with ACK lysis buffer (150mM NH4Cl, 10mM KHCO3, 0.1mM EDTA, pH 7.3). All 
samples were then washed twice by centrifugation (300g, 5mins, 4°C) with resuspension in 
FACS-buffer. 
 Determination of cell numbers 2.3.2.
Total leukocytes were stained with 0.4% trypan blue (Sigma) included for live/dead cell 
discrimination (1:1 ratio) and counted using a Neubauer haemocytometer (Optik Labor, 
Germany). 10µl of mixed cell suspension was loaded onto the haemocytometer and cells 
counted under a light microscope (Olympus BH2-RFCA, 20X lens). Dead cells appear blue due 
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to uptake of dye and were excluded. Leukocyte number was calculated by inclusion of trypan 
blue dilution, pre-dilutions made of counting, and haemocytometer adjustment factor: 
Leukocyte number/ml = No. cells counted x 2 (x pre-dilution) x 104 
Blood leukocyte number was expressed at cells/ml of blood (as determined by measuring 
volume of blood obtained), and peritoneal cavity, spleen, and BM number was expressed as 
total cells. Leukocytes were adjusted to a concentration of 1x106 cells/ml in FACS-buffer. 
 Immunofluorescence labelling of leukocytes 2.3.3.
1x105 cells were incubated with 0.5µg FcγIII/II receptor blocking antibody (Fc-block™) for 
20mins at 4°C to prevent unspecific Fc-receptor binding, followed by addition of fluorescently-
labelled primary antibody cocktail containing Gr1, B220, CD3, CD115 and F4/80 combinations 
to label leukocyte subsets. Antibodies to TLR2, TLR4, TLR6, dectin-1, CXCR2, CXCR4, CCR1, 
CCR2, CCR3, CCR5, C5aR or isotype control antibodies were also included in certain studies. 
Samples were incubated for 30mins in the dark at 4°C with the antibody cocktail. 
 Flow cytometry 2.3.4.
Antibody-labelled cells were washed twice with FACS-buffer by centrifugation at 300g for 
5mins at 4°C and resuspend in 200µl cold FACS-buffer to achieve a single cell suspension. 
Samples were run on LSRFortessa flow cytometer (BD) using FACSDiva software. Samples were 
compensated for multi-colour fluorescence overlap using either single-stained cells or 
CompBeads. At least 20,000 events were acquired per sample. Periodically a live/dead cell 
marker (1µg/ml DAPI or 1.25µg/ml 7-ADD) was added just before data acquisition to check the 
protocol had not resulted in decreased viability.  
 Identification of leukocyte subsets  2.3.5.
Data was analysed using FlowJo version 7.6.4 (Treestar) and leukocytes were identified from 
the sample data by forward scatter (FSC) and side scatter (SSC) profile (Figure 2.1A). 
Neutrophils were identified as Ly6G(Gr1)high cells (Figure 2.1B), and monocytes by the 
expression of CX3CR1 and subdivided as CX3CR1
lowGr1med cells (classical monocytes) and 
CX3CR1
highGr1- cells (non-classical monocytes) (Figure 2.1B). CX3CR1
+ cells were confirmed as 
monocytes by CD115 expression (Figure 2.2).  
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Figure 2.1. Leukocyte subset gating strategies. Leukocytes were isolated from murine blood, 
bone marrow, spleen and peritoneal cavity and subsets were analysed by flow cytometry. (A) 
Total leukocytes were first gated based on FSC/SSC profile. (B) After selection on the leukocyte 
gate, neutrophils were classified as Gr1high, classical monocytes as CX3CR1
lowGr1+, and non-
classical monocytes as CX3CR1
highGr1-. CX3CR1
-Gr1- population was selected with subsequent 
gating on (C) B220+ B cell and (D) CD3+ T cell populations. (E) Peritoneal lavage samples were 
also stained for macrophages (F4/80+ cells). 
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Figure 2.2. Confirmation of CX3CR1-GFP
+ cells as CD115+ monocytes. (A) Classical- and non-
classical monocytes were defined as CX3CR1
lowGr1+ and CX3CR1
highGr1- respectively. (B) Both 
CX3CR1
+ populations were confirmed as monocytes by expression of CD115. 
CX3CR1
-Gr1- populations (Figure 2.1B) were gated and subsequent B220+ populations identified 
as B cells (Figure 2.1C), and CD3+ populations as T cells (Figure 2.1D). Macrophages were 
identified as F4/80high (Figure 2.1E). Populations were checked for the negative expression of 
the other markers (Table 2.1). All subsets were also back-gated and FSC/SSC profiles compared 
with that of single stained cells.  
 Calculation of leukocyte subset numbers  2.3.6.
Percentage of leukocyte subsets was calculated using acquired flow cytometry data as:   
Subset % = No. events positive for subset marker/ No. events in leukocyte gate 
Numbers of leukocyte subsets were expressed x104 for peritoneal, spleen and BM cells, and 
x104/ml for blood cells and calculated using percentage of events and total cells counted on 
the haemocytometer:  
Subset no.(x104) = (No. total cells/ subset %) x104 
Leukocyte Subset Positive Markers Negative Markers 
Neutrophils Gr1high CX3CR1
-B220-CD3- 
Classical monocytes CX3CR1
lowGr1medCD115+ B220-CD3- 
Non-classical monocytes CX3CR1
highGr1-CD115+ B220-CD3- 
B cells B220+ Gr1-CX3CR1
-CD3- 
T cells CD3+ Gr1-CX3CR1
-B220- 
Macrophages F4/80+ Gr1-CX3CR1
-B220-CD3- 
Table 2.1. Identification of leukocyte subsets by the expression cell-specific markers. 
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 Determination of cell surface receptor expression on leukocyte subsets 2.3.7.
Cell surface TLR2 (Figure 2.3), TLR4, TLR6 and dectin-1 on specific leukocyte subsets were 
determined by flow cytometry. Expression was calculated as a ratio of test antibody median 
fluorescence intensity (MFI) versus that of an isotype control antibody (mouse IgG1 (TLR2), rat 
IgG2a (all others)) to achieve the relative fluorescence intensity (RFI). Cell surface CXCR2, 
CXCR4, CCR1, CCR2, CCR3, CCR5 and C5aR were also determined by flow cytometry and 
expressed as MFI. Where MFI was used, samples were run on the same cytometer, on the 
same day, with the same cytometer settings for the most accurate comparisons. 
Figure 2.3. Representative flow cytometry plots showing expression of TLR2 on leukocyte 
subsets. Subsets were identified based on cell markers and the expression of TLR2 was 
assessed on gated populations of (A) neutrophils, (B) classical monocytes, (C) non-classical 
monocytes, (D) B cells, (E) T cells and (F) macrophages (shown as insets). TLR2 expression was 
calculated as a ratio of the medium fluorescence intensity (MFI) of anti-TLR2 antibody 
(coloured histograms) versus that of an isotype control antibody (grey filled histograms). 
Results were expressed as relative fluorescence intensity (RFI). This method was also applied 
to TLR4, TLR6, dectin-1 and CXCR4 expression.  
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 Preparation of zymosan 2.3.8.
Zymosan A (lot #BCBF4506V, Sigma) was prepared by transferring 250mg of zymosan powder 
into 50ml of sterile PBS. The mixture was heated and stirred for 30mins until boiling and 
allowed to cool for 1-2hrs, keeping covered. After cooling, the mixture was divided into 5x 
10ml aliquots on ice and centrifuged at 300g for 10min at 4°C. Supernatants were removed 
and zymosan was washed with 5ml sterile PBS on ice. Centrifuge and washing was repeated 3 
times. The mixture was then divided into 2 tubes of 12.5ml that were again centrifuged (300g, 
10mins, 4°C) and washed 3 times with 5ml sterile PBS. The remaining tube contained 250mg of 
zymosan in 5ml PBS. Aliquots of 10mg of zymosan were obtained by aliquoting 200µl of 
mixture into eppendorf tubes. Aliquots were centrifuged at 1000g for 5mins, supernatants 
removed, and dry pellets were stored at -20°C until use.     
 Induction of peritonitis 2.3.9.
10mg zymosan aliquots (as prepared in 2.3.8) were resuspended in 5ml sterile PBS to achieve a 
2mg/ml concentration. Resuspended zymosan was sonicated for 30s and vortexed as 
previously described (Navarro-Xavier et al., 2010). Peritonitis was induced by injecting 1mg 
zymosan intraperitoneally (i.p.) in 0.5ml sterile PBS.  
 Characterisation of male and female peritoneal cytokine and 2.4.
chemokine environment in naïve and inflamed conditions 
 Preparation of peritoneal and spleen samples for cytokine array 2.4.1.
Lavage of the peritoneal cavity of naïve, 1h- or 3h-zymosan treated mice was carried out as 
described in section 2.3.1, after schedule 1 killing. Samples were centrifuged at 300g for 5mins 
at 4°C and the lavage fluid supernatant harvested and stored at -80°C until analysis. Cell pellets 
were resuspended in FACS-buffer, pre-incubated with anti-mouse Fc-block™ (20mins, 4°C), 
followed by incubation with fluorescently labelled anti-mouse Gr1 antibody in FACS-buffer for 
30mins at 4°C in the dark (as described in section 2.3.3). Samples were then prepared as in 
2.3.4 and run on the LSRFortessa flow cytometer to determine Gr1high neutrophil numbers as 
an assessment of the inflammation. Naïve lavage fluid supernatant was used for cytokine array 
if <1% neutrophils were present, and zymosan-treated samples used if >50% present.  
Spleen lysates were also analysed by array. To prepare the lysates, whole spleens were mixed 
with 1ml PBS supplemented with 1% triton X-100 and 1% protease and phosphatase inhibitor 
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cocktail (spleen lysis buffer) in 2ml homogenisation tubes with 2.8mm ceramic beads (Stretton 
Scientific, Derbyshire, UK). Spleens were subject to homogenisation using a Precellys®24 
homogeniser (Stretton Scientific) at 5000rpm for 3x30seconds. Samples were then centrifuged 
at 3500g at room temperature for 5mins, and the supernatants transferred to fresh tubes. 
Spleen lysate supernatants were then centrifuged at 17000g for 10mins and the supernatants 
harvested and stored at -80°C until analysis.      
  Proteome Profiler™ array 2.4.2.
Peritoneal lavage fluids or spleen lysates were thawed and protein content determined using 
Pierce™ BCA protein assay kit (Thermo Scientific) as described by the manufacturers. Cytokines 
and chemokines in lavage fluid were compared between naïve and peritonitis-induced male 
and female mice using Proteome Profiler™ Array kits for mouse cytokine array panel A, and 
mouse chemokine array (R&D Systems). Arrays were performed as per the manufacturer’s 
instructions probing pre-coated membranes with equal amounts of male and female protein. 
Briefly, nitrocellulose membranes had duplicate spots of specific panels of capture antibodies. 
Equal amounts of peritoneal lavage supernatants or spleen lysates were mixed with a cocktail 
of biotinylated detection antibodies and the sample/antibody mixture incubated overnight 
with the capture antibody-containing membrane. Cytokine and detection antibody complexes 
that were present bound to respective capture antibodies on the membrane. Membranes 
were then washed to remove unbound material and Streptavidin-HRP was added to bind to 
biotinylated detection antibodies. Chemokine levels were measured by the subsequent 
addition of chemiluminescent detection reagents with exposure of membranes for equal 
times. The light produced at each spot was proportional to the amount of cytokine bound.  
 Array quantification 2.4.3.
Array blots were scanned simultaneously using a HP colour LaserJet CM2320Fx MFP printer 
scanner (Hewlett Packard) and the resultant scans were converted to jpeg format using Adobe 
Photoshop. The jpeg images used for quantification were all adjusted to a pixel density of 
300dpi and the dot intensity quantified by densitometry using ImageJ (NIH, Bethesda, USA). 
Cytokine and chemokine levels were presented as pixel density (arbitrary units (AU)). Test dots 
were also compared to control references dots on the membranes. 
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 Statistics 2.5.
Data was expressed as arithmetic mean ± standard error of the mean (SEM). Analysis was 
carried out using GraphPad Prism 6.03 (GraphPad, San Diego, CA). Statistical significance was 
evaluated by unpaired two-tailed Student’s t-test, or 1- or 2-way ANOVA followed by 
Bonferroni’s post-test for multiple comparisons. Data was classed as significant when p values 
were below 0.05. 
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 Sex-differences in leukocyte subsets and TLR Chapter 3:
expression in naïve mice 
 Introduction 3.1.
Detection of pathogens or damaged tissue by TLR-mediated PAMP or DAMP recognition 
represents the first step in mounting the inflammatory response. The presence of TLRs on 
immune cells is widely accepted and vast numbers of studies report the presence of TLR 
message in leukocytes. Most well described are TLR4, as the LPS receptor, and TLR2 due to its 
highly promiscuous nature and hence plethora of ligands. High TLR2 and TLR4 mRNA has been 
demonstrated in human monocytes, whilst conversely message for these TLRs is also described 
in low levels in T cells, B cells, and NK cells (Muzio et al., 2000; Hornung et al., 2002; Zarember 
et al., 2002). Human neutrophils and mast cells also express TLR2 and TLR4 mRNA (Muzio et 
al., 2000; Supajatura et al., 2001). Human blood DCs express various TLRs depending on the 
subset, however only myeloid DCs express TLR2 and TLR4 (Kadowaki et al., 2001). Surprisingly, 
only a handful of groups have detailed TLR protein on leukocytes. Monocytes are reported to 
express relatively high levels of TLR2 and TLR4 protein on their cell surface, compared to low 
levels on neutrophils, and no expression on eosinophils (Sabroe et al., 2002), whilst 
macrophages also express TLR2 and TLR4 protein (Henning et al., 2008). Despite the vast 
amount of literature describing immune cell TLR expression, a comprehensive study into the 
expression of protein on leukocytes subsets from different storage compartments has yet to 
be carried out. Sex-differences in leukocyte TLR phenotype have previously been reported with 
female murine peritoneal macrophages exhibiting greater TLR2 and TLR4 message and protein 
(Scotland et al., 2011). The magnitude of such differences with regards to other leukocyte 
subsets and in the context of other storage compartments has been little explored.  
The extent of readily deployable leukocyte pools is another highly important factor in the 
ability to mount an inflammatory response and clear an infection. The number of leukocytes in 
the tissue, circulation, and storage pools (i.e. BM or spleen), represents an instrumental factor 
in the capacity of the immune system to remove the pathogen or damaged tissue and restore 
homeostasis. Conversely, mass mobilisation of leukocytes and their subsequent accumulation 
in the tissue, if not finely regulated, can represent a series of events that are no longer 
protective, but instead become detrimental to the host. Sex differences in the extent of 
leukocyte pools are surprisingly poorly reported. One study however, shows female mice have 
more resident macrophages, T lymphocytes and B lymphocytes in the peritoneum than male 
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littermates (Scotland et al., 2011). Dimorphisms in resting leukocyte numbers may pose 
implications for disease, certain types of which are known to clinically exhibit sex-bias both in 
terms of occurrence and severity (Marriott et al., 2006a). Sex-differences in TLR phenotypes 
are likely to add to such implications. 
 Aims 3.2.
Despite reports of sexual dimorphism in peritoneal leukocyte numbers, it is first important to 
characterise this further in different leukocyte compartments in order to fully understand 
trafficking in males and females in inflammation. Furthermore, despite previous 
characterisation of both leukocyte TLR2 and TLR4 protein, further investigations are required 
to understand the expression of these receptors between compartments, and on other specific 
leukocyte subsets. Differences in leukocyte TLRs between compartments may indeed elude to 
a potential role of TLRs themselves in leukocyte mobilisation and trafficking beyond PAMP 
recognition. Therefore, the specific aims were to: 
 Investigate sex differences in the leukocyte subset composition of various leukocyte pools 
extending upon previous reports in the peritoneal cavity to include the circulation, BM, 
and spleen.  
 Assess expression of TLR2 and TLR4 cell surface protein expression on leukocyte subsets 
from each source to achieve a comprehensive basal leukocyte subset expression profile in 
male and female mice. 
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 Results 3.3.
 Male and female basal total leukocyte numbers  3.3.1.
To further explore the extent of physiological sex-differences in peritoneal leukocytes seen 
previously, total basal cells in other major leukocyte-containing compartments were first 
investigated. In naïve mice, no significant difference in total circulating, BM or spleen 
leukocytes were observed (p>0.05) (Figure 3.1). In agreement with previously published data, 
female mice had significantly (p<0.001) more peritoneal leukocytes than males (4.4±0.20 x106 
vs 3.3±0.20 x106, Figure 3.1) (Scotland et al., 2011).  
 
 
  
Figure 3.1. Total leukocyte numbers in naïve male and female mice. Total numbers of 
leukocytes isolated from male () and female () mouse blood (n=14/13), peritoneal cavity 
(n=24/26), bone marrow (BM) (n=9/8) and spleen (n=12/15) were determined using trypan 
blue exclusion and a haemocytometer. Bars represent the mean ± SEM. Significant differences 
between the sexes were determined by Student’s t-test, *** (p<0.001). 
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 Male and female mouse spleen and BM characteristics 3.3.2.
Male and female comparisons in this study were made using aged-matched mice, and the male 
mice were therefore larger than female counterparts (p<0.05) (Figure 3.2A). To eliminate the 
possibility of animal size effecting significant cell count differences, circulating cells were 
displayed as a concentration (per ml of blood), and femurs and spleens were weighed (Figure 
3.2A). No difference in femur (p>0.05) and spleen (p>0.05) weights were observed in those 
obtained from male and female mice (Figure 3.2). This suggests the available store of BM and 
splenic leukocytes is similar for both sexes. Of note, female mice have bigger spleens in 
relation to their body size than aged-matched males (p<0.05) (Figure 3.2). 
 
  
 Male Female p value 
Weight (g) 25.0 ± 2.58 (n=99) 20.2 ± 2.16 (n=94) <0.001 
Femur (mg) 81.6 ± 17.00 (n=9) 76.4 ± 27.18 (n=6) NS 
Femur: body weight (mg/g) 3.2 ± 0.74 (n=9) 3.80 ± 1.42 (n=6) NS 
Leukocytes: femur (x105/mg) 2.2 ± 0.78 (n=6) 2.76 ± 0.60 (n=5) NS 
Spleen (mg) 90.2 ± 19.24 (n=15) 87.38 ± 25.12 (n=17) NS 
Spleen: body weight (mg/g) 3.7 ± 0.62 (n=17) 4.4 ± 1.01 (n=17) <0.05 
Leukocytes: spleen (x105/mg) 10.4 ± 3.11 (n=12) 9.0 ± 3.37 (n=14) NS 
A 
Figure 3.2. Murine body and organ characteristics. (A) Table of measurements from naïve 
male and female mice. Data are displayed as mean ± SEM of n number of experiments, as 
displayed in parentheses.  Female data were compared to male by Student’s t-test and the p 
value displayed. NS, not significant. (B) Representative spleens from male and female naïve 
mice. Scale bar, 1cm. (C) Representative femurs from male and female naïve mice. Scale bar, 
1cm. 
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 Sex-differences in peritoneal cavity and spleen, but not blood or BM, leukocyte 3.3.3.
subsets 
Neutrophils were present in the circulation, BM and spleen of naïve male and female mice. As 
expected in uninflamed conditions, in the peritoneum there was an absence of neutrophils 
(Figure 3.3A). Classical monocytes, non-classical monocytes, B cells, and T cells were found in 
all compartments, although only a negligible number of classical monocytes were found in the 
naïve peritoneum (Figure 3.3B-E). In naïve mice, males exhibited over 2-fold more neutrophils 
(p<0.01), classical- (p<0.01) and non-classical monocytes (p<0.001) in their spleens versus 
females (neutrophils: 44.7±7.94 x105 vs 18.7±2.00 x105; classical monocytes: 16.1±2.49 x105 vs 
7.7±0.82 x105; non-classical monocytes: 14.5±1.75 x105 vs 6.6±0.75 x105, Figure 3.3A-C). 
Despite constituting over 70% of splenic leukocytes, no significant differences in B cell (p>0.05) 
and T cell (p>0.05) numbers were observed (Figure 3.3D-E).  
Confirming previous reports, the naïve murine female peritoneal cavity contained more 
macrophages (p<0.001) and B cells (p<0.01) than male counterparts, although no difference in 
T cells was observed (Figure 3.3D-F). Male and female mice had similar numbers of peritoneal 
non-classical monocytes (p>0.05), and both had an absence of neutrophils and very few 
classical monocytes (Figure 3.3A-C). No sex-differences were seen in BM (p>0.05) or circulating 
(p>0.05) subset numbers, though unexpectedly male mice displayed slightly more blood 
neutrophils than females (p<0.05).   
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Figure 3.3. Basal leukocyte populations from different compartments of naïve male and 
female mice. Leukocytes isolated from blood, peritoneal cavity, bone marrow (BM) and spleen 
of male () and female () mice. (A) Neutrophils, (B) classical monocytes, (C) non-classical 
monocytes, (D) B220+ B cells, (E) CD3+ T cells, and (F) peritoneal macrophages were identified 
by flow cytometry. Data are presented as mean ± SEM of n animals where n≥7 (blood), n≥7 
(cavity), n≥5 (BM), and n≥11 (spleen) animals. Differences between males versus females were 
determined using Student's t-test and indicated by * (p<0.05), ** (p<0.01) and *** (p<0.001). 
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 No difference in TLR2 and TLR4 expression on leukocyte subsets from different 3.3.4.
compartments 
To obtain a comprehensive TLR2 and TLR4 expression profile for male and female murine 
leukocytes, subsets from different compartments of naïve mice were assessed for presence of 
receptors on the cell surface by flow cytometry. Monocytes expressed highest amounts of 
TLR2, with both classical and non-classical subsets comparable in expression. Neutrophils, 
peritoneal macrophages and B cells expressed moderate amounts of TLR2, whilst T cells 
expressed a very small amount of the receptor (Figure 3.4). TLR4 on the other hand was most 
abundant on peritoneal macrophages, followed by the monocyte subsets and neutrophils with 
comparable expression and finally B cells, with T cells again demonstrating very low expression 
of TLR4 (Figure 3.5). Leukocyte subsets showed no differences in expression of TLR2 (p>0.05) 
(Figure 3.4) or TLR4 (p>0.05) (Figure 3.5) if obtained from blood, tissue, BM, or spleen. 
Contrary to previous work, no significant difference in expression of TLR2 (p>0.05) or TLR4 
(p>0.05) was seen on peritoneal macrophages from male versus female mice (Scotland et al., 
2011). Similarly, no sex-differences were observed in the expression of either receptor on 
classical monocytes (p>0.05), non-classical monocytes (p>0.05), and B cells (p>0.05), from any 
of the compartments sampled. T cell TLR2 and TLR4 expression were similar between the 
sexes, apart from in the peritoneal cavity where female T cells had more TLR2 than males 
(p<0.05) (Figure 3.4F).  
Neutrophils displayed some small but significant sex-differences in TLR expression. Those from 
male BM had both higher TLR2 (p<0.001) and TLR4 (p<0.05) compared to neutrophils from 
female BM. TLR2 and TLR4 expression on circulating neutrophils were however similar 
between the sexes (p>0.05). Aside from the aforementioned differences, male and female 
leukocytes from blood, peritoneum, spleen and BM showed comparable TLR2 and TLR4 
expression levels. Of note however, splenic classical monocytes displayed a trend towards 
higher expression in male versus female mice (p=0.076). 
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Figure 3.4. Basal leukocyte TLR2 expression profile. Surface TLR2 was assessed on murine 
leukocyte subsets. (A) Representative histograms showing TLR2 expression (green) and an IgG 
control (grey fill). Quantification of TLR expression on male () and female () (B) 
neutrophils, (C) classical monocytes, (D) non-classical monocytes, (E) B220+ B cells, and (F) 
CD3+ T cells from blood, BM, spleen, and peritoneal cavity (where present), and (G) peritoneal 
macrophages. TLR2 was expressed as relative fluorescence intensity (RFI) to isotype control 
antibody. Differences in expression between males and females were assessed using Student’s 
t-test and significance indicated by * (p<0.05), and *** (p<0.001). Data shown as mean ± SEM 
of n experiments: (B-D) n=12/14 (blood), n=3/5 (cavity), n=8 (BM), n=5 (spleen); (E-F) n=6/4 
(blood), n=4 (cavity), n=5 (BM), n=5 (spleen); (G) n=16/19.  
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Figure 3.5. Basal leukocyte TLR4 expression profile. Surface TLR4 was assessed on murine 
leukocyte subsets. (A) Representative histograms showing TLR4 expression (blue) and an IgG 
control (grey fill). Surface TLR4 was assessed on male () and female () (B) neutrophils, (C) 
classical monocytes, (D) non-classical monocytes, (E) B220+ B cells, and (F) CD3+ T cells from 
blood, BM, spleen, and peritoneal cavity (where present), and (G) peritoneal macrophages. TLR4 
was expressed as relative fluorescence intensity (RFI) to isotype control antibody. Differences in 
expression between males and females were assessed using Student’s t-test and significance 
indicated by * (p<0.05). Data presented as mean ± SEM. Data shown as mean ± SEM of n 
experiments. (B-D) n=12/14 (blood), n=3/5 (cavity), n=8 (BM), n=5 (spleen); (E-F) n=6/4 (blood), 
n=4 (cavity), n=5 (BM), n=5 (spleen); (G) n=10/12.  
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 Discussion 3.4.
Sexual dimorphisms in basal peritoneal macrophage number and phenotype have been 
implicated in the differential responses to inflammatory stimuli in mice. Little attention has 
however been paid to the phenotype of other leukocyte types and the source of such cells. In 
this chapter, an extensive comparison of resting male and female murine leukocyte numbers 
from diverse pools was conducted using flow cytometry. This chapter provides clear evidence 
of sex differences in specific leukocytes pools (Table 3.1). Females exhibited greater numbers 
of resident peritoneal leukocytes, more specifically macrophages and B cells, than age-
matched males, confirming recently reported observations (Scotland et al., 2011). Contrary to 
previous reports, no sex-difference in numbers of CD3+ T cells was seen. A possible explanation 
may lie with antibody sensitivity: Whilst all other leukocyte markers were the same as for the 
published sex-differences (Scotland et al., 2011), T cell anti-CD3 antibody clone KT3 was used 
compared to the 17A2 clone in this study. In addition, males surprisingly had greater numbers 
of circulating neutrophils under resting conditions than females. This is in agreement with a 
haematological survey of 11 inbred mouse strains that also showed 8 week C57BL/6 male mice 
had 2-fold more blood neutrophils than aged-matched females (Jackson, 2014). 
Most notably, male mice had significantly larger stores of splenic neutrophils and monocytes 
than females. This is the first report of such a difference and is compounded by similar 
lymphocyte numbers and spleen masses. This demonstrates firstly that the spleen may 
represent a pool of mature innate immune cells that may be mobilised and utilised in infection 
or tissue damage, and secondly that this may be more greatly exploited by male mice due to 
enhanced size of the store. Recent studies have demonstrated that the spleen contains 
Blood      >       =        =         =         =  - 
Peritoneum      -       =        =         <         =  < 
BM      =       =        =         =         =  - 
Spleen      >       >        >         =         =  - 
Table 3.1. Summary of sex-differences in leukocyte subset numbers in naïve mice. Sex 
differences are represented by ‘<’ or ‘>’. Hyphen indicated not applicable for this leukocyte 
source. , male; , female. 
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proliferating myeloid cell progenitors that give rise to their progeny in a process coined 
extramedullary haematopoiesis (Robbins et al., 2012). Compared to WT controls 
atherosclerotic-prone ApoE-/- mice were found to have more granulocyte/macrophage 
colonies and more haematopoietic stem cells in their spleens, indicative of myeloid cell 
proliferation. It would be useful to characterise the nature of the male and female splenic 
neutrophils and in particular monocytes, and in addition the myeloid cell progenitors, to assess 
whether the male spleen indeed possesses more of these cells, and whether they are in a 
greater state of proliferation compared to females.    
This chapter also sought to explore the basal pattern recognition receptor leukocyte 
phenotype, as female murine resident macrophages have been shown to have greater TLR 
expression compared to males. Despite remarkable interest in the functional role of TLRs in 
inflammation and immunity, the expression profile of TLR protein is incompletely 
characterised. In order to explore the extent of dimorphism in the expression of TLRs, flow 
cytometry was employed to investigate receptor expression on the above-mentioned 
leukocyte subsets. Cells were sampled from various leukocyte pools to assess whether location 
and storage environments affected TLR phenotype. Focus was kept to TLR2 and TLR4, as these 
are the best characterised and have previously displayed sexual-dimorphisms in macrophages. 
The present study failed to detect a sex-difference in the expression of TLR2 and TLR4 on 
resident macrophages. A possible explanation again lies in antibody selection. Anti-TLR2 clone 
T2.5 and anti-TLR4 clone MTS510 were selected after preliminary testing based on their 
preferential RFI versus other tested antibodies (Appendix 2). Previously observed sex-
differences were seen with anti-TLR2 clone 6C2 and anti-TLR4 clone UT41. The notoriety of TLR 
antibodies as being poor is one explanation for the lack of protein data in the literature and 
the majority of expression data being message-based, and likewise for difficulty in replicating 
such results as in this chapter. Furthermore, TLR expression was presented as relative 
fluorescence intensity (RFI), a more stringent measure to take into account non-specific 
binding of IgG and changes to cytometer settings. This is in comparison to previously shown 
TLR sex-differences that were presented as median fluorescence intensity (MFI), the crude 
readout of the test antibody only.  
Additionally, in the study that reported female mouse macrophages to have greater TLR2 and 
TLR4 expression, peritoneal cells were collected in media without EDTA, unlike in this study 
where buffer contained EDTA. The study in question consequently recovered 1.5-fold fewer 
cells from the cavity than obtained in this thesis, leaving scope to speculate the most adherent 
macrophages may not have been recovered, excluding their TLR profile from the analysis. Such 
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macrophage subsets differing in TLR expression is not inconceivable due to the known M1 and 
M2 phenotypes. Variance in pattern recognition receptor expression in males and females is 
however a debated subject with no clear answers, in particular at the basal level. 
This study found male BM neutrophils have a small but significantly increased expression of 
TLR2 and TLR4 compared to females. Sex-differences in relation to neutrophil TLRs have not 
previously been reported. Interestingly, circulating neutrophil TLR2 and TLR4 is similar 
between the sexes. This may suggest differences in the stores are an indication of different 
maturation or activation states, or conversely may suggest male neutrophils are more ‘poised’ 
for PAMP and DAMP detection in proximity to the BM. Sexual dimorphism in neutrophil TLR 
expression in this compartment, remote from the site of inflammation leaves scope for the 
exploration of potential function of these receptors in leukocyte trafficking. The consequence 
of this observation will be explored in future chapters by monitoring leukocyte subset 
expression temporally in an acute inflammatory model. 
This chapter has also shown levels of TLR2 and TLR4 were similar between the murine classical 
and non-classical monocyte subsets. This suggests detection of respective ligands is not biased 
to a particular subset, as would have been likely based on the inflammatory function of 
classical monocytes. Indeed, some studies show both subsets are able to be activated by TLR 
ligands, more specifically human CD16- classical preferentially sense surface TLR ligands 
(including TLR2 and TLR4), and CD16+ non-classical monocytes sense more so via intracellular 
TLRs (Strauss-Ayali et al., 2007; Cros et al., 2010; Saha et al., 2011). This finding is contrary to 
the implications of this investigation. In support however is a report on human monocytes that 
shows no difference in TLR2 or TLR4 protein between CD16- classical, and CD16+ non-classical 
subsets (Aguilar-Ruiz et al., 2011). No reports of differential monocyte TLR2 and TLR4 
expression between males and females are present in the literature. Similar expression of both 
receptors on monocyte subsets between the sexes was observed in all compartments 
sampled.  
Key findings: 
 Sexual dimorphisms are present in the magnitude of certain murine leukocyte pools, 
specifically the spleen and peritoneum.  
 Basal pathogen sensing capabilities of leukocytes, from various localisations, are on the 
whole not different between the sexes. 
 Male BM neutrophils express more TLR2 and TLR4 than those from females. 
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 Sex-differences in leukocyte recruitment in zymosan Chapter 4:
peritonitis  
 Introduction 4.1.
Recruitment of specific leukocytes is considered to underlie the pathogenesis of many 
diseases, i.e. monocyte infiltration in atherosclerosis or neutrophil recruitment in 
ischaemia/reperfusion injuries. Sex-differences in leukocyte recruitment in acute inflammation 
have previously been demonstrated in rodents with female mice recruiting significantly less 
leukocytes to the peritoneum in response to both GBS bacterial-induced peritonitis and 
zymosan-induced peritonitis. The latter was shown to be attributed to lesser neutrophil 
infiltration as lymphocyte and macrophage numbers were similar (Scotland et al., 2011). 
Correspondingly, in a rat model of abdominal aortic aneurysms, females accumulated 
significantly less neutrophils than males (Sinha et al., 2006). Whether this extends to other 
leukocyte subsets, such as the monocyte subsets, is currently unknown.  
The mechanisms of sex-differences in leukocyte recruitment are also unclear. Dimorphisms in 
upstream events in the inflammatory response are not well documented, and to date no 
studies have shown whether sex-difference in tissue recruitment extends into the circulation. 
Similar circulating leukocytes in males and females but fewer recruited cells may be suggestive 
of a sex-difference in transendothelial migration mechanics, i.e. rolling, activation, adhesion, 
crawling or transmigration. Male hypercholersterolemic rabbits demonstrated more monocyte 
adhesion and subendothelial migration, and in addition exhibited higher endothelial VCAM-1 
expression than females (Nathan et al., 1999). Beyond this study however, sex differences in 
such processes have been poorly reported in the literature.  
Therefore, to understand the effect of male or female sex on the recruitment of leukocytes in 
acute inflammation, a murine zymosan induced peritonitis model of acute inflammation was 
employed. Murine zymosan peritonitis was first described as a suitable model of acute 
inflammation in 1985, and was characterised by vascular changes and mediator production 
leading to leukocyte accumulation at the inflammatory focus (Doherty et al., 1985). This model 
was firstly chosen as zymosan is known to induce inflammatory pathways that result in the 
accumulation of both neutrophils and monocytes, allowing the study of the trafficking of both 
cell types (Getting et al., 1997). Secondly, due to a previously published zymosan dose-
response that validated a 1mg dose (i.p.) to elicit transient inflammation characterised by 
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neutrophil clearance, whereas a 10mg dose causes persistent tissue neutrophils, systemic 
inflammation and impaired restoration of tissue homeostasis, despite eventually resolving 
(Navarro-Xavier et al., 2010). Owing to an interest of this study being the potential of 
infiltrating leukocytes to be damaging rather than protective in an acute setting, the 1mg dose 
was selected. In addition, due to the observation in the previous chapter that male murine BM 
neutrophils were higher in TLR2 than those from females, the selection of zymosan as a TLR2 
ligand was appropriate to further investigate the temporal expression profile of this receptor 
in inflammation. Finally, zymosan previously produced an inflammatory reaction that was 
dimorphic between males and females, providing scope for this study to investigate sex-
differences further (Scotland et al., 2011).  
 Aims 4.2.
Although a sex-bias in many human diseases is hypothesised to be driven by differences in 
leukocyte recruitment, there is a lack of evidence in the literature to support this, likely due to 
the nature of obtaining such measurements. A robust understanding of the mechanisms of 
sex-differences in leukocyte recruitment in inflammation in rodents is therefore essential in 
understanding human disease and designing new, more targeted therapies. Consequently, this 
chapter has the following specific aims: 
 Confirm and further identify sex-differences in leukocyte subset recruitment in the 
zymosan peritonitis model of acute inflammation. 
 Investigate the effect of inflammation on circulating leukocyte numbers to advance 
understanding of the dynamics of this acute inflammatory reaction.  
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 Results 4.3.
 Neutrophils infiltrate and are cleared in murine zymosan peritonitis  4.3.1.
Leukocyte infiltration to the peritoneal cavity in response to 1mg intraperitoneal zymosan was 
assessed in male and female mice. By 3h, peritoneal leukocytes increased 3-4-fold in number 
(p<0.001), significantly more so in male versus female mice (p<0.05) (Figure 4.1A). Leukocyte 
numbers showed a trend to reduction over time, but remained elevated through 96h post 
induction of inflammation. To confirm the resolving nature of the innate inflammatory 
response to zymosan, neutrophil numbers in the peritoneal cavity of male and female mice 
were monitored at various time points until clearance. Zymosan induced rapid and significant 
(p<0.001) influx of neutrophils into the murine peritoneal cavity peaking to a significantly 
(p<0.05) extent in male compared to female mice at 3h post induction of inflammation (Figure 
4.1B). In line with previous reports neutrophils were virtually absent from the cavity of both 
sexes by 96h, indicating the transient nature of the 1mg zymosan dose as previously seen 
(Navarro-Xavier et al., 2010). 
 
Figure 4.1. Immune cell recruitment in murine zymosan peritonitis. Male () and female () 
mice were treated with zymosan (1mg, i.p.) for the indicated time points. (A) Total leukocytes 
and (B) neutrophils recovered from the peritoneal cavity. Data are shown as mean ± SEM of at 
least 14 (0h), 16 (3h), 10 (24h), and 3 (48h, 72h, 96h) mice. Sex differences in the number of 
cells in the peritoneal cavity at each time point was determined by Student’s t-test and 
significance indicated by * (p<0.05).  
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 Sex-differences in leukocyte recruitment following zymosan peritonitis 4.3.2.
Intraperitoneal zymosan induced accumulation of neutrophils and classical monocytes in the 
cavity after 3h. Male mice recruited 11.4±1.12 x106 neutrophils at this time, significantly more 
than 8.0±0.91 x106 in females (p<0.05) (Figure 4.2A). Similarly, males amassed significantly 
more (p<0.01) classical monocytes at the same time point than females (2.7±0.35 x105 vs 
1.52±0.21 x105, Figure 4.2B). Numbers of cavity non-classical monocytes decreased during 
peritonitis 2.5-fold, to the same extent in both sexes (Figure 4.2C). Despite females having 
more resident peritoneal macrophages than males under basal conditions as described in 
Chapter 3, administration of zymosan caused clearance of over 95% of macrophages by 3h in 
both sexes (Figure 4.2D). Like macrophages, peritoneal B220+ B cells were more numerous in 
the naïve female cavity. 3h after zymosan administration male cavity B cells increased 2-fold 
(5.4±0.63 x105 to 11.4±1.64 x105) (p<0.05) whilst no change in female B cell numbers was seen 
in the inflammation (p>0.05) (Figure 4.2E). CD3+ T cell numbers were similar between the sexes 
(p>0.05) and unchanged in response to zymosan at the early time point of 3h (p>0.05) (Figure 
4.2F).   
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Figure 4.2. Leukocyte subset recruitment in zymosan peritonitis. Male () and female () 
mice were treated with or without zymosan (1mg, i.p.) for 3h. Flow cytometry was used to 
determine the numbers of (A) neutrophils, (B) classical monocytes, (C) non-classical monocytes, 
(D) macrophages, (E) B220+ B cells, and (F) CD3+ T cells in the peritoneal cavity. Data displayed 
as mean ± SEM of n mice where n≥14 (neutrophils), n≥10 (classical and non-classical 
monocytes), n≥9 (macrophages), n≥7 (B cells), and n≥9 (T cells). Comparison of cell numbers at 
specific time points in female versus male mice was achieved using Student’s t-test, with 
significant differences indicated by * (p<0.05), ** (p<0.01).  
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 Sex-differences in circulating leukocytes following zymosan peritonitis 4.3.3.
Significant accumulation of neutrophils (p<0.001) and classical monocytes (p<0.001) was seen 
in the circulation of male and female mice treated with zymosan (1mg, i.p.), peaking at 3h. The 
3h peak of neutrophilia was significantly (p<0.01) greater in males (2.7±0.26 x106/ml) 
compared to females (1.6±0.20 x106/ml, Figure 4.3A). Equally, classical monocytosis at 3h was 
significantly (p<0.001) more so in male mice (14.3±1.56 x105/ml) versus female mice (6.5±1.21 
x105/ml, Figure 4.3B). Circulating numbers of non-classical monocytes did not significantly 
change throughout the peritonitis in either sex (p>0.05). At 3h post zymosan however, a trend 
toward differential non-classical monocyte regulation resulted in significantly (p<0.01) more 
cells in the male than female circulation (2.0±0.22 x106/ml vs 1.1±0.13 x105/ml, Figure 4.3C).  
By 24h after the induction of peritonitis, blood neutrophils, classical monocytes, and non-
classical monocytes had returned to near basal (0h) levels and were no longer different in 
number between the sexes (p>0.05).  
Circulating B cells declined in number 3h after zymosan administration, significantly in male 
mice (p<0.05) and with a trend toward so in female mice (Figure 4.3D). After 24h, the numbers 
of B cells in both sexes recovered, with female numbers returning to basal levels, and males 
elevated beyond the naïve state (p<0.01). This exaggerated response meant at 24h male mice 
had significantly augmented circulating B cells versus females (1.6±0.18 x106/ml vs 1.1±0.69 
x106/ml) (p<0.05). No significant difference in the number of CD3+ T cells in the blood was seen 
up to 24h post zymosan (p>0.05) (Figure 4.3E). Furthermore, male and female mice had similar 
numbers of T cells at the time points analysed (p>0.05).  
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Figure 4.3. Circulating leukocyte subsets in zymosan peritonitis. Zymosan (1mg, i.p.) was 
administered to male () and female () mice to induce peritonitis. Numbers of (A) 
neutrophils, (B) classical monocytes and (C) non-classical monocytes in the blood were 
determined at 0h (n≥13), 3h (n≥15), 24h (n≥10 (neutrophils); n≥4 (monocytes)), 48h (n=3), 72h 
(n=3), and 96h (n=3). (D) Numbers of B220+ B cells and (E) CD3+ T cells were determined at 0h 
(n≥7), 3h (n≥15) and 24h (n≥7). Data is presented as mean ± SEM. Sex-differences at each time 
point were determined by Student’s t-test and significance indicated by * (p<0.05), ** 
(p<0.01), and *** (p<0.001).  
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 Discussion 4.4.
The results in this chapter provide evidence for sexual dimorphisms in the size of the 
inflammatory response in mice. To understand whether sex-differences in leukocyte 
recruitment are reproducible and extend beyond that of neutrophils, the effect of sex was 
examined in the murine zymosan peritonitis model of acute inflammation. Indeed, neutrophil 
accumulation in the peritoneal cavity at 3h post-zymosan was greater in male compared to 
female mice (Figure 4.4). Most strikingly, male mice recruited significantly more classical 
monocytes at this time. Interestingly, although monocyte infiltration was previously 
considered to follow that of neutrophils (Soehnlein et al., 2010), this model demonstrates the 
ability of classical monocytes and neutrophils to extravasate at the same time, although 
neutrophils continued to be the principle cell type. Furthermore, while a reduction in the 
number of recruited neutrophils may be suggested to underlie the reduction in the number of 
recruited classical monocytes seen in female mice, no correlation exists between the 
recruitment of these cell types (Appendix 3). To fully disprove this theory however, neutrophil 
depletion studies could be carried out as have previously been described for thioglycollate 
peritonitis (Henderson et al., 2003).  
Sex-differences in the recruitment of neutrophils and classical monocytes are equally reflected 
in the blood, with males exhibiting greater numbers of both leukocyte subsets 3h after 
induction of peritonitis compared to females (Figure 4.4). The neutrophilia and classical 
monocytosis was, however, transient as by 24h circulating numbers of both cell types returned 
to basal levels. This is in line with the predicted half-life of a circulating neutrophil of 6-8h 
(Summers et al., 2010). A sex-difference in the recruitment of neutrophils and classical 
monocytes therefore appears to be upstream of such disparities already present in the 
circulation at that time. It is furthermore suggestive that male and female leukocyte adhesion 
and transendothelial migration mechanisms and kinetics are similar, and a difference in the 
female cells is not the reason for fewer leukocytes in the peritoneum in response to i.p. 
zymosan. Nevertheless, to fully prove this hypothesis, evaluation of such kinetics would have 
to be assessed either in vivo using intravital microscopy of the mesentery for example, or ex 
vivo with endothelial monolayers.   
Consistent with the literature, resident peritoneal macrophages diminished in number by 3h 
after induction of peritonitis (Navarro-Xavier et al., 2010). The fate of these macrophages was 
not commented on in the previous report however it is conceivable that after PAMP 
recognition, cellular activation, cytokine and chemokine production, and zymosan 
phagocytosis, these cells undergo apoptosis, accounting for their clearance. Non-classical 
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Figure 4.4. Summary of sex-differences in leukocyte recruitment in zymosan peritonitis. (A) 
Summary of basal circulating (blood) and peritoneal cavity (tissue) neutrophils, classical 
monocytes, non-classical monocytes, B cells, and T cells in male ( ) and female ( ) mice. 
Negligible numbers of neutrophils and classical monocytes were present in the naïve cavity. 
Sex-differences are indicated by ‘>’ or ‘>’; no difference is indicated by ‘=’. (B) Summary of 
leukocyte accumulation in the blood and tissue in response to zymosan (1mg, i.p.). Arrows 
indicate either increase (↑) or decreased (↓) numbers after 3h in male and female mice. 
Larger arrows indicate greater increase in cells versus the other sex. Broken arrows depict the 
likely direction of leukocyte movement, where ‘?’ designates uncertainty in this. No arrows 
signify no suggestion of trafficking or sex-differences. 
monocytes similarly reduce during inflammation, approximately halving in number after 3h. 
The fate of these cells is less clear and not supported by evidence in the literature. A small 
increase in circulating non-classical monocytes in male mice is seen at this time however a 
‘reverse’ abluminal to luminal migration in such a model is unlikely and not previously 
reported. Furthermore, such a phenomenon is not reflected in the female that instead sees a 
trend toward reduced circulating non-classical monocytes. In fact, the origin of monocyte 
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subsets is highly debated. Some argue that classical monocytes can give rise to non-classical 
monocytes, doing so by downregulating the Ly6C antigen (Varol et al., 2007). There is, 
however, no evidence of the reverse of this differentiation occurring, thus a shuttling between 
monocyte phenotypes is unlikely to explain the observation in this study of increased classical 
monocytes and decreased non-classical monocytes in peritonitis. It is therefore most plausible 
and likely to say classical monocytes are a distinct population that extravasate from the 
circulation to the tissue in zymosan peritonitis. 
As expected, T cell numbers in the cavity do not change at the onset of peritonitis in either sex. 
Conversely and as elucidated in the previous chapter, naïve female mice possess more 
peritoneal B cells than males. During the onset phase of zymosan peritonitis this sex-difference 
is lost due to increased numbers of B cells in the male cavity. This is suggestive of either 
recruitment or local proliferation. Although the increase in male cavity B cells is mirrored by a 
reduction in the circulation, potentially signifying cell recruitment, a reduction in circulating B 
cells is equally observed in the female mouse despite no change in peritoneal B cell number 
during the inflammation. While B cells are generally considered to proliferate in the germinal 
centres, those present in the peritoneal (and pleural) cavity are not ‘normal’ B-2 B cells but 
mostly B-1 B cells (Kantor et al., 1993). B-1 cells differ from B-2 cells as firstly despite being the 
primary producers of natural antibodies, they do not develop into memory B cells. They also 
differ on their ability to self-renew from current peritoneal B-1 cells, compared to the B-2 
subset which are replenished from BM B cells (Hayakawa et al., 1986). This means they 
proliferate to replace older cells (Baumgarth, 2011). Whether the extra B cells in the male 
peritoneum after 3h zymosan are due to proliferation is unknown, however additional 
experiments using CFSE could address this.  
Although 3h would be considered very early for the adaptive immune response, B-1 cells are 
not regarded as members of the adaptive immune system, but rather the humoral immune 
system. Quick responses of these cells have previously been documented whereby peritoneal 
B-1 cells rapidly migrated to the spleen and differentiated into plasma cells in response to LPS 
(Tung et al., 2007). It is conceivable that the relative protection female mice see in zymosan 
peritonitis may be attributed to the B-1 cells in the peritoneal cavity. The reasons for this may 
lie in the capacity of B-1 cells to secrete IgM in greater quantities than IgG (Baumgarth, 2011). 
Certain secreted IgM antibodies have been shown to be specific for apoptotic cells, and as 
such may promote clearance of activated macrophages that have phagocytosed zymosan. It is 
plausible that as females are already known to have more IgM (Bouman et al., 2005) 
potentially due to greater numbers of B-1 cells, thereby increasing clearance of apoptotic 
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macrophages and reducing the need for such an intense innate immune cell influx. To 
investigate such hypotheses it would first be essential to determine the relative quantities of 
B-1 cells in the naïve and inflamed peritoneum of male and female using specific cell markers 
beyond the pan-marker of B220. Furthermore, peritoneal and circulating IgM levels could also 
be compared between the sexes.  
This chapter has shown differences in the leukocyte responses of male and female mice to an 
acute inflammatory stimulus. More specifically, it shows differences in the circulating and 
subsequently recruited number of neutrophils and classical monocytes. In order to fully dissect 
the mechanisms of sex-differences in circulating and subsequently recruited neutrophils and 
classical monocytes in the zymosan peritonitis model, the main leukocyte storage pools must 
be investigated.  
Key findings: 
 1mg zymosan (i.p.) induced rapid accumulation of neutrophils in the peritoneal cavity of 
male and female mice by 3h after administration. These neutrophils were cleared by 96h. 
 Classical monocytes also entered the cavity 3h after induction of zymosan peritonitis. 
 Male mice recruit more neutrophils and classical monocytes to the peritoneal cavity at an 
early, onset, 3h time point after the induction of inflammation in the zymosan peritonitis 
model. 
 Male mice have greater accumulation of circulating neutrophils and classical monocytes 
at the 3h time point post zymosan administration. 
 Male mice have increased peritoneal B cell numbers 3h after induction of inflammation, 
whilst females show no change in cell numbers.  
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 Temporal regulation of leukocyte TLR expression in Chapter 5:
zymosan peritonitis 
 Introduction  5.1.
Since the discovery of Drosophila Toll over 20 years ago, mammalian isoforms TLR2 and TLR4 
have been arguably the most studied. Their role in the initiation of the inflammatory response 
is extremely important as TLR knockout mice are highly susceptible to infection and are unable 
to mount a proper immune response. This is exemplified by TLR2 deficient mice, which have 
impaired survival in response to Gram-positive bacterial infection (Takeuchi et al., 2000). In 
addition, TLR4-mutant C3H/HeJ mice, characterised by a point mutation in the TLR4 
cytoplasmic region, and C57BL/10ScNJ mice, characterised by a null mutation of Tlr4, are 
highly susceptible to Gram-negative bacterial infections with reduced and delayed chemokine 
production (Poltorak et al., 1998; Hoshino et al., 1999). Not surprisingly, compounds were 
developed to target these receptors and initially proved highly efficacious in certain 
inflammatory conditions. Despite the many that have been synthesised, no compound that 
targets either receptor has reached the clinic owing to failure in late stage trials. The reasons 
for these failures remain unclear, however as the precise role of TLRs in the inflammatory 
response beyond that of PAMP/DAMP recognition is not well characterised, it is unsurprising 
these drugs failed. Moreover, the exact cellular targets of such compounds are also not 
evident, and whether they target tissue macrophage, EC, neutrophil, or monocyte TLRs, for 
example, is unclear. Indeed, these drugs could potentially be targeting TLRs on any cell type, at 
any location.  
What has been reported, however, is that TLR-targeting compounds dampen leukocyte 
recruitment responses (Arslan et al., 2010b). It is therefore essential to fully understand the 
expression profile of TLR2 and TLR4 on leukocyte subsets during a course of inflammation. This 
may provide evidence for modulation of receptor expression during leukocyte recruitment, 
and furthermore provide potential time points at which TLR-targeted therapies may be better 
administered to limit uncontrolled leukocyte recruitment and subsequent tissue damage. In 
addition, as females have been demonstrated to have relative protection versus males in 
inflammatory disorders, it would be useful to study the temporal expression profile of both 
receptors to ascertain a comparative profile for both sexes. Indeed, identification of sex-
differences in leukocyte TLR2 and TLR4 regulation during inflammation may provide more sex-
specific methods of targeting inflammatory disorders pharmacologically.    
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Previous chapters, in agreement with the literature, have demonstrated that leukocyte subsets 
express cell surface TLR2 and TLR4. ECs are likewise thought to express TLR2 and TLR4 
although there is less evidence in the literature, particularly for expression of TLRs at the 
protein level (Mullick et al., 2008; Andonegui et al., 2009). Leukocytes also express a plethora 
of cell adhesion molecules and receptors that aid the transmigration from the luminal to the 
abluminal side of the vessel by binding to ligands expressed on the endothelium (Nourshargh 
et al., 2010). L-selectin is one such example, binding to endothelial PSGL-1 to promote 
leukocyte rolling then subsequently being shed during TEM (Ley et al., 2007). This study also 
therefore hypothesised that TLRs may play a role more directly in leukocyte recruitment, 
interacting with the endothelium to potentially aid TEM and in doing so may exhibit modulated 
receptor expression. 
 Aims 5.2.
Sex-differences in basal leukocyte subset TLR2 and TLR4 expression have been described 
already in this thesis, with male BM leukocytes expressing more TLR2 and TLR4 than females, 
and male peritoneal T cells also expressing more TLR2. Dimorphisms in the temporal regulation 
of leukocyte TLRs following acute inflammation may represent a novel mechanism underlying 
sex-differences in leukocyte recruitment and inflammatory disease. To further determine 
whether this may provide a potential mechanism, the following specific aims were addressed: 
 Investigate the temporal expression profile of TLR2 and TLR4 on the surface of circulating 
leukocyte subsets following acute inflammation in the mouse zymosan peritonitis model. 
 Investigate the temporal expression profile of TLR2 and TLR4 on the surface of tissue 
resident and recruited leukocyte subsets in the murine peritoneal cavity following 
zymosan peritonitis. 
 Compare the circulating and peritoneal leukocyte TLR2 and TLR4 expression profiles in 
male and female mice following zymosan peritonitis. 
 Compare TLR expression on neutrophils and classical monocytes in the circulation to 
those already recruited to the peritoneum to gain insight into any changes during TEM 
and therefore any more direct involvement of leukocyte TLRs in this process.       
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 Results 5.3.
 Temporal regulation of circulating leukocyte TLR2 and TLR4 in zymosan 5.3.1.
peritonitis 
Flow cytometry was used to measure expression of TLR2 and TLR4 on the surface of blood 
leukocyte subsets from male and female mice treated with zymosan (1mg, i.p.) to induce 
peritonitis. As determined in previous chapters, expression of both receptors on the specific 
leukocyte subsets was similar in male and female naïve mice (p>0.05). Female blood 
neutrophil TLR2 was significantly (p<0.05) higher on cells present after the peak of neutrophilia 
at 24h (2.4±0.12) versus naïve and peak (3h) inflamed states (1.7±0.09 and 1.5±0.08 
respectively) (Figure 5.1A). Towards the resolution phase (>72h) of the peritonitis, TLR2 
expression returned to basal levels. No significant change in male neutrophil TLR2 was 
observed throughout the inflammation (p>0.05).  
Circulating classical monocyte TLR2 levels were similar in the course of inflammation in both 
male and female mice (p>0.05) (Figure 5.1B). Like neutrophils, female non-classical monocytes 
were transiently elevated in TLR2 (p<0.05) at 24h versus control (3.9±0.33 versus 2.9±0.12) yet 
those cells present afterwards showed similar expression to control conditions (p>0.05) (Figure 
5.1C). Again, male non-classical monocyte TLR2 was similar in inflammation to unstimulated 
(0h) conditions (p>0.05). B220+ B cells and CD3+ T cells had low and unchanged TLR2 (p>0.05) 
and TLR4 (p>0.05) expression in inflammation (Figure 5.1D-E).  
Expression of circulating murine leukocyte TLR4 was also examined. TLR4 expression was 
transiently higher on neutrophils at 24h compared to those at 0h in both male (24h: 3.2±0.29; 
0h: 2.1±0.23) (p<0.05) and female (24h: 3.2±0.26; 0h: 2.1±0.18) (p<0.001) mice (Figure 5.2A). 
Aside from this, neutrophil TLR4 was similar throughout the time course of zymosan peritonitis 
in both sexes (p>0.05). By the same pattern, classical monocytes also transiently show higher 
TLR4 expression at 24h compared to control in both male (24h: 4.4±0.56; 0h: 2.6±0.25) 
(p<0.01) and female (24h: 3.8±0.39; 0h: 2.4±0.27) (p<0.01) mice (Figure 5.2B). At all other time 
points however, TLR4 expression did not differ from control in either sex (p>0.05). No 
significant changes in non-classical monocyte (p>0.05), B220+ B cell (p>0.05), or CD3+ T cell 
(p>0.05) TLR4 expression were observed at all times sampled following induction of 
inflammation (Figure 5.2C-E).  
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Figure 5.1. Temporal expression profile of TLR2 on circulating leukocyte subsets during 
zymosan peritonitis. Male () and female () mice were injected with 1mg zymosan i.p. to 
induce peritonitis. Surface TLR2 was assessed on (A) neutrophils, (B) classical monocytes, (C) 
non-classical monocytes, (D) B220+ B cells, and (E) CD3+ T cells in the blood at the indicated 
time points after induction of inflammation. TLR2 expression was measured as relative 
fluorescence intensity (RFI) to an isotype control antibody. Data shown is the mean ± SEM of 
neutrophils and monocyte subsets: n≥12 mice (0h), n≥13 (3h), n≥9 (24h), n=3 (48h), n=2 (72h), 
n=3 (96h); B and T cells: n≥5 (0h), n≥6 (3h), n≥5 (24h). Temporal changes in expression versus 
naïve conditions were determined by 1-way ANOVA with Bonferroni’s post-test for multiple 
comparisons. Significant differences in males were indicated by # (p<0.05), and in females by * 
(p<0.05).  
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Figure 5.2. Temporal expression profile of TLR4 on circulating leukocyte subsets during 
zymosan peritonitis. Male () and female () mice were treated with zymosan (1mg, i.p.) for 
the indicated times to induce peritonitis. Cell surface TLR4 was evaluated on (A) neutrophils, 
(B) classical monocytes, (C) non-classical monocytes, (D) B220+ B cells, and (E) CD3+ T cells in 
the circulation at the specified time points post induction of zymosan peritonitis. TLR4 
expression was measured as relative fluorescence intensity (RFI) to isotype control antibody. 
Data displayed as mean ± SEM of neutrophils and monocyte subsets: n≥12 mice (0h), n≥13 
(3h), n≥9 (24h), n=3 (48h), n=2 (72h), n=3 (96h); B and T cells: n≥5 (0h), n≥6 (3h, 24h). Changes 
in expression versus naïve (0h) conditions were determined by 1-way ANOVA with Bonferroni’s 
post-test for multiple comparisons. Significant differences in males were indicated by # 
(p<0.05), ## (p<0.01) and in females by ** (p<0.01), and *** (p<0.001).  
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 Temporal regulation of peritoneal leukocyte TLR2 and TLR4 in zymosan 5.3.2.
peritonitis 
In contrast to accumulated neutrophils in the peritoneal cavity at 3h, those present at 24h 
post-zymosan expressed significantly (p<0.001) higher TLR2 in both male (3h: 1.8±0.08; 24h: 
3.2±0.30) and female mice (3h: 1.5±0.07; 24h: 3.2±0.33) (Figure 5.3A). Despite female 
neutrophils at 24h still having elevated TLR2 (p<0.05), this observation was transient as both 
male and female neutrophils analysed at all other later time points did not differ in their 
expression of TLR2 to those first recruited at 3h (p>0.05). Not enough neutrophils or classical 
monocytes were present in the naïve peritoneum to determine TLR2 expression (Figure 5.3B). 
No significant change in TLR2 expression was evident on non-classical monocytes at 3h versus 
0h in either sex however a trend towards increased TLR2 on female cells in inflammation was 
seen (p=0.068) (Figure 5.3C). No modulation of TLR2 levels on B220+ B cells (p>0.05) or CD3+ T 
cells (p>0.05) was seen during the inflammation (Figure 5.3D-E). 
Comparable to TLR2, TLR4 was transiently higher on neutrophils at 24h in the cavity of both 
male (3h: 2.2±0.17; 24h: 3.4±0.27) (p<0.01) and female (3h: 1.8±0.14; 24h: 3.4±0.27) (p<0.001) 
mice (Figure 5.4A). This subsided by 48h in males whereby expression resembled that of the 
neutrophils at 3h, however TLR4 remained elevated on female neutrophils throughout the 
inflammation until 96h. As with TLR2, not enough classical monocytes were present in the 
naïve cavity to accurately determine TLR4 expression, and thus it’s change in inflammation 
(Figure 5.4B). 
Expression of non-classical monocyte TLR4 was significantly (p<0.001) lower on those cells 
present in the male, but not female, peritoneum at 3h post-zymosan versus 0h (3.3±0.11 
versus 1.5±0.11) (Figure 5.4C). Peritoneal B220+ B cells from female mice showed a small but 
significant (p<0.05) reduction in TLR4 expression in response to zymosan (0h: 2.2±0.20; 3h: 
1.6±0.14; 24h: 1.5±0.09), whilst those from males did not differ from naïve controls (p>0.05)   
(Figure 5.4D). No change in CD3+ T cell TLR4 with inflammation was apparent (p>0.05) (Figure 
5.4E).  
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Figure 5.3. Temporal TLR2 expression profile on peritoneal leukocyte subsets in response to 
zymosan peritonitis. Male () and female () mice were treated with zymosan (1mg, i.p.) to 
induce inflammation. Cell surface TLR2 was determined on (A) neutrophils, (B) classical 
monocytes, (C) non-classical monocytes, (D) B220+ B cells, and (E) CD3+ T cells in the peritoneal 
cavity at the indicated time points post induction of zymosan peritonitis. TLR2 expression was 
measured as relative fluorescence intensity (RFI) to isotype control antibody. Changes in 
expression on non-classical monocytes and lymphocytes (B and T cells) over time versus naïve 
conditions, and changes on neutrophils over time versus those first present at 3h, were 
determined by 1-way ANOVA with Bonferroni’s post-test for multiple comparisons. Significant 
differences in males were indicated by ### (p<0.001), and in females by * (p<0.05), and *** 
(p<0.001). NA, not applicable as cell number was too low to quantify expression. Data shown as 
mean ± SEM. Neutrophils: n≥15 mice (3h), n≥10 (24h), n=3 (48h, 72h), n=2 (96h); classical 
monocytes: n≥5 (3h); non-classical monocytes: n≥3 (0h), n≥5 (3h); B and T cells: n≥3 (0h), n≥6 
(3h, 24h).  
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Figure 5.4. Temporal TLR4 expression profile on peritoneal leukocyte subsets in response to 
zymosan peritonitis. Male () and female () mice were treated with zymosan (1mg, i.p.) to 
induce inflammation. TLR4 expression was determined on the surface of peritoneal (A) 
neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) B220+ B cells, and (E) 
CD3+ T cells at the indicated time points after induction of peritonitis. TLR4 was expressed as 
relative fluorescence intensity (RFI) to isotype control antibody. Changes in expression on non-
classical monocytes, B cells and T cells over time versus naïve conditions, and changes on 
neutrophils over time versus those first present at 3h, were determined by 1-way ANOVA with 
Bonferroni’s post-test for multiple comparisons. Significant differences in males were indicated 
by ## (p<0.01), ### (p<0.001), and in females by * (p<0.05), and *** (p<0.001). NA, not 
applicable due to cell number too low to quantify expression. Data shown as mean ± SEM. 
Neutrophils: n≥14 mice (3h), n≥10 (24h), n=3 (48h, 72h), n=2 (96h); classical monocytes: n≥5 
(3h); non-classical monocytes: n≥3 (0h), n≥5 (3h); B and T cells: n≥3 (0h), n≥6 (3h, 24h). 
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 Potential role of TLRs in transendothelial migration 5.3.3.
Chapter 4 of this thesis showed that in response to zymosan peritonitis, neutrophils and 
classical monocytes are recruited to the tissue at a peak of 3h. Both neutrophils and classical 
monocytes also express TLR2 and TLR4. Changes in TLR2 and TLR4 on leukocytes from the 
circulation to the tissue may represent a more direct involvement of these receptors in TEM. 
The rationale being that leukocyte recruitment in inflammation is reduced with TLR antagonist 
treatment (Arslan et al., 2010b). To gain insight into whether leukocyte TLR2 or TLR4 are more 
directly involved in TEM, the expression of TLR2 and TLR4 was compared on non-recruited 
circulating leukocytes versus those already recruited (transmigrated) in response to 
intraperitoneal zymosan.  
TLR2 (p>0.05) and TLR4 (p>0.05) expression was similar on neutrophils present in the blood 
(not transmigrated) versus the peritoneal cavity (transmigrated) of male and female mice at 3h 
post induction of peritontitis (Figure 5.5). Classical monocytes however displayed a trend 
towards an upregulation of TLR2 on entering the tissue as those cells in the cavity showed a 
tendancy for higher TLR2 expression than those still in the circulation in both sexes (Figure 
5.6A). This was not however significant. No significant differences in classical monocyte TLR4 
expression was observed between circulating and recruited monocytes in male or female mice 
(Figure 5.6B).     
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Figure 5.5. Comparison of circulating and recruited neutrophil TLR expression. (A) Effect of 
transmigration on neutrophil TLR2 and (B) TLR4 expression was evaluated in male and female 
mice treated with zymosan (1mg, i.p.) for 3h. Cells in the circulation (blood, light grey bars) 
versus those already recruited (cavity, dark grey bars) at 3h post-zymosan were compared for 
TLR expression. Expression is quantified as relative fluorescence intensity (RFI) compared to an 
isotype antibody. Differences in TLR expression between cellular compartments were assessed 
by Student’s t-test. Data shown as mean ± SEM of at least 4 (blood), and 6 mice (cavity). 
Figure 5.6. Comparison of circulating and recruited classical monocyte TLR expression. (A) 
Effect of transmigration on classical monocyte TLR2 and (B) TLR4 expression was assessed in 
male and female mice treated with zymosan (1mg, i.p.) for 3h. Cells in the circulation (blood, 
light grey bars) compared to those recruited (cavity, dark grey bars) at 3h post-zymosan were 
compared for TLR expression. TLRs were expressed as relative fluorescence intensity (RFI) to 
isotype control antibody. Differences in TLR expression between cellular compartments were 
assessed by Student’s t-test. Data shown as mean ± SEM of at least 4 (blood), and 5 mice 
(cavity). 
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 Discussion 5.4.
The results in this chapter show that TLR2 and TLR4 expression on certain circulating and tissue 
leukocyte subsets are temporally modulated in the murine zymosan induced peritonitis model 
of acute inflammation. Most strikingly, neutrophils in both the circulation and the peritoneal 
cavity at the post-peak response time of 24h were homogeneously higher in both TLR2 and 
TLR4 compared to those neutrophils in the respective compartments at earlier time points. 
This was despite neutrophils being fewer in number at 24h as shown earlier in this thesis. A 
possible explanation may lie with neutrophil subsets. It has been reported that LPS induces 3 
subsets of circulating human neutrophils, distinguishable by nuclear morphology and 
expression of cell surface markers (Pillay et al., 2012). Indeed, a subset defined as CD11cbright/ 
CD62Ldim/ CD11bbright/ CD16bright was able to suppress T cell proliferation via H2O2 release in a 
Mac-1 dependent manner. Further investigation of both phenotype and function of TLRhigh 
neutrophils at 24h may identify possible roles for these cells in dampening of the immune 
response and resolution of inflammation. Alternatively, as neutrophils are decreasing in 
number by 24h, it is possible the cells are apoptotic or in a state of stress whereby the 
expression of many molecules, TLRs included, are upregulated. To determine whether this is 
the case, further phenotypical analysis of these cells must be carried out. Although in some 
cases the elevated receptor expression persisted through to 48h after the induction of 
inflammation, the general trend was transient and TLRs return to basal levels shortly after. Of 
note, this phenomenon was observed in both male and female mice, and this lack of 
dimorphism was in line with similar neutrophil numbers in the both the blood and tissue 
between the sexes at the 24h time point.  
Conversely, neutrophils in the peritoneal cavity of male mice at the 3h peak of cell recruitment 
were significantly higher in TLR2, and showed a trend towards higher TLR4, than those in the 
female peritoneum. As previously eluded to in this thesis, naïve neutrophils in the circulation 
of male and female mice have similar TLR2 and TLR4 expression. Neutrophils in the male BM 
however, express more TLR2 and TLR4 in comparison to females. Thus, it may be fair to 
speculate that as blood neutrophils would rapidly extravasate in response to zymosan, those 
cells in the BM and spleen may be mobilised and recruited a little later, and these neutrophils 
are in fact accumulating in the tissue at 3h, higher in TLR2 and TLR4 in male mice. It is 
therefore essential to further investigate the BM and spleen as stores of deployable 
neutrophils.  
Another explanation may lie within dimorphisms in the extent of inflammatory cell 
recruitment. This thesis has already shown male mice recruit more neutrophils than females in 
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peritonitis. It is therefore tempting to speculate that in addition to more cells, males may also 
require a somewhat more activated neutrophil phenotype in order to respond effectively to 
the PAMP. A characteristic of this activation may constitute upregulation of PRRs, including 
TLR2 and TLR4, however further analysis of these neutrophils phenotype and function would 
be required to prove such a hypothesis. This is not however the first example of modulation of 
TLRs in inflammation, for example TLR2 and TLR4 on neutrophils were elevated in human 
sepsis patients (Härter et al., 2004). Nevertheless, neutrophil TLR2 and TLR4 expression is 
relatively low, and so the physiological relevance of the modulation to these small degrees 
remains unknown. Ex vivo assays comparing TLRhigh and TLRlow neutrophils would likely provide 
some insight into this.   
Unlike clear patterns of temporal TLR modulation on neutrophils, the remaining circulating 
leukocyte subsets show some specific but more random changes in TLR2 and TLR4. Circulating 
male and female classical monocytes have transiently increased expression of TLR4, but not 
TLR2 at 24h after induction of peritonitis. Similarly, circulating male and female non-classical 
monocytes have transient increased expression of TLR2, but not TLR4, at 24h after zymosan. It 
is perhaps possible that these cells represent monocytes released from storage pools such as 
the BM or spleen, which exhibit a different TLR phenotype. Although under basal conditions 
monocytes from such stores have similar TLR2 and TLR4 expression to their circulating 
counterparts, it is possible over 24h of inflammation that reserve pool leukocytes upregulate 
TLRs by some mechanism. Thus, it would be necessary to investigate the BM and spleen 
storage pools, not only with regard to trafficking of leukocytes, but also with regard to 
temporal expression patterns of TLR2 and TLR4.  
As perhaps predicted due to their adaptive immune nature, no modulation of circulating or 
peritoneal cavity lymphocyte TLRs was seen at the time points covered, except for a small, but 
nonetheless significant reduction in female cavity B cell TLR4 expression. Classical monocytes 
that had accumulated in the male peritoneal cavity after only 3h were not only more 
numerous as demonstrated already in this thesis, but also showed a trend towards having 
more TLR2, but not TLR4, than females. Of note these monocytes had higher expression than 
circulating counterparts. It could be proposed that if male classical monocytes are higher in 
TLR2, they may have potential to be involved in the exaggerated response to zymosan male 
mice demonstrated compared to females. Increased PAMP recognition by male classical 
monocytes may propagate the inflammatory response and this may even encourage further 
neutrophil recruitment, although the order of this opposes the accepted paradigm (Soehnlein 
et al., 2010). An alternative explanation may lie with inherent differences between other male 
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and female innate immune cells. Female macrophages are more numerous, better at 
phagocytosis, and have greater NADPH oxidase activity than male equivalents (Scotland et al., 
2011). It is possible that female mice clear zymosan earlier than males and it is therefore more 
necessary for the male classical monocytes with the aforementioned higher TLR2 to indeed 
have higher receptor expression in order to aid zymosan recognition and pathogen clearance. 
To explore this hypothesis, the use of labelled zymosan in a similar time course would 
determine such clearance. Interestingly, male peritoneal non-classical monocytes at 3h after 
zymosan are lower in TLR4, but not TLR2, with the same trend evident in females. A possible 
explanation aligns with the reduction in the number of these cells at this time point. It could be 
that non-classical monocytes, although early in the inflammation, may be differentiating to an 
M2 macrophage or DC phenotype. Further experiments would be required to determine the 
nature of these cells.  
A further aim of this chapter was to gain insight into whether TLR2 and TLR4 were more 
directly involved in leukocyte recruitment from the circulation to the tissue. This thesis has 
already demonstrated neutrophils and classical monocytes to be virtually absent from the 
peritoneum in naïve mice but to accumulate in the tissue within 3h in response to zymosan 
peritonitis. Receptor expression was therefore compared on cells remaining in the blood with 
those already recruited (i.e. transmigrated) with the hypothesis that if TLR2 or TLR4 were 
directly involved in TEM then the receptor might be shed, internalised, or down regulated on 
entering the tissue, in a similar fashion to that of L-selectin (Ley et al., 2007). No significant 
difference in receptor expression between the blood and peritoneum was evident for either 
neutrophils or classical monocytes. This is suggestive of these receptors not playing a role in 
the leukocyte-endothelial interaction. To fully exclude this possibility however, the adhesion, 
rolling, crawling and TEM mechanics should be investigated with intravital microscopy in TLR2 
and TLR4 deficient versus WT mice, or alternatively in vitro using endothelial monolayers.  
Overall, this chapter has shown male and female circulating and recruited neutrophils regulate 
expression of TLR2 and TLR4 temporally over the time course of the murine zymosan 
peritonitis model of acute inflammation. Furthermore, experiments suggest no change in the 
receptors occurs after TEM. Classical monocytes similarly show no change in their TLR2 and 
TLR4 expression on transmigration. This chapter also shows temporal modulation of these 
receptors expression is indeed evident on some other leukocyte subsets however no pattern in 
this regulation is clear. 
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Key findings: 
 Cavity neutrophils transiently show more TLR2 and TLR4 at 24h after induction of 
peritonitis in both male and female mice. 
 Cavity non-classical monocytes showed reduced TLR4, but not TLR2, 3h post-zymosan in 
male mice, and showed a trend towards this in females.  
 Female, but not male, peritoneal B cells after 3 and 24h of zymosan peritonitis had lower 
TLR4. 
 TLR2 and TLR4 expression on neutrophils and classical monocytes was similar on those 
remaining in the circulating versus those already recruited in response to zymosan 
peritonitis.  
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  Investigating sex-differences in tissue cytokine Chapter 6:
environments in zymosan peritonitis 
 Introduction 6.1.
The typical paradigm suggests that upon PAMP or DAMP recognition by innate immune cell 
PRRs, cells are activated and inflammatory mediators are released, activating and leading to 
the recruitment of other inflammatory cells. Such mediators include cytokines (e.g. TNF and IL-
1β), chemokines (e.g. CCL2 and CXCL1), and chemoattractants (e.g. LTB4). Collectively, 
networks of inflammatory mediators indicate the site of infection, and activate and induce 
changes in the endothelium, in doing so promoting leukocyte recruitment. The characteristics 
of this response are specific to the dose and nature of the stimuli and are therefore highly 
variable. In the same process immune regulatory mediators such as IL-10 and lipoxins are 
released that control the inflammatory response and ensure the pathogen or damaged tissue 
is cleared whilst avoiding the dangerous and potentially fatal so-called ‘cytokine storm’.  
Chapter 4 of this thesis demonstrated sex-differences in leukocyte recruitment in an acute 
inflammatory model in mice. To investigate these findings and furthermore determine at 
which stage in the immune response these sex-differences initiate, the cytokine environments 
of male and female mice during zymosan peritonitis were studied. In addition, the potential 
capability of male and female murine macrophages to detect zymosan was investigated by 
assessing the expression of zymosan-associated PRRs TLR2, TLR6, and dectin-1 on the surface 
of these cells.  
Sex-differences in cytokine responses have previously been described in both humans and 
animals. For example, in healthy adults male monocytes were able to produce more TNF than 
females (Lefevre et al., 2012), whilst in a disease state, female sepsis patients exhibited more 
IL-10, and less TNF, than males (Fish, 2008). In rodents, female rats had reduced expression of 
TNF, IL-1β, and IL-6 after acute myocardial I/R compared to males (Ertan et al., 2007), and 
furthermore produced less CCL3, CCL5, CCL24, and CCL28 during abdominal aortic aneurysms 
(Sinha et al., 2006). There are many, sometimes conflicting, reports providing evidence for 
different inflammatory mediator responses in males and females in inflammation. Differential 
cytokine responses of male and female mice may indicate reasons for dimorphisms in the 
inflammatory response to zymosan peritonitis. Should this be the case, the influence of sex 
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should be considered when proposing pharmacological interventions in inflammatory 
disorders both at the developmental and clinical stages.   
 Aims 6.2.
This thesis has shown male mice accumulate more neutrophils and classical monocytes in the 
tissue and circulation in response to zymosan peritonitis. As a result, we sought to dissect 
whether the mechanisms of such dimorphisms in leukocyte trafficking in inflammation were 
linked to differences in cytokine environments and responses. Therefore, this chapter has the 
following specific aims: 
 Investigate sex-differences in the expression of zymosan-sensing receptors on peritoneal 
macrophages. 
 Examine sex-differences in peritoneal cytokine and chemokine environments in naïve 
mice. 
 Determine the key cytokines released in the tissue during the early phases of zymosan 
peritonitis. 
 Investigate any sex-differences in cytokine production in the cavity in zymosan peritonitis. 
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Figure 6.1. Sex-differences in peritoneal macrophage zymosan receptor expression. 
Expression of TLR2, TLR6, and dectin-1 were assessed on resident peritoneal macrophages 
isolated from naïve male () and female () mice. (A) Peritoneal lavage leukocyte gating 
strategy based on FSC and SSC. (B) Subsequent gating on F4/80high cells to identify 
macrophages. (C) Expression of TLR2 (n≥18), TLR6 (n≥14), and dectin-1 (n≥11) evaluated as 
relative fluorescence intensity (RFI) to an isotype antibody. Data is shown as mean ± SEM of n 
mice. Differences between sexes were determined by Student’s t-test and significance 
indicated by * (p<0.05).  
 Results 6.3.
 Peritoneal macrophage zymosan receptor expression 6.3.1.
Previous results confirmed in Chapter 3 demonstrate female mice have significantly more 
resident peritoneal macrophages than male counterparts. To determine any differences in the 
ability of male and female mice to recognise the PAMP, naïve male and female macrophages 
were assessed for the cell surface expression of the zymosan receptors TLR2, TLR6, and dectin-
1. Levels of TLR2 and the more highly expressed TLR6 were not significantly different on 
F4/80high macrophages from male and female mice (p>0.05) (Figure 6.1). Conversely, female 
peritoneal macrophages had a small but significant (p<0.05) increased expression of dectin-1 
on their cell surface compared to males (RFI: 4.5±0.17 versus 4.1±0.12, respectively) (Figure 
6.1).  
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Figure 6.2. Basal peritoneal cavity cytokine environment. Cytokine profile of naïve male () 
and female () murine peritoneal lavage supernatants was determined using the Proteome 
Profiler™ mouse cytokine array. (A) Representative arrays with male and female blots exposed 
for equal times. (B) Semi-quantification of cytokines by densitometry. Expression represented 
as pixel density. Data are shown are a mean ± SEM of 2 mice.  
 Basal peritoneal cytokine environments 6.3.2.
The cytokine profile in the resting peritoneal cavity was next investigated using cytokine 
arrays. Peritoneal fluid was obtained from naïve male and female mice and the protein content 
of each sample quantified using the BCA protein assay. Peritoneal cell fractions were analysed 
by flow cytometry and deemed ‘naïve’ if less than 1% of leukocytes were neutrophils. 4mg of 
protein was assayed with the Proteome Profiler™ mouse cytokine array (R&D Systems) and 
male and female membranes were exposed for equal times (3mins) (Figure 6.2A). 
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Densitometry was employed as a semi-quantitative method to determine cytokine expression, 
and densities under 500AU were considered below the range of reliable detection. An 
equivalent profile was also seen when densities were plotted relative to control spots (Control 
spots are shown in Appendix 4). Soluble ICAM-1 (sICAM-1) was the highest expressed molecule 
in both male and female peritoneal fluid however overall few cytokines were present in high 
quantities (Figure 6.2B). Complement component C5a showed a trend towards being greater in 
male compared to female peritoneal fluid. Conversely, the mean CCL2 was higher in the 
female versus male cavity. All other cytokines showed similar expression between the 
peritoneal fluids of untreated male and female mice.  
To obtain a full profile of basal mediators in the naïve peritoneum, 4mg of protein from the 
same samples were assayed with the Proteome Profiler™ mouse chemokine array (R&D 
Systems). Blots, as shown in Figure 6.3A, were again subjected to densitometry for semi-
quantification of chemokine expression. CCL6, chemerin, and CCL9 were in relative abundance 
in the naïve peritoneal fluid (Figure 6.3B). Overall, of the panel of chemokines studied, levels 
were similar between males and females.   
Figure 6.3. Basal peritoneal cavity chemokine environment. Chemokine profile of naïve male 
() and female () murine peritoneal lavage supernatants was determined using the 
Proteome Profiler™ mouse chemokine array. (A) Male and female arrays (n=1) as exposed for 
equal times. (B) Semi-quantification of cytokines by densitometry. Expression represented as 
pixel density.  
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 Zymosan-mediated cytokine environments 6.3.3.
Having established comparable basal peritoneal cytokine environments in male and female 
mice, the inflammatory cytokine profile was next investigated. Mice were treated with 
zymosan (1mg, i.p.) for 3h, the time point at which dimorphisms in the accumulation of 
leukocytes in the blood and tissue were observed. Peritoneal lavage yielded fluid for the 
assessment of cytokines, and cells for the assessment of inflammation as determined by 
neutrophil accumulation. Peritoneal conditions were evaluated as ‘inflamed’ to a degree 
Figure 6.4. Peak inflammation peritoneal cytokine profile. Male () and female () mice 
were treated with zymosan (1mg, i.p.) for 3h and the cytokine content of the peritoneal lavage  
supernatants were determined by Proteome Profiler™ mouse cytokine array. (A) 
Representative arrays. (B) Cytokine expression as semi-quantified by densitometry. Data 
shown is mean ± SEM of 2 experiments. 
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Figure 6.5. Peak inflammation peritoneal chemokine profile. Zymosan (1mg, i.p.) was 
administered to male () and female () mice to induce peritonitis. The cytokine content of 
the peritoneal lavage fluids after 3h of peritonitis were determined by Proteome Profiler™ 
mouse chemokine array. (A) Representative arrays. (B) Chemokine expression as semi-
quantified by densitometry. n=1. 
analogous to those in previous chapters if greater than 50% of cells were neutrophils. Protein 
contents of male and female peritoneal lavage fluid were determined by the BCA protein assay 
and Proteome Profiler™ cytokine array membranes were subsequently incubated with equal 
amounts of protein (4mg). In addition, membranes of male and female mice were exposed for 
the same time (3mins). In comparison to the naïve peritoneal cytokine profiles (Figure 6.2), 
peritoneal samples from mice after 3h of zymosan peritonitis indicated induced expression of 
numerous cytokines (Figure 6.4A). Semi-quantification by densitometry revealed the most 
highly expressed cytokines to be IL-6, CXCL10, CCL2 and CXCL1 (Figure 6.4B). The expression of 
TIMP-1, sCIAM-1, G-CSF, C5a, IL-1β, M-CSF, CXCL2, IL-1ra, and CCL4 were also induced above 
the 500AU limit of accurate quantification enforced. No large sex-differences in the expression 
of the key cytokines were observed, however small trends towards greater levels of C5a, IL-6, 
TREM-1 and IL-1β in male versus female mice were observed.  
By the same means, and to fully establish the inflammatory cytokine profile in early zymosan 
peritonitis, the Proteome Profiler™ mouse chemokine array was also employed. In a similar 
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fashion to the cytokine array, there was clear induction of chemokine expression in zymosan-
treated mice in comparison to naïve animals (Figure 6.5A). Increased expression in CCL6, CCL9, 
IL-16, CXCL10, CCL2, CXCL1, C5a, CCL12 and CCL8 were evident (Figure 6.5B). Of note, 
chemokine levels as measured by array with densitometry were similar between male and 
female mice.  
As peritoneal cavity cytokine and chemokine environments had thus far proved similar 
between male and female mice, an earlier time point was investigated. Sex-differences in 
leukocyte recruitment in peritonitis were evident at 3h, therefore it was rationalised that 
establishment of chemokine gradients would be generated prior to this time point. Male and 
female mice were therefore given zymosan (1mg, i.p.) and the peritoneal lavage taken after 
1h. Lavage supernatants were assessed for protein content using the BCA protein assay and 
5.9mg protein were analysed using the Proteome Profiler™ mouse cytokine array (Figure 
6.6A). High expression of C5a, sICAM-1, IL-6, CXCL10, CXCL1, M-CSF, CCL2, CXCL2 and TIMP-1, 
as quantified by densitometry, demonstrated the early-inflamed profile of peritoneal cavity 
was more abundant in cytokines versus control conditions (Figure 6.6B). Expression of 
cytokines was similar between male and female mice, with the exception of CCL3, which 
despite low expression, was 3-fold higher in male mice. 
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Figure 6.6. Early peritonitis cytokine environment. Male () and female () mice were 
treated with intraperitoneal zymosan (1mg, 1h) to induce peritonitis. Peritoneal lavage 
supernatants were analysed for the cytokine profile using Proteome Profiler™ mouse cytokine 
array. (A) Male and female membranes, as exposed for equal times. (B) Cytokines expression 
as determined by densitometry (n=1).  
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 Discussion 6.4.
This chapter investigated the initiation stages of the immune response to explore the potential 
mechanisms that underlie sexual dimorphisms in leukocyte recruitment during peritonitis. 
Detection of intraperitoneal zymosan occurs through PRRs TLR2, TLR6, and dectin-1 on 
resident peritoneal macrophages. The TLR2-TLR6 heterodimer is required for the inflammatory 
response and activation of NFκB. Dectin-1 on the other hand is a C-type lectin family member 
that despite involvement in induction of classical inflammatory responses is also responsible 
for zymosan phagocytosis (Gantner et al., 2003). Ligation of this receptor has been shown to 
enhance TLR-mediated activation of NFκB, but also to trigger the production of ROS. It should 
be noted however that this is not an exhaustive characterisation of the expression of zymosan 
receptors as complement receptors CR3 and C5aR have also been implicated in its detection 
(Ross et al., 1985; Mullaly et al., 2007).  
As already demonstrated in Chapter 3, resident peritoneal macrophages from male and female 
mice exhibit similar cell surface expression of TLR2. This chapter extends this finding to equally 
show the expression of TLR6 is not significantly different between sexes, indicating 
dimorphisms in the leukocyte recruitment response is unlikely to stem from differences in 
zymosan recognition and thus TLR activation. Similar TLR6 expression between the sexes is in 
line with previously published mRNA data (Scotland et al., 2011). On the other hand, 
macrophages from female mice show a small but nevertheless significant increase in the 
expression of the zymosan phagocytosis receptor dectin-1 compared to male macrophages. 
Although this does not represent a vast difference in cell phenotype between the sexes, it is in 
line with previous reports of greater uptake of zymosan in female versus male macrophages 
(Scotland et al., 2011). To fully determine any sex-differences in the ability of the peritoneal 
cavity to detect zymosan however, it would be useful to also assess the expression of the 
afformentioned complement receptors C3R and C5aR. In addition it would be of use to 
investigate the expression of TLR2/TLR6 on other resident peritoneal cells such as mesothelial 
cells and mast cells to fully dismiss dimorphisms in zymosan recognition. 
Having demonstrated similar zymosan-sensing apparatus of peritoneal macrophages, the 
production of cytokines was next investigated. It was hypothesised that differences in the 
nature and amount of cytokines and chemokines produced by male and female peritoneal 
immune cells could account for sex-differences in accumulation of leukocytes both in the 
tissue and the circulation. Sex-differences in leukocyte recruitment have previously been 
linked to cytokine production in the literature as more chemokine prodcution in male rats with 
abdominal aortic aneurysms correlated with more neutrophil accumulation in males, whilst 
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the opposite was true for equally treated female rats (Sinha et al., 2006). However despite 
indications for sex-differences in both leukocyte recruitment and cytokine production in the 
literature, few studies connect the two, leaving a lack of evidence for the underlying cause of 
dimorphisms in inflammatory diseases.  
Under basal conditions sICAM-1, CCL6, chemerin, and CCL9 were most highly expressed in the 
peritoneal fluid (Table 6.1). sICAM-1 generation is not well defined, however it is proposed 
both that cell surface ICAM-1 shedding by proteases, and specific sICAM-1 transcription are 
possible (Witkowska et al., 2004). The exact reason for high sICAM-1 in unstimulated 
conditions in this chapter is unclear as it is generally associated with pro-inflammatory 
responses, however nanomolar range concentrations have previous been identified in the 
serum of healthy volunteers indicating some basal levels are normal (Lawson et al., 2009).  
Cytokine 
Alternative 
Name 
Receptor/ Target 
Chemoattractant 
Neutrophils          Monocytes 
CCL2 MCP-1 CCR2   
IL-6 - IL-6Ra + gp130 - - 
CXCL10 IP-10 CXCR3   
TIMP-1 - MMP2, MMP9 - - 
CXCL1 KC CXCR2   
sICAM-1 CD54 LFA-1, Mac-1, fibrinogen - - 
C5a - C5aR1   
CXCL2 MIP-2α CXCR2   
CCL6 C10 CCR1   
CCL9 MIP-1γ/ CCL10 CCR1   
G-CSF - G-CSF-R - - 
IL-1β - IL-1R1 - - 
M-CSF - CSF-1R - - 
Chemerin RARRES2 CMKLR1 - - 
IL-16 - CD4 - - 
CCL4 MIP-1β CCR1, CCR5   
CCL8 MCP-2 CCR1, CCR2, CCR5   
Table 6.1. Key cytokines and chemokines produced during early murine zymosan peritonitis. 
Mice were treated with zymosan (1mg, i.p.) for 3h and the cytokine profile of the peritoneal 
cavity was assessed by Proteome Profiler™ arrays. Details of the highest expressed cytokines 
are presented alongside their reported function to act as neutrophil or monocyte 
chemoattractants. Hyphen (-) indicates the molecule does not directly possess chemokine 
activity. 
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One study however showed micromolar concentrations of sICAM-1 inhibit the ICAM-1/LFA-1 
interaction in vitro (Meyer et al., 1995), suggesting that in naïve mice high sICAM-1 may have 
the potential to maintain tissue homeostasis by damping the inflammatory outcomes of such 
an interaction. ELISA of the peritoneal fluid would be required to fully quantify the levels of 
sICAM-1 in mice to begin investigating it’s function in the naïve peritoneum. CCL6 is expressed 
in relatively high levels as determined by chemokine array and densitometry. This is in contrast 
to another study which showed low CCL6 levels (<0.5ng/ml) in the control peritoneal cavity by 
ELISA (Coelho et al., 2007). The cell surface receptor for CCL6 is CCR1, thus CCL6 is chemotactic 
for monocytes (LaFleur et al., 2004; Berahovich et al., 2005). Put in context alongside previous 
descriptions of myeloid cell differentiation (Nardi et al., 2009), it may be possible that via 
CCR1, CCL6 in the naïve peritoneal cavity is playing a role in monocyte recruitment and 
differentiation for the repopulation of resident macrophages.  
Also found to be present in similar levels to CCL6 was chemerin, known also as retinoic acid 
receptor responder protein 2 (RARRES2). Chemerin is chemotactic for macrophages and DCs 
by binding to CMKLR1 (Wittamer et al., 2003) and therefore it may play a role in the 
homeostasis of the naïve peritoneal cavity. Furthermore, chemerin is highly expressed in white 
adipose tissue and has been implicated in adipocyte biology (Bozaoglu et al., 2007), therefore 
it is also possible peritoneal chemerin is not playing a role in immune regulation, but rather is 
functioning with respect to the peritoneal fat observed in these mice. Also in abundance in the 
naïve cavity was CCL9, a chemokine constitutively expressed in macrophages and also secreted 
from follicle-associated epithelium such as those present around Peyer’s patches (Zhao et al., 
2003). As both macrophages and Peyer’s patches are found within the peritoneal cavity, it is 
unsurprising CCL9 was relatively highly expressed. CCL9 is known to be chemotactic for DCs 
and monocytes, both of which express the CCL9 receptor CCR1 (Berahovich et al., 2005). It 
could be speculated that high basal CCL9 is required for recruitment of these cells for 
repopulation of the cavity with DCs and macrophages. Further experiments would 
nevertheless need to be carried out to determine such hypotheses on the function of highly 
expressed basal chemokines.  
Importantly, no sex-differences were observed in the peritoneal fluids of male and female 
naïve mice besides in levels of CCL2. Levels of this chemokine in female mice were 
heterogenous with one high expressing and one low expressing mouse, therefore more 
samples would be required to determine whether female mice have more basal CCL2 than 
males. If this were the case, it may offer explanation to the previous findings in this thesis, and 
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published reports, that more resident macrophages are present in the female peritoneal cavity 
(Scotland et al., 2011).  
In line with the nature of the inflammatory response, cytokine and chemokine expression was 
amplified by 3h of zymosan peritonitis in comparison to basal conditions. Cytokines with 
augmented expression were comprised of classical proinflammatory mediators (i.e. IL-1β, C5a, 
and IL-6), neutrophil-associated chemokines (i.e. CXCL1 and CXCL2), and monocyte-associated 
chemokines (i.e. CCL2, CXCL10, CCL8). In addition, growth factors (i.e. G-CSF and M-CSF) and 
inflammation inhibitors (i.e. TIMP-1 and IL-1ra) were also induced during zymosan peritonitis 
(Table 6.1). Contrary to other reports, only a small amount of TNF was produced after 3h of 
zymosan versus control, however arrays such as those used in these studies are only semi-
quantitative compared to the ELISAs describing TNF responses in the literature (Gantner et al., 
2003). Likewise to the analysis of basal conditions, no clear differences in the cytokine and 
chemokine responses were evident between the sexes after 3h of zymosan peritonitis. Sex-
differences in leukocyte recruitment were observed by 3h, therefore an early 1h peritonitis 
time point was investaged as establishment of chemotactic gradients would have been 
required prior to leukocyte recruitment. Peritoneal cytokine expression was indeed already 
augmented at the 1h early time point compared to control. CCL3 and IL-1β levels appeared 
greater in male peritoneal fluid versus females however female values were on the border of 
accurate detection. The levels of all other cytokines were once more not different between 
male and female mice, although small trends resembling sexual dimorphisms were observed, 
such as for C5a, IL-16, IL-1β, and TREM-1. It might be suggested that such minor differences in 
the context of this degree of inflammation (accumulation of approximately 8-11x107 
neutrophils) is unlikely to account for such disparity in the recruitment of male and female 
leukocytes.  
Key findings: 
 Male and female mouse resident peritoneal macrophages exhibit similar levels of 
zymosan-sensing TLR2/TLR6. 
 Dectin-1 expression on female peritoneal macrophages is small but significantly greater 
than males. 
 Zymosan peritonitis induced upregulation of a plethora of cytokines and chemokines as 
early as 1h, including neutrophil and monocyte chemoattractants. 
 No major sex-differences in cytokine and chemokine profile or expression level, as 
determined by array, were evident in naïve or zymosan-treated mice. 
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 Mobilisation of bone marrow leukocyte stores Chapter 7:
 Introduction  7.1.
Uncontrolled influx of immune cells such as neutrophils can have dangerous consequences and 
have been implicated in the pathogenesis of many inflammatory diseases such as sepsis, I/R 
injury, and arthritis. One of the first steps in the trafficking of immune cells to the site of 
infection however, is mobilisation of leukocytes from the bone marrow (BM). It represents a 
large and rapidly releasable source of leukocytes and is therefore highly important. 
Mobilisation of BM stores can vastly expand the number of circulating leukocytes, thus 
amplifying the total number of cells available for recruitment. The BM therefore functions not 
only as a site of haematopoiesis, but also as a readily releasable cellular storage pool. 
Chapter 4 of this thesis shows that female mice accumulate fewer neutrophils and classical 
monocytes in their circulation and tissue during zymosan peritonitis in comparison to male 
counterparts. Similarly, in certain inflammatory diseases men display more exaggerated 
responses compared to women. Increasing evidence suggests this may be the result of 
augmented leukocyte recruitment (Marriott et al., 2006a; Scotland et al., 2011). The 
mechanism behind this theory and the source of additional leukocytes in males are not 
however clear. What is clear is that the BM is pivotal as a source of leukocytes for defence 
from infection, and furthermore much literature is available detailing mechanisms regulating 
leukocyte production, retention, and release (Borregaard, 2010; Shi et al., 2011a). Whether 
sex-differences in the mobilisation of these stores in inflammation exist however has not been 
studied. 
BM classical monocytes have recently been shown to emigrate in response to circulating TLR 
ligands (Shi et al., 2011b). In addition, BM neutrophils and monocytes have been shown in the 
literature and in this thesis to express cell surface TLRs including TLR2 and TLR4 (Charmoy et 
al., 2007; Papatriantafyllou, 2011; Thomas et al., 2013). This thesis has already described that 
neutrophils from the BM of male mice are significantly higher in TLR2 and TLR4 than those 
from female mice. To complement these findings and further dissect whether this difference in 
TLR expression plays a role in leukocyte trafficking beyond PAMP and DAMP recognition in the 
tissue, the expression of BM leukocyte TLRs during the inflammatory reaction of zymosan 
peritonitis was also investigated.    
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 Aims 7.2.
As similar pattern recognition and cytokine responses in male and female mice fail to explain 
the sex-differences in leukocyte recruitment during zymosan peritonitis, the BM of male and 
female mice was investigated. This chapter sought to evaluate the TLR characteristics of BM 
leukocytes and test the hypothesis that differences in the mobilisation of BM leukocyte stores 
underlie protection from circulating and tissue leukocyte accumulation observed in zymosan 
peritonitis. Therefore the specific aims were to: 
 Investigate sex-differences in mobilisation of BM leukocytes during murine zymosan 
peritonitis.  
 Compare the BM leukocyte temporal TLR2 and TLR4 expression profile during 
inflammation in male and female mice. 
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 Results 7.3.
 BM leukocyte mobilisation in murine zymosan peritonitis 7.3.1.
Zymosan peritonitis (1mg, i.p.) induced significant trafficking of neutrophils (p<0.001), classical 
monocytes (p<0.001), B cells (p<0.05) and T cells (p<0.01), with a trend in non-classical 
monocytes (p=0.051) (Figure 7.1). Neutrophils reduced approximate 2-fold in number in the 
BM of male and female mice after 3h compared to control conditions (male: 0h: 6.1±0.54 x106, 
3h: 3.6±0.64 x106; female: 0h: 5.2±0.41 x106, 3h: 2.7±0.24 x106, Figure 7.1A). By the same 
pattern, classical monocyte numbers in the BM were also reduced around 2-fold by 3h in male 
and female mice compared to controls (male: 0h: 12.7±1.59 x105, 3h: 6.3±0.81 x105; female: 
0h: 11.0±0.12 x105, 3h: 5.6±0.53 x105, Figure 7.1B). Non-classical monocytes displayed a small 
trend to reduced cell numbers in response to zymosan (Figure 7.1C). By 72h, neutrophils and 
monocytes returned to levels comparable to basal conditions. 3h of zymosan peritonitis 
induced a trend towards a transient increase in BM B220+ B cell numbers in both sexes (Figure 
7.1D). Zymosan did not affect BM CD3+ T cell numbers in male mice however and increase in 
cell numbers at 3h was seen in the female BM, resulting in more cells in the female versus the 
male BM at this early time point (4.1±0.44 x105 vs 2.4±0.41 x105, Figure 7.1E). By 24h, female T 
cell numbers decreased to that of control. 
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Figure 7.1. Leukocyte mobilisation from the murine BM during peritonitis. Zymosan (1mg, 
i.p.) was administered to male () and female () mice to induce peritonitis. (A) Numbers of 
neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) B220+ B cells and (E) CD3+ 
T cells were counted from the right femur bone marrow at the indicated time points. Data are 
presented as the mean ± SEM of n mice. For neutrophils and monocytes: n≥8 (0h), n=13 (3h), 
n=9 (24h), n=3 (48-96h); B and T cells: n≥9 (0h), n≥10 (3h), n≥5 (24h). Male and female 
mobilisation was compared by 2-way ANOVA with Bonferroni’s post-test, and significance 
indicated by * (p<0.05).  
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Figure 7.2. Neutrophil CXCR4 expression. Zymosan (1mg, i.p.) was administered to male () 
and female () mice to induce peritonitis. The expression of CXCR4 on neutrophils isolated 
from (A) blood and (B) BM at 0h, 3h, 24h, 48h, 72h, and 96h was evaluated. CXCR4 was 
expressed at relative fluorescence intensity (RFI) to isotype antibody. Data is expressed as 
mean ± SEM of 3 (0h) or 2 mice (3-96h). 
 The CXCR4/CXCL12 axis 7.3.2.
Sex-differences in the accumulation of leukocytes in the circulation and tissue during 
peritonitis were not explained by the hypothesis of differential mobilisation of BM stores. To 
confirm these findings, the expression of CXCR4 on neutrophils was assessed between the 
sexes with the rationale that high CXCR4 expression is indicative of homing back to the BM, 
whilst low CXCR4 suggests mobilisation. Very low (RFI<2) and unchanging expression of CXCR4 
was seen on neutrophils in the male and female mouse circulation throughout zymosan 
peritonitis until 96h (Figure 7.2A). CXCR4 expression on neutrophils in the BM was both higher 
and more variable in response to zymosan (Figure 7.2B). Lowest expression was observed at 
3h, whilst highest was seen at 24h post-zymosan. By 72h CXCR4 had returned to basal levels. 
Under basal conditions, a trend towards higher CXCR4 expression on male compared to female 
BM neutrophils was seen. 
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 Temporal expression profile of BM leukocyte TLR2 and TLR4 in murine 7.3.3.
zymosan peritonitis 
In response to zymosan peritonitis, female BM neutrophils had significantly (p<0.01) increased 
expression of TLR2 by 24h (0h: 1.5±0.08; 24h: 2.1±0.15) that returned to levels equivalent to 
control by 48h (Figure 7.3A). Male mouse neutrophils showed a trend toward this. No 
significant changes in the expression of TLR2 on BM classical- and non-classical monocytes, B 
cells, or T cells was observed at the time points studied in response to zymosan (Figure 7.3B-E). 
Both monocyte subsets however showed a similar, albeit not significant, pattern to that 
described for neutrophils with a trend to increased TLR2 expression at 24h that returned to 
basal levels by 48h.   
The expression profile of female BM neutrophil TLR4 during zymosan peritonitis was analogous 
to that of TLR2, increasing significantly (p<0.001) at 24h (0h: 2.0±0.17; 24h: 3.5±0.29) and 
returning to control levels by 48h (Figure 7.4A). Although not significant, a trend toward 
increased BM neutrophil TLR4 was also evident in male mice. Female BM classical monocyte 
TLR4 showed the same pattern, with a significant but transient increase in receptor expression 
at 24h (0h: 2.3±0.26; 24h: 3.8±0.42) that again returned to levels comparable to control by 48h 
(Figure 7.4B). No significant differences in the expression of TLR4 on male BM classical 
monocytes was seen however a trend towards the transient increased at 24h was observed. 
The expression of TLR4 on non-classical monocytes, B cells, and T cells in the BM was similar 
throughout the peritonitis (Figure 7.4C-E).  
 
 
Chapter 7 
 
127 
 
  
Figure 7.3. Temporal expression profile of BM leukocyte TLR2 during zymosan peritonitis. BM 
leukocytes were isolated at the indicated time points from male () and female () mice 
treated with zymosan (1mg, i.p.) to induce peritonitis. TLR2 expression was assessed on the 
surface of (A) neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) B220+ B 
cells, and (E) CD3+ T cells. TLR2 was expressed as relative fluorescence intensity (RFI) to isotype 
control antibody. Change in expression versus control (0h) conditions was determined by 1-
way ANOVA with Bonferroni’s post-test for multiple comparisons and significant differences in 
males were indicated by # (p<0.05) and in females by ** (p<0.01). Data are presented as mean 
± SEM of n mice where for neutrophils and monocytes n=8 (0h), n≥8 (3h), n=9 (24h), n=3 (48h, 
72h, 96h), and for B and T cells n≥5 (0h, 3h, 24h).  
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Figure 7.4. Temporal profile of BM leukocyte TLR4 expression during zymosan peritonitis. 
Male () and female () mice were treated with zymosan (1mg, i.p.). Cell surface TLR4 was 
evaluated on (A) neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) B220+ B 
cells, and (E) CD3+ T cells isolated from the BM at the indicated times after induction of 
inflammation. TLR4 was expressed as relative fluorescence intensity (RFI) to isotype control 
antibody. Changes in expression over time versus under control conditions (0h) were 
determined by 1-way ANOVA followed by Bonferroni’s post-test for multiple comparisons. 
Significant differences in males were indicated by # (p<0.05) and in females by * (p<0.05), and 
*** (p<0.001). Data are presented as mean ± SEM of n mice where for neutrophils and 
monocytes n=8 (0h), n≥8 (3h), n=9 (24h), n=3 (48h, 72h, 96h), and for B and T cells n≥5 (0h, 3h, 
24h).  
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 Discussion 7.4.
The BM represents the site of both production and storage of many innate immune cells. For 
example it contains a large storage pool of mature neutrophils, termed the BM reserve (Furze 
et al., 2008). The rate of the release of these cells has been demonstrated as a major 
determinant of the number of circulating neutrophils (Martin et al., 2003a). The results in the 
chapter show clearly that the murine BM represents a reserve of mature leukocytes. In 
response to zymosan peritonitis, a rapid, significant reduction in the number of both 
neutrophils and classical monocytes is indicative of their mobilisation (Figure 7.5). Indeed, at 
3h post induction of inflammation when BM leukocytes are at their lowest, circulating 
counterparts consequently peak in number. Previous studies have shown that zymosan 
Figure 7.5. Summary of leukocyte trafficking in murine bone marrow during zymosan 
peritonitis. Summary of neutrophils, classical-monocytes, non-classical monocytes, B cells, and 
T cells in bone marrow of male ( ) and female ( ) mice treated with zymosan to induce 
peritonitis. Solid arrows indicate either increase (↑) or decreased (↓) numbers after 3h in 
male and female mice. Larger arrows indicate greater increase or decrease in cell number. 
Broken arrows represent likely trafficking between compartments. No arrows signify no 
change in cell number or no suggestion of trafficking.  
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induces mobilisation of neutrophils from the BM at a similar time point and to a similar extent 
than described in this chapter (Takeshita et al., 2004). No description of the mobilisation of BM 
classical monocytes has however been reported for this reaction. Mobilisation of neutrophils 
and classical monocytes from the BM in response to zymosan peritonitis was evident to the 
same extent in male and female mice.  
Measurement of mobilisation by this method may be deemed crude by some and potentially 
even masking any sex-differences, however at present it represents the standard approach in 
studying such responses of BM leukocytes. More recently, a more accurately quantifiable 
method of mobilisation was developed whereby femoral artery and vein cannulation in situ 
allows perfusion of the hind limb vasculature and thus collection of exiting cells (Pitchford et 
al., 2010). Such a method could be utilised to confirm the mobilisation findings in this thesis, 
and furthermore confirm similar mobilisation in male and female mice. 
To confirm the lack of sexual dimorphism in the BM leukocyte responses to zymosan, 
neutrophil retention signal was studied. It is well documented that CXCL12 (SDF-1α), produced 
constitutively in the BM by stromal cells, acts via neutrophil CXCR4, creating a mechanism of 
neutrophil retention in the BM (Eash et al., 2010). During inflammation BM neutrophil CXCR4 
is downregulated and CXCR2 is upregulated causing the cells to lose their CXCL12 retention 
signal, and become chemotactic towards circulating CXCR2 ligands (i.e. CXCL2) (Furze et al., 
2008). Moreover, senescent circulating neutrophils are considered to upregulate CXCR4 and in 
doing so acquire the ability to migrate towards CXCL12 and thus home back to the BM for 
clearance (Martin et al., 2003a; Rankin, 2010). In line with previous reports, neutrophils from 
the blood of male and female mice were consistently low in CXCR4 on their cell surface (Martin 
et al., 2003a).  In contrast, expression of CXCR4 on BM neutrophils was higher than those in 
the circulation. Interestingly, expression was highest at 24h perhaps suggestive of aged 
neutrophils returning to the BM after peaking in number earlier in the circulation. After 24h, 
BM neutrophil CXCR4 expression declined as the inflammation reached resolution. No sex-
differences in CXCR4 expression were observed during zymosan peritonitis, in particular at 3h 
when male mice had more leukocytes both in their circulation and tissue compared to female 
mice. Under naïve conditions however, males showed a trend towards greater CXCR4 
expression on BM neutrophils, contrary to possible hypothesis than a ‘weaker’ BM 
CXCR4/CXCL12 retention axis may result in greater release of neutrophils in inflammation. Low 
n numbers however mean direct conclusions are not possible, nevertheless no sex-differences 
in CXCR4 expression back up similar mobilisation profiles in male and female mice in response 
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to zymosan. It would also be useful to evaluate monocyte CCR2 expression between the sexes 
to confirm no differences in the CCL2/CCL7/CCR2 axis. 
This chapter also continued the investigation of a role of leukocyte TLRs in trafficking beyond 
local PAMP and DAMP recognition. As demonstrated in Chapter 3, male BM neutrophils are 
significantly higher in TLR2 and TLR4 than female equivalents. Such differences in PPRs may 
indicate a role for TLRs in the mobilisation and migration of leukocytes from the BM to the site 
of inflammatory insult. Temporal analysis of leukocyte subset TLRs during zymosan peritonitis 
indicated little change in the expression of TLR2 and TLR4 on BM leukocytes. Exceptions 
include neutrophils, specifically at 24h after induction of peritonitis, which show higher 
expression of both receptors significantly in females and with a trend in males. In addition, 
classical monocyte TLR4 is also higher at 24h significantly in females and with a trend in males. 
The reasons for this modulation of TLR expression solely at this time point are unclear. 
Alternatively, due to a reduced size of the neutrophil and classical monocyte reserve pools at 
this time point, it is plausible that these remaining cells would require a heightened capacity to 
respond to pathogens or damaged tissue whilst newer leukocytes reach maturation to 
replenish the pool. It is possible also that BM mobilisation occurs by numerous methods with 
initial disruption of retention signals triggering a first wave (i.e. at 3h), and by 24h a large 
enough chemokine gradient would be established in the plasma to further draw leukocytes 
from their remote stores in a second wave. These later cells may be in a more activated state 
than early in the inflammation and may therefore have upregulated TLRs. Although such large 
chemotactic gradients are reported to occur (Jia et al., 2008), no evidence for release of BM 
leukocytes at this time point is evident in the circulation. It should also be noted that 
elevations in TLR expression are only small and with this in mind the biological relevance of 
such a small alteration in expression may be questioned.  
A final explanation for temporal differences in TLR expression amongst neutrophils only in 
zymosan peritonitis may lie within different subsets. A subset of neutrophils identified as 
CD11cbrightCD62LdimCD11bbrightCD16bright in the circulation has been shown to suppress T cell 
proliferation in vivo (Pillay et al., 2012). It is conceivable the origin of such cells is indeed the 
BM, and by 24h post induction of inflammation it is again plausible T cell proliferation would 
be favourable. These studies were however described in humans therefore further analysis of 
these cells would be required. For example, investigations into hydrogen peroxide release, 
nuclear morphology, and integrin Mac-1 expression, all of which were either distinct or 
required for suppression of human T cells by the above-mentioned neutrophils.  
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Overall, it is clear that murine zymosan peritonitis induces mobilisation of BM leukocyte stores, 
most prominently those of neutrophils and classical monocytes. Sexual dimorphisms in 
leukocyte accumulation in the blood and peritoneal cavity are not however explained by 
differential utilisation of BM stores as mobilisation is equivalent in male and female mice. This 
is further backed up by similar expression of CXCR4 between the sexes. Additionally, BM 
leukocyte TLR2 and TLR4 overall demonstrated limited modulation of expression, further 
suggestive of a redundant role for them in the BM as one might expect.       
Key findings: 
 Zymosan peritonitis induces mobilisation of neutrophils and classical monocytes from the 
mouse BM by 3h. 
 The degree and temporal profile of neutrophil and classical monocyte BM mobilisation is 
similar in male and female mice. 
 Similar mobilisation profiles between male and female mice were consolidated with 
similar neutrophils CXCR4 expression during zymosan peritonitis.  
 Female mouse BM neutrophils have significantly greater expression of TLR2 and TLR4 on 
neutrophils at 24h post induction of peritonitis versus resting conditions. Male mouse 
neutrophils show the same trend.  
 No other major changes in the expression of TLR2 and TLR4 on BM leukocytes were 
evident in response to zymosan. 
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 The spleen as a leukocyte storage pool Chapter 8:
 Introductions  8.1.
The spleen is considered a multifunctional organ with roles in blood filtration, removal of old 
erythrocytes, metabolism of senescent cells and haemoglobin, as well as in antibody synthesis 
(Bronte et al., 2013). It consists of mainly B and T lymphocytes, and specialised splenic 
macrophages. Despite its multiple complex functions, the exact importance of the spleen is 
unclear, as both human and rodents who have undergone splenectomy are able to live a 
normal life (Robinette et al., 1977; Higashijima et al., 2009). The main risk of splenectomy is 
infection, however such a risk is routinely controlled by regular low-dose antibiotics (Mebius et 
al., 2005). 
More recently, alternative roles for the spleen have been proposed. The BM is well accepted, 
and also demonstrated in Chapter 3 of this thesis, to represent a large leukocyte storage pool 
(Ma et al., 1999). The spleen of mice has recently also been shown to have a similar role 
(Swirski et al., 2009). It was reported to exhibit a population of bone fide monocytes, 
undifferentiated and analogous to those in the circulation. In accordance with these previous 
reports, Chapter 3 also showed the presence of both classical and non-classical monocytes in 
the resting spleen. In response to MI, Ly6C(Gr1)high classical monocytes are reported to rapidly 
exit the spleen, and not the BM, and migrate to the damaged myocardium. Accordingly, 
splenic classical, but not non-classical, monocytes enter the circulation and accumulate in 
lesions in atherosclerosis-prone mice (Robbins et al., 2012). It is however unclear whether this 
occurs in diverse inflammatory models. Of note, the spleen did not contribute neutrophils in 
the former model despite these cells being present in the injured tissue, thus the BM is the 
likely primary site for neutrophil mobilisation in MI.  
Characterisation of the role of the spleen in disease is poor, meaning its role as a leukocyte 
reservoir is unclear. It is essential more studies are done to establish its function in this 
context. Chapter 3 showed that neutrophils are present in the resting spleen. More recent 
studies have also demonstrated splenic neutrophils were found in the B cell area and exhibited 
specific functions in the context of splenic B cells (Puga et al., 2012). The existence and 
proportionality of neutrophils, and neutrophil subsets with specific functions, is not well 
documented. Overall, it is clear that great naivety still exists with regards to the function of the 
spleen, and more specifically with its role in the immune response and inflammation.  
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Blood flow through the highly organised splenic structures, each of which contains specific sets 
of immune cells, suggests the spleen has an important role in immune surveillance. Marginal 
zone and marginal zone metallophillic macrophages are two splenic macrophage subsets 
possessing specific sets of PRRs that are capable of trapping circulating pathogens (Mebius et 
al., 2005; Bronte et al., 2013). The role of other splenic innate immune cells, such as 
monocytes and neutrophils, in the context of PAMP and DAMP recognition, is poorly 
documented, as is the TLR expression profile of splenic leukocytes.  
The presence of mature monocytes and neutrophils has therefore been established in the 
spleen, however to date no reports of sex-differences exist. Previous results in this thesis have 
demonstrated similar basal leukocyte numbers in the BM of male and female mice. In addition, 
no sex-differences in their BM mobilisation profiles were evident in response to zymosan 
peritonitis. In order to explain the sexual dimorphism in leukocyte accumulation in the blood 
and tissue during peritonitis the spleen was investigated as a source of leukocytes. More 
specifically, a source of leukocytes this thesis has already demonstrated to be different in male 
and female mice. Understanding the role of the spleen in male and female mice in 
inflammation is crucial to full understanding of sex-differences in the murine zymosan 
peritonitis model.  
 Aims 8.2.
Sex-differences in leukocyte trafficking in zymosan peritonitis are evident early in the 
inflammatory reaction. To establish the source of the additional cells male mice possess in 
response to zymosan, the spleen was investigated as significantly more neutrophils and 
monocytes were found in the male resting spleen (Chapter 3). In addition the effect of 
inflammation on innate immune cell TLRs is unclear and will be investigated to finalise the 
temporal characterisation of leukocyte subset TLR expression in different compartments. The 
following specific aims were therefore addressed in this chapter: 
 Investigate changes in leukocyte subset numbers in the spleen during murine zymosan 
peritonitis. 
 Examine sex-differences in leukocyte trafficking in the mouse spleen in response to 
zymosan. 
 Determine the influence of zymosan peritonitis on splenic leukocyte TLR2 and TLR4 
expression in male and female mice. 
 Explore possible mechanisms for sex-differences in basal splenic neutrophil and monocyte 
numbers.  
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 Results 8.3.
 Sex-differences in splenic leukocyte trafficking 8.3.1.
As previously described in Chapter 3 of this thesis, naïve male mouse spleens had significantly 
more neutrophils, classical and non-classical monocytes than female mice. No sex-differences 
in the numbers of splenic lymphocytes were reported. In response to zymosan peritonitis, at 
the time point of 3h when peak neutrophilia and leukocyte recruitment were observed, the 
number of neutrophils in the male spleen were not different to control conditions (p>0.05) 
(Figure 8.1A). Conversely, female mice had significantly (p<0.01) more neutrophils in their 
spleens compared to controls (3h: 5.1±1.72 x106; 0h: 1.9±0.20x106, Figure 8.1A). Zymosan 
peritonitis induced a significant (p<0.05) reduction in the numbers of classical monocytes in 
the male spleen (3h: 0.7±0.14 x106; 0h: 1.6±0.25x106, Figure 8.1B). No change in the number of 
these cells in response to zymosan was seen in females (p>0.05). By 3h of peritonitis, male and 
female mice therefore had similar numbers of splenic neutrophils and monocytes. No change 
in female splenic non-classical monocytes was evident in response to zymosan (Figure 8.1C). 
During this early phase of inflammation, no changes in the numbers of CD3+ T cells or B220+ B 
cells were observed in the spleens of male or female mice compared to control (Figure 8.1D-E). 
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Figure 8.1. Splenic leukocyte subset trafficking during zymosan peritonitis. Male () and 
female () mice were treated with or without zymosan (1mg, i.p.) for 3h. The number of (A) 
neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) B220+ B cells and (E) CD3+ 
T cells in the spleen were assessed for change in leukocyte number in inflammation. Change in 
the number of splenic leukocytes after 3h zymosan compared to control (0h) conditions was 
assessed using Student’s t-test and significance indicated by * (p<0.05) and ** (p<0.01). Data 
are expressed as mean ± SEM of n mice where for 0h n≥11 (males), n≥14 (female), and for 3h 
n≥5.  
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 Splenic leukocyte TLR2 and TLR4 expression in zymosan peritonitis 8.3.2.
Murine splenic leukocytes were shown in Chapter 3 to express TLR2 and TLR4. The influence of 
inflammation on the expression of TLRs on splenic leukocytes was assessed in the zymosan 
peritonitis model, using the 3h time point at which peak leukocyte accumulation responses in 
the periphery were observed.  No sex-differences or modulation of TLR2 on neutrophils, non-
classical monocytes, B cells, or T cells was detected in response to intraperitoneal zymosan 
(Figure 8.2). On the other hand, female classical monocytes at 3h showed trends toward higher 
TLR2 than those at 0h (3h: 3.6±0.28; 0h: 2.4±0.25, Figure 8.2B). As similar trend was also 
observed in male mice.  
Figure 8.2. Splenic leukocyte TLR2 expression in early zymosan peritonitis. TLR2 expression 
was assessed on (A) neutrophils, (B) classical monocytes, (C) non-classical monocytes, (D) 
B220+ B cells, and (E) CD3+ T cells from the spleen of male () and female () mice treated 
with or without zymosan (1mg, i.p.) for 3h to induce peritonitis. Receptor expression was 
displayed as relative fluorescence intensity (RFI) to isotype antibody. Alterations in TLR2 
expression with inflammation (3h) versus control conditions in male and female mice were 
determined by 1-way ANOVA with Bonferroni’s post-test and significant differences indicated 
by * (p<0.05). Data are displayed as mean ± SEM (n≥5).  
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Figure 8.3 Splenic leukocyte TLR4 expression in early zymosan peritonitis. TLR4 expression 
was assessed on the surface of (A) neutrophils, (B) classical monocytes, (C) non-classical 
monocytes, (D) B220+ B cells, and (E) CD3+ T cells from the spleen of male () and female () 
mice treated with or without zymosan (1mg, i.p.) for 3h to induce peritonitis. Receptor 
expression was displayed as relative fluorescence intensity (RFI) to isotype antibody. Changes 
in TLR4 expression in male and female mice with inflammation were determined by S1-way 
ANOVA with Bonferroni’s post-test with significant differences indicated by * (p<0.05). Data 
are displayed as mean ± SEM (n≥5). 
Similar to the observations with TLR2, there was no evidence of modulation of the receptor in 
response to zymosan peritonitis in any of the leukocyte subsets (Figure 8.3).  
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 Basal splenic cytokine environments 8.3.3.
To investigate potential mechanisms for the sex-differences in basal splenic leukocyte 
neutrophil and monocyte numbers, the naïve splenic cytokine/chemokine environment was 
assessed with the rationale that a greater chemotactic ambience in the male spleen would 
result in a larger storage pool of certain leukocyte subsets. The environment of the resting 
spleen was studied using cytokine arrays. Spleen lysate supernatants were obtained from 
naïve male and female mice and the protein contents of each were quantified using the BCA 
protein assay. 1.5mg of protein was assayed with the Proteome Profiler™ mouse cytokine 
array (R&D systems) and the membranes with male and female samples were exposed for 
3mins (Figure 8.4A). Control reference spots confirmed successful assay (Appendix 4). Cytokine 
expression was semi-quantified using densitometry and densities under 500AU were deemed 
below the range of reliable quantification. Of those molecules analysed, CCL5, CXCL9, sICAM-1, 
IL-1ra, CXCL10, and IL-1α were present in the highest levels in the naïve spleen (Figure 8.4B). 
Key monocyte and neutrophil associated chemokines such as CCL2, CXCL1, CXCL2, and CCL3 
were lowly expressed. Of note, similar cytokine/chemokine expression profiles were observed 
in spleens from male and female mice.  
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Figure 8.4. Naïve splenic cytokine environment. Cytokine profile of naïve male () and female 
() murine spleens was determined using the Proteome Profiler™ mouse cytokine array. (A) 
Representative arrays with male and female blots exposed for equal times. (B) Semi-
quantification of cytokines by densitometry. Expression represented as pixel density. Data are 
shown are a mean ± SEM of 2 mice.  
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 Expression profile of leukocyte chemokine receptors in the spleen 8.3.4.
Assessment of the splenic chemokine environment by array revealed similar profiles for male 
and female mice. In addition it revealed the presence of those molecules with neutrophil or 
monocyte chemotactic capabilities such as CCL2, CCL3, CCL5, C5a, and CXCL12, which were 
present in vastly ranging relative quantities, but to similar extents in both sexes. The 
corresponding receptors on leukocyte subsets from the spleens of male and female mice were 
therefore assessed to investigate the observed sexual dimorphisms in the composition of the 
leukocyte splenic reservoir.  
CXCL1 and CXCL2 are potent neutrophil-attracting chemokines that exert their functions via 
CXCR2. Correspondingly, CXCR2 was highly expressed on the splenic neutrophil cell surface, 
Figure 8.5. Basal splenic leukocyte CXC chemokine receptor expression. Leukocytes were 
isolated from the spleens of male () and female () naïve mice. The expression of CXCR2 and 
CXCR4 was assessed on the cell surface of (A) neutrophils, (B) classical monocytes, (C) non-
classical monocyte, (D) B220+ B cells, and (E) CD3+ T cells. Receptor expression is displayed as 
median fluorescence intensity (MFI). Data are displayed as the mean ± SEM (n=6). Differences 
in receptor expression were determined by Student’s t-test and significance indicated by * 
(p<0.05).  
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and expressed less on the surface of the other leukocyte subsets (Figure 8.5). No significant 
difference between the expression of CXCR2 on the surface of male and female splenic 
leukocytes was observed (p>0.05). CXCL12 on the other hand acts on CXCR4 on neutrophils, 
but also on monocytes, to retain these cells in the BM. CXCR4 was expressed in similar levels 
on the surface of neutrophils, monocyte subsets, and B cells from the spleen (Figure 8.5). Non-
classical monocytes from the female spleen however, had significantly (p<0.05) higher levels of 
CXCR4 than those from the male spleen (female MFI: 3003±359.6; male MFI: 1821±108.9, 
Figure 8.5C).   
Chemokines CCL2, CCL3, and CCL5 were all detectable, albeit at low levels, in the mouse spleen 
as determined by cytokine array. CC chemokines are more promiscuous than those containing 
the CXC motif and exert their effects through binding to a selection of CC chemokine 
receptors. CCR1, CCR2, CCR3 and CCR5 represent key monocyte chemokine receptors that are 
associated with the above ligands. CCR1 represents a receptor for an array of ligands primarily 
chemotactic for monocytes but in some cases for neutrophils also. Consequently, CCR1 was 
most highly expressed on the monocyte subsets and neutrophils, but was also expressed on T 
cells, in line with CCL5 also a T cell chemoattractant, and B cells (Figure 8.6). CCR2, the 
receptor responsible for the chemotactic properties of CCL2 for classical monocytes, are well 
documented, and it is known not to attract neutrophils. In the spleen, CCR2 was found to be 
most highly expressed on classical monocytes, followed by the non-classical subset, with very 
low expression on neutrophils and lymphocytes (Figure 8.6). CCR3 is the receptor for 
chemokines including CCL5, CCL7, CCL11 and CCL13, and CCR5, the receptor for chemokines 
including CCL3, CCL4 and CCL5, showed low expression on all splenic leukocyte subsets studied 
(Figure 8.6). Notably, no sex-differences in the expression of CCR1, CCR2, CCR3, or CCR5 were 
evident on splenic leukocyte subsets with the exception of non-classical monocyte CCR2 which 
was more greatly expressed on male (MFI: 20.6±1.01 x103) versus female cells (MFI: 13.0±1.69 
x103) (p<0.01) (Figure 8.6C). 
Finally addressed was the complement component C5a receptor, C5aR. Although not its 
primary function, C5a also represents an effective chemoattractant for neutrophils and 
monocytes via C5aR. C5aR was highly expressed on splenic neutrophils, with moderate 
monocytic expression and low lymphocyte expression. Sex-differences were again evident on 
non-classical monocytes with female cells exhibiting significantly (p<0.01) higher expression of 
C5aR versus male cells (MFI: 4.6±0.35 x103 versus 2.8±0.34 x103, Figure 8.6C). All other splenic 
leukocyte subsets demonstrated similar expression levels between the sexes. 
 
Chapter 8 
 
143 
 
 
Figure 8.6. Basal splenic leukocyte CC chemokine and complement receptor expression. 
Leukocytes were isolated from the spleens of male () and female () untreated mice. Cell 
surface expression of CCR1, CCR2, CCR3, CCR5, and C5aR was assessed on (A) neutrophils, (B) 
classical monocytes, (C) non-classical monocyte, (D) B220+ B cells, and (E) CD3+ T cells. 
Receptor expression is displayed as median fluorescence intensity (MFI). Data are displayed as 
the mean ± SEM (n=6). Differences in receptor expression were determined by Student’s t-test 
and significance indicated by ** (p<0.01).  
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 Discussion 8.4.
This chapter demonstrates differential trafficking of leukocyte subsets to and from the murine 
spleen in the zymosan peritonitis model of acute inflammation. Chapter 4 of this thesis 
described male mice to accumulate more neutrophils and classical monocytes in the 
circulation during peritonitis, and furthermore recruit more of these cells to the peritoneal 
cavity peaking at 3h after zymosan administration. To address the mechanism of such 
dimorphisms, the leukocyte storage pools were investigated with the hypothesis that male 
mice utilised these reserves differentially to female mice. Investigations into the BM however 
yielded similar mobilisation responses in male and female mice. This chapter therefore 
evaluated the spleen as another leukocyte storage pool.  
It has already been demonstrated in Chapter 3 of this thesis that the spleen indeed represents 
a pool of neutrophils and monocytes in addition to the well characterised B and T cells. 
Furthermore, sex-differences in basal numbers were observed with male mice possessing 
significantly more neutrophils, classical and non-classical monocytes compared to females. In 
response to zymosan peritonitis, classical monocytes were found to mobilise from the spleen 
of male, but not female mice (Figure 8.7). Mobilisation of splenic classical monocytes in 
inflammation is in line with a previous study that demonstrated such cells exited the spleen in 
response to myocardial I/R in mice (Swirski et al., 2009). The function and fate of mobilised 
splenic classical monocytes in male mouse peritonitis is not however clear. Indeed, 
mobilisation of splenic monocytes has yet to be reported in response to infection. It could be 
hypothesised that these cells represent the additional classical monocytes that accumulate in 
the male circulation compared to females, and those cells that also are subsequently recruited 
to the tissue in zymosan peritonitis. Whether they are actually recruited to the tissue is 
uncertain in this model. Transplantation of spleens from CX3CR1
+/gfp to WT mice however 
would definitively address this hypothesis. Alternatively, a failure to observe sex-differences in 
circulating and recruited classical monocyte numbers after splenectomy would also be highly 
suggestive of these additional cells originating in the spleen.  
In a similar fashion to the classical subset, non-classical monocytes were not mobilised from 
the spleens of female mice by 3h post zymosan. A wide spread of data for male mouse non-
classical monocytes responses made conclusions difficult. Although total monocytes have been 
shown to exit the spleen and the classical subset shown to accumulate in the tissue in 
myocardial I/R as described above, the topic of splenic non-classical monocyte mobilisation 
remains unclear as the exiting monocytes were not studied in subsets (Swirski et al., 2009; 
Ingersoll et al., 2011). Mobilisation of non-classical monocytes at the 3h time point would 
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however be contrary to the two accepted phases of these cells, firstly as patrolling cells that 
extravasate within 1h, and secondly later in the inflammation in tissue remodelling and wound 
repair (Auffray et al., 2009a).  
Unlike classical monocytes, neutrophils were not mobilised from the spleens of male or female 
mice during early zymosan peritonitis. This is in line with the lack of reports of splenic 
neutrophil mobilisation in inflammation. In female mice however, neutrophils traffic to the 
spleen, a phenomenon that was not observed in males (Figure 8.7). Accumulation of 
neutrophils in the spleen in inflammation has been previously described in response to viral 
infection (Norris et al., 2013). In addition, homing to the spleen (as well as the BM and liver) is 
a well described process for the uptake and removal of senescent neutrophils (Summers et al., 
2010), and may suggest that male and female neutrophils early in zymosan peritonitis are at 
different stages of maturity. Another possible explanation for the observations described may 
Figure 8.7. Summary of splenic leukocyte trafficking during zymosan peritonitis. 
Administration of intraperitoneal zymosan and subsequent detection by resident macrophages 
in male ( ) and female ( ) mice induces leukocyte trafficking to and from the spleen. Solid 
arrows indicate either increase (↑) or decreased (↓) numbers after 3h of peritonitis. Broken 
arrows represent likely direction of trafficking between compartments. 
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lie within the recently described B cell-helper neutrophils (Puga et al., 2012). Neutrophils 
identified around the specialised B cell area marginal zone in the spleen of mice were able to 
induce various functions in B cells including immunoglobulin class switching, somatic 
hypermutation, and antibody production. Furthermore, neutropenic patients had fewer and 
hypomutated marginal zone B cells, identifying a role for these neutrophils in humans also. 
This study is consistent with an increasing number of other works that show neutrophils not 
only act in innate immunity, but can also do so in the context of adaptive immunity. It is 
conceivable that the homing of neutrophils specifically to the female spleen is indeed inducing 
B cell responses that dampen the immune response, or at least initiate early adaptive 
responses that account for a less severe reaction in female mice. Analysis of the localisation 
and extent of peri-marginal zone neutrophils in sectioned spleens of naïve and zymosan-
treated male and female mice could test such a hypothesis.      
To investigate the mechanism behind the sex-differences in basal splenic neutrophil and 
monocyte numbers, the splenic chemokine environments of male and female mice were 
assessed with the rationale that different splenic environments account for different immune 
cell reserve pools. Cytokine arrays revealed a comparable cytokine/chemokine profile in male 
and female spleens. In line with the function of the spleen primarily as a lymphoid organ, CCL5, 
CXCL9 and CXCL10 all possessing T cell chemotactic abilities, were found in high relative 
quantities. sICAM-1 and IL-1ra were also detected in moderate relative quantities. High sICAM-
1 signal is likely derived from residues of endothelium or leukocytes, both of which are 
abundant in the spleen and are known to be ICAM-1 expressing (Dennig et al., 1994; Lin et al., 
2000). The role of either the soluble or membrane bound ICAM-1 in the spleen is not however 
well documented. It is furthermore probable that IL-1ra, as a natural inhibitor of IL-1R, is 
abundant in order to dampen the immune response due to the concentrated nature of 
immune cells in the spleen. Nevertheless, the cytokine/chemokine profiles of the male and 
female mouse spleen were similar, indicating the splenic environment is unlikely to underlie 
sex-differences in basal leukocyte subsets. The use of such arrays however is not quantitative 
and to fully define differences in the male and female splenic chemokines ELISAs of specific key 
molecules should be carried out.        
As assessment of basal splenic cytokine/chemokine environments elucidated no explanation 
for the observed sex-differences, expression of splenic leukocyte receptors were investigated. 
Molecules expressed in the spleen with neutrophil or monocyte chemotactic properties were 
identified from the arrays with male and female splenic leukocytes assessed for the expression 
of the corresponding receptors (i.e. CCR1, CCR2, CCR3, CCR5), and in addition for receptors 
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known to be involved in the chemotaxis of these cells (i.e. CXCR2, CXCR4). Neutrophils from 
male and female mouse spleens expressed similarly high levels of CXCR2, whilst all other 
leukocyte subsets showed very low receptor expression in both sexes. Despite high neutrophil 
CXCR2, only negligible levels of its ligands CXCL1 and CXCL2 were detected in the array. 
Investigations into other CXCR2 ligands such as CXCL3, CXCL5, CXCL6, and CXCL7 may reveal 
retention axes, however from this data it is unlikely that neutrophils are retained in the spleen 
via the actions of CXCL1 and CXCL2. In addition, the expression of CXCR2 on splenic neutrophils 
suggests that despite their lack of mobilisation in response to zymosan peritonitis, they may 
exit the spleen should the chemotactic signal from CXCR2 ligands be strong enough. 
In the BM, neutrophils and classical monocytes are retained via the CXCL12/CXCR4 axis, with 
CXCL12 expressed by BM stromal cells in high amounts under basal conditions (Ma et al., 
1999). Others have demonstrated that CXCL12 is expressed in the red pulp of the spleen (Puga 
et al., 2012), making a similar axis plausible in the context of the spleen. Neutrophils, 
monocytes, and B cells displayed similar levels of CXCR4. No difference in expression levels 
between the sexes was observed on neutrophils, classical monocytes, B or T cells. Female non-
classical monocytes however had significantly elevated CXCR4 expression versus male cells. 
This contradicts the sex-differences in basal splenic non-classical monocyte numbers whereby 
male mice exhibit more of these cells compared to females. Added to similar expression levels 
in neutrophils and classical monocytes, it could be that a stronger retention axis that overrides 
that of CXCL12/CXCR4 exists in the spleen and is responsible for differential leukocyte subset 
numbers in uninflamed conditions.   
CC-chemokine receptors, although generally not associated with neutrophil chemotaxis, 
showed similar expression between neutrophils, monocytes and lymphocytes of CCR1, CCR3 
and CCR5. CCR2 however, shown to be important for classical monocyte trafficking to the 
spleen in bacterial infection (Serbina et al., 2006) and one of the most potent monocyte 
chemoattractants (Boring et al., 1997), was very highly expressed on classical monocytes, and 
was also expressed in relatively high levels on the non-classical subset. The expression of the 
latter is a debated subject, with some describing non-classical monocytes as CCR2- (Geissmann 
et al., 2010) and others describing them as CCR2low (Shi et al., 2011a). This chapter 
demonstrates in the context of the spleen, these cells indeed express the CCR2 receptor. 
Further analysis of splenic leukocyte subset receptors yielded similar expression of CCR1, 
CCR2, CCR3 and CCR5 between the sexes. The exception from this rule however was non-
classical monocytes that indeed displayed sexual dimorphisms with respect to chemokine 
receptors. In addition to higher CXCR4 expression in females, non-classical monocytes were 
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also higher in C5aR in females, and higher in CCR2 in males. The reasons for sex-differences in 
the expression of these receptors are unclear. Although not highly expressed as demonstrated 
in the cytokine array, C5a represents an effective chemoattractant for neutrophils and 
monocytes via C5aR and so was analysed in addition to the classic chemokine receptors. With 
the exception of the aforementioned differences in non-classical monocytes, the expression of 
C5aR was comparable between male and female mice. 
As described in Chapter 3, splenic neutrophils, monocytes, B220+ B cells and CD3+ T cells 
express TLR2 and TLR4, albeit in particularly low levels on T cells. The temporal assessment of 
these receptors on leukocytes in different compartments during inflammation was analysed in 
the spleen. Expression was assessed at the early time point in the zymosan peritonitis model in 
male and female mice with the hypothesis that sex-differences in remote leukocyte TLRs may 
also play a role in cellular mobilisation. This thesis has already demonstrated no sex-
differences in the TLR2 and TLR4 expression on neutrophils, classical monocytes, non-classical 
monocytes, B cells and T cells. During early (3h) zymosan peritonitis, when leukocyte 
mobilisation and tissue accumulation peaked, similar expression was also seen on the said 
male and female leukocyte subsets. The only exception being at this time point, female splenic 
B220+ B cells had a trend towards more TLR4 than males. Owing to the spleen being a complex 
organ for B cells, with both marginal zone and follicular types as well as plasmablasts and 
plasma cells (Mebius et al., 2005), it is difficult to draw conclusions on this modulation and the 
inclusion of more markers to differentiate B cell type would be required. Moreover, in 
response to 3h of zymosan peritonitis little modulation of either TLR2 or TLR4 was observed, 
apart from a trend towards an increase in the expression of classical monocyte TLR2 in female 
mice. The reasons for this change are unclear however it represents only a small upregulation 
of the receptor and therefore the likelihood of any biological consequences may be 
questioned.   
Overall, this chapter extends upon the sexual dimorphisms in basal splenic leukocyte subset 
pools and outlines key differences in the trafficking of these leukocytes to and from the spleen 
in the zymosan peritonitis model. Both an accumulation of female neutrophils and a 
mobilisation of male classical monocytes logically address the sex-differences in leukocyte 
responses in inflammation with greater accumulation of neutrophils and classical monocytes in 
the male blood and tissue. Whether the mobilised classical monocytes represent cells that 
contribute to pathogen clearance, or host tissue damage is at present unclear. Furthermore, 
whether additional neutrophils in the female spleen contribute to more efficient resolution of 
inflammation also remains open for further investigation. Little modulation of splenic 
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leukocyte TLR2 and TLR4, and overall similar expression between male and females, suggests 
these receptors have little involvement in the responses to zymosan at the time point studied. 
Nevertheless, the mechanisms behind sex-differences under naïve conditions continue to 
remain uncertain as similar splenic cytokine/chemokine profiles were observed between the 
sexes, in addition to similar expression of the key neutrophil and monocyte chemokine 
receptors on the splenic leukocytes. Although a long and diverse path exists between the 
zymosan peritonitis inflammatory model and human disease, improving knowledge of the role 
of the spleen may provide new targets for the treatment of inflammatory disorders.         
Key findings: 
 Neutrophils traffic to the spleen in female, but not male, mice early during zymosan 
peritonitis.  
 Classical monocytes exit the male, but not female, spleen during zymosan peritonitis. 
 Similar basal splenic cytokine/chemokine profiles exist between the sexes. 
 No difference was seen in the expression of CXCR2, CXCR4, CCR1, CCR2, CCR3, CCR5, and 
C5aR on male and female murine splenic neutrophils, classical monocytes, B220+ B cells, 
and CD3+ T cells. 
 Male mouse splenic non-classical monocytes had greater CCR2 expression, and reduced 
C5aR and CXCR4 expression compared to females.  
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 General Discussion Chapter 9:
 Project overview 9.1.
Considerable sex-differences exist in both the prevalence and severity of immune diseases in 
humans. Whilst men are more prone to diseases with an inflammatory nature, they are 
relatively protected in autoimmune diseases (Whitacre, 2001). This disparity is most evident in 
conditions involving excess or uncontrolled activation and recruitment of leukocytes, for 
example I/R injuries and infection (Luster et al., 2005). Such diseases also represent the 
indications of new TLR2 and TLR4 targeted therapies (Ehrentraut et al., 2011b; Arslan et al., 
2012). The precise mechanisms underlying sexual dimorphisms in inflammatory diseases are 
not well understood. More recently disparities in the phenotype of innate immune cells have 
been reported between the sexes (Scotland et al., 2011). Female mouse tissue leukocytes 
were shown to be both more numerous and more abundant in TLR2 and TLR4, resulting in a 
more efficient, and less severe, response to inflammagens. This study therefore aimed to 
comprehensively analyse the temporal profile of leukocyte recruitment and TLR expression in 
male and female mice during the zymosan peritonitis model of acute inflammation. The 
findings of this work contribute to our understanding of sex-differences both in the innate 
immune cell storage pools, and the leukocyte trafficking responses during acute inflammation. 
This thesis has demonstrated for the first time: 
 Greater basal neutrophil and monocyte stores in the male mouse spleen. 
 Higher basal TLR2 and TLR4 expression on male BM neutrophils. 
 Sex-differences in the trafficking of neutrophils and classical-monocytes during zymosan 
peritonitis. 
 Limited regulation of TLR2 and TLR4 expression on leukocyte subsets during zymosan 
peritonitis.  
 Sex-differences in basal splenic leukocyte pools 9.1.1.
Due to previous reports of female mice having more resident peritoneal and pleural cavity 
leukocytes compared to aged-matched male counterparts (Scotland et al., 2011), initial studies 
investigated sex-differences in leukocyte subset compositions in other leukocyte containing 
pools. These experiments not only showed greater numbers of macrophages and B cells 
occupying the naïve female mouse peritoneum, a finding reflected in the literature, but also 
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unveiled the murine spleen as a dimorphic pool of leukocytes. The results revealed male mice 
to have larger numbers of neutrophils, classical, and non-classical monocytes compared to 
female counterparts. No differences in the numbers of lymphocytes were observed. This is the 
first description of such differences in the murine spleen composition.  
Monocytes that enter tissues are considered to differentiate into macrophages. Indeed 3 
specific splenic macrophage subsets exist (red-pulp, marginal zone, and metallophilic), all of 
which are monocyte-derived (Mebius et al., 2005). More recently however, the spleen has 
been shown to act as a reservoir for mature, undifferentiated monocytes in both humans and 
mice (Swirski et al., 2009; van der Laan et al., 2014). Correspondingly, the splenic monocytes 
described in this study indeed appear undifferentiated, resembling those in the circulation 
both with regards to CD115 and CX3CR1 expression, and also in terms of their FSC/SSC 
(size/complexity) profile. It can therefore be concluded that monocytes present in the spleens 
in this study are indeed bona fide monocytes available for release should the body require 
them. 
The spleen functioning as a reservoir for neutrophils is more controversial. Neutrophils were 
considered not to reside in the spleen in the absence of infection however recently a new 
subset, termed ‘B-helper’ neutrophils was reported (Puga et al., 2012). These neutrophils 
specifically colonised peri-marginal zone areas of the spleen under resting conditions, forming 
NET-like structures to interact with B cells. The consequences of such interactions caused B cell 
activation and stimulated Ig class switching, somatic hypermutation, and antibody production. 
Notably, these neutrophils were phenotypically distinct from circulating counterparts. No 
difference in expression of Gr1 or FSC/SSC profile was evident between those neutrophils in 
the spleen and circulation in the experiments in this thesis. Whether the neutrophils described 
in this thesis are of the B-helper subset remain unknown and further studies would be 
required to define both their phenotype and function. Should the splenic neutrophils prove 
analogous to those in the circulation, these cells may represent a readily releasable pool that 
are utilised in response to specific infectious stimuli (although not in response zymosan, as 
shown in this thesis). Conversely, should they be identified as B-helper neutrophils, this could 
have substantial consequences in the development of potential therapies. Vaccines, for 
example, could be developed that increase splenic B-helper neutrophil number and function, 
thus stimulating B cells to produce more antibodies. The fact that male mice potentially have 
more of these neutrophils means male and females would likely respond differently to such a 
therapy.  
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The implications of male mice having more neutrophils and monocytes than female mice 
provide wide scope for extrapolation into the worlds of immune disorders and therapies. 
However before extensive conclusions and implications can be made, similar studies in 
humans must be performed. Although the overall structure of the human spleen is similar to 
that of the mouse, differences exist in the white pulp (Mebius et al., 2005). More specifically, 
whilst mice have a simpler single marginal zone surrounding the T-cell area and B cell follicles 
of the white pulp, humans have an inner and outer marginal zone which itself is surrounded by 
a larger perifollicular zone (Figure 9.1). Very recently the presence of neutrophils in the resting 
human spleen was described (Nagelkerke et al., 2014). These neutrophils were however 
comparable to those in the circulation and exhibited none of the B-helper characteristics or 
functions that were described in mice. Whether B-helper neutrophils are absent in all humans 
and thus are mouse-specific is still unclear. Spleen samples used in the described study were 
excess tissue from healthy organ transplant donors. If the donors were living or deceased 
however, is not clear due to ambiguity in the methods. Although it is very plausible B-helper 
neutrophils are not present in humans, the nature of the samples and donors mean it is still 
possible these cells exist in the human spleen. Furthermore, if those neutrophils reported in 
the human spleen are not of a B-helper nature, the question still remains as to their function. 
Experiments to both investigate the localisation and phenotype of human splenic neutrophils 
may reveal some indications with regards to their function. 
Figure 9.1. Structural differences between mouse and human splenic white pulp. The 
marginal zone surrounds the splenic white pulp. Whilst mice have a single marginal zone, 
humans have both an inner and outer zone which itself is surrounded by the perifollicular 
zone. Human and mice also have differences in the location of terminating blood vessels. 
(Reproduced from Puga et al., 2005). 
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Interestingly, female mice had comparable spleen sizes and total leukocytes to aged-matched 
males, suggesting a difference in body size does not affect this key lymphoid organ. In 
agreement with these findings, spleens from men and women have also been shown to be 
similar in size (Machalek et al., 1998). This suggests, in addition to similar splenic lymphocyte 
numbers between the sexes, that female mice do not have fewer neutrophils and monocytes 
because they are smaller than aged-matched male comparisons. With the aim to elucidate the 
mechanism by which different leukocytes were present in the male and female spleen, initial 
investigations examined potential retention axes. No differences in either cell surface 
chemokine receptors or splenic chemokines themselves were evident between the sexes. 
Although not every potential axis was examined, key ones known to exist for other storage 
pools (i.e. CXCL12/CXCR4, CCL2/CCR2) were studied but did not reveal any potential 
mechanisms to explain the observed sex-differences. As already discussed, the functions of 
neutrophils and monocytes in the naïve spleen are yet to be elucidated. Further investigation 
into the functions of these cells may provide insight into the prominent chemokine-chemokine 
receptor interactions by which they are retained and released from the spleen. Studies of the 
localisation of neutrophils and monocyte subsets within the spleen could be important to shed 
light on their functions.  
Overall the sex-differences identified in the splenic leukocyte pool may have important 
translational implications. However the significance of such a finding can only be established 
and utilised if similar dimorphisms are identified in humans. As yet, no studies have evaluated 
the leukocyte compositions of the spleens of men and women. Conducting such studies may 
well reveal the spleen as a contributing factor to inflammatory or autoimmune diseases that 
exhibit disproportion in their prevalence between the sexes. As such, this difference could be 
exploited to develop new therapeutics to treat such diseases in a more personalised manner.  
 Differential trafficking of neutrophils and classical monocytes in male and 9.1.2.
female mice during zymosan peritonitis 
Previous studies have reported reduced severity and neutrophil recruitment in peritonitis in 
female mice (Scotland et al., 2011). To investigate the influence of sex on the recruitment of 
other leukocyte subsets, i.e. monocytes, the zymosan peritonitis model of acute inflammation 
was employed. Male mice recruited significantly more neutrophils and classical monocytes to 
the peritoneal cavity 3h after induction of peritonitis. Interestingly, this data shows neutrophils 
and classical monocytes are able to extravasate at the same time. This suggests that although 
neutrophil-mediated monocyte recruitment has previously been described (Soehnlein et al., 
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2009a), neutrophils and classical monocytes can also be recruited simultaneously, likely via 
chemotactic gradients established by activated macrophages. The ability of classical 
monocytes to be recruited independently of neutrophils has also previously been documented 
(Henderson et al., 2003). The temporal involvement of non-classical monocytes in zymosan 
peritonitis is not as clear. In the dermis, non-classical monocytes reportedly patrol the 
endothelium and extravasate within 1h upon inflammagen application. The data in this thesis 
does not support such trafficking as by 3h peritoneal non-classical monocyte numbers are 
lower than control conditions. To fully establish the time at which non-classical monocytes 
play a role in the response to zymosan, an earlier and later time point should be analysed.  
Also of note is the rapid loss of resident peritoneal macrophages, with almost complete 
clearance after 3h of zymosan peritonitis. The fate of these macrophages is not clear, but is in 
agreement with previous reports (Navarro-Xavier et al., 2010). It is most plausible that after 
the detection and phagocytosis of zymosan, macrophages undergo apoptosis and were 
therefore cleared. In line with the current paradigm, it is likely that infiltrating classical 
monocytes differentiate to repopulate macrophage populations, although this currently 
remains speculative in the case of zymosan peritonitis (Randolph, 2011).   
Sexual dimorphism in cavity leukocyte accumulation detailed in this thesis also highlights the 
possibility that male or female sex may influence the ability of leukocytes to transmigrate. To 
determine if this was the case, the influence of peritonitis on the circulating leukocyte number 
was evaluated. For the first time males were shown to also have greater numbers of 
neutrophils and classical monocytes in their circulation at the 3h time point. Since greater 
leukocyte numbers were evident upstream of the transmigration process, differences in the 
ability of male and female neutrophils and classical monocytes to transmigrate was deemed an 
unlikely explanation for the dimorphism in accumulated cavity immune cells. Indeed, previous 
studies have shown both differences in tissue accumulation and blood accumulation (Hannawa 
et al., 2006; Scotland et al., 2011), but few have linked the two. Little evidence exists to 
support differential transmigration with surprisingly no in vivo reports to date detailing 
integrin and adhesion molecule differences between the sexes in the context of neutrophils, 
monocytes or ECs.  
To determine the source of the additional circulating and peritoneal cells male mice 
accumulate during zymosan peritonitis, major leukocyte storage pools were studied. 
Neutrophils and classical monocytes exited the BM by 3h to equivalent extents in both sexes, 
demonstrating the importance of the BM storage pool in contributing leukocytes to the 
response to the peritonitis. Although the BM has long been established as the origin of 
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monocytes from the common monocyte-macrophage-DC precursor (MDP), the development 
of the subsets is a debated topic (Saha et al., 2011). The literature contains evidence for both 
subsets deriving independently from a common precursor, but also for the non-classical (Ly6C-) 
deriving from classical (Ly6C+) subset (Varol et al., 2007; Auffray et al., 2009a; Geissmann et al., 
2010). The data generated in this thesis demonstrates the presence of both monocyte subsets 
in the BM, however classical monocytes were approximately 3-fold more numerous than non-
classical. Such a difference in numbers was not evident in the circulation, however from the 
data obtained it is unfortunately not possible to comment on, or contribute to the knowledge 
of, monocyte subset development beyond that both subsets were indeed present in the 
resting BM and circulation.   
In contrast to the BM, the splenic leukocyte storage pool demonstrated evidence of sexual 
dimorphisms. This study shows for the first time that neutrophils traffic to the spleen of female 
mice in zymosan peritonitis, a phenomenon not observed in males. Conversely, male, but not 
female, mice demonstrate a release of their splenic classical monocyte pool. Homing of 
neutrophils to the spleen in females, coupled with a release of the additional splenic classical 
monocytes in males, produces the gross outcome of more neutrophils and classical monocytes 
in the male circulation. This is in agreement with the data in this thesis and produces a logical 
model for sex-differences in leukocyte trafficking in early zymosan peritonitis (Figure 9.2). This 
represents the first report of differential trafficking of leukocyte subsets in the spleen between 
male and females.  
The relative contribution of the spleen to the peritonitis can be demonstrated by comparing 
cell numbers to that of the BM. Due to the closed system nature of the inflammation, an ‘in 
silico’ model can essentially be developed. Changes in numbers of neutrophils and classical 
monocytes are demonstrated in Table 9.1. By these means, it is clear that despite the spleen 
being a dimorphic pool of these cells, the BM is by far the biggest contributor in terms of 
mobilised cells. Indeed, these cells are released in excess with a large number unaccounted for 
in the compartments analysed (blood, spleen, peritoneal cavity). Whilst this model assumes 
equal BM leukocyte mobilisation from primarily the long bones (Boggs, 1984), it is highly 
possible that these are heterogeneous depending on the bone and proximity to the stimulus, 
therefore the total BM release may represent an over estimation. Other explanations for the 
large number of additional cells that are not accounted for by the BM may be trapping in other 
organs, such as the lung and liver, as is known to occur in other inflammatory diseases 
(Woodfin et al., 2011). Furthermore, there is likely to be a large number of both neutrophils 
and classical monocytes that are in various stages of the leukocyte adhesion cascade that are 
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unlikely to have been successfully isolated, be it rolling, crawling, or undergoing 
transendothelial migration throughout the highly vascular mesentery. Therefore whilst the 
spleen appears the minority contributor to the overall mobilised classical monocytes, further 
studies must be carried out to determine whether the recruited cells do in fact originate from 
the spleen. It is plausible that the phenotype, function, or primed status of splenic classical 
monocytes differ from that of the BM and that whilst they are fewer in number, they are 
better equipped to traffic to a site of inflammatory insult and remove the pathogen or 
damaged tissue.  
 
 Neutrophils Classical Monocytes 
Male Female Male Female 
Total Blood* +3.2x106 +1.4x106 +1.8x106 +0.64x106 
Peritoneal Cavity +11.4x106 +8.0x106 +0.27x106 +0.15x106 
Spleen - +3.2x106 +0.90x106 - 
Total BM$ -20x106 -20x106 -5.2x106 -4.3x106 
Surplus +5.4x106 +7.4x106 +2.2x106 +3.5x106 
Table 9.1 Summary of changes in neutrophil and classical monocyte numbers in murine 
zymosan peritonitis. Neutrophils and classical monocytes were isolated from the blood, 
peritoneal cavity, spleen, and femur of male and female mice treated with or without zymosan 
(1mg i.p., 3h). Figures in the table indicate the number of leukocytes that have increased (+) or 
decreased (-) during the inflammation. *Total blood is values adjusted for total blood volume 
assuming 1.5ml for males and 1.2ml for females. $Total BM assumes 8 long bones, therefore 
femur leukocyte number x8. Surplus indicates the number of cells released from the BM but 
not accounted for in the other compartment studied.  
 
The mechanisms by which neutrophils home to the spleen and classical monocytes exit the 
spleen are unclear. In a mouse model of MI, classical monocytes were shown to leave the 
spleen and accumulate in the circulation and myocardium in a process dependent on 
angiotensin II and the monocyte angiotensin II receptor 1 (AT-1) (Swirski et al., 2009). Whether 
angiotensin II may firstly play a role in classical monocyte trafficking in zymosan peritonitis, 
and secondly account for the sex-differences observed with regards to monocytes, is not clear.  
No reports of differences in angiotensin II concentrations or activities in men and women exist 
in the literature, however the AT-2 receptor is located on the X chromosome (Fish, 2008). 
During investigations of angiotensin II-dependent splenic monocyte egress in MI, only the AT-1 
was studied leaving scope to evaluate the role of AT-2 also to explain sex-differences in 
classical monocyte trafficking identified in this thesis.  
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Figure 9.2. Summary of sex-differences in neutrophil and classical monocyte trafficking in 
zymosan peritonitis. Administration of zymosan to the peritoneal cavity induced differential 
trafficking of neutrophils and classical monocytes in (A) male and (B) female mice after 3h.. 
Neutrophils and classical monocytes egressed from the bone marrow and accumulated in the 
circulation (blood) and peritoneum (tissue). Both cell types trafficked differently to or from the 
spleen in male and females. Block arrows indicate increase (↑) or decrease (↓) in the 
indicated cell numbers in the specified compartment. Dashed lines denote the direction of 
movement between compartments after 3h of zymosan peritonitis.   
Chapter 9 
 
158 
 
Paradoxically, despite male mice mounting a more exaggerated response to zymosan 
peritonitis at the peak 3h time point, neutrophils in both the circulation and peritoneal cavity 
by 24h were similar in number between the sexes. This data is highly robust as sex-differences 
still prevail should the data be presented as percentage leukocytes, subset numbers versus 
body weight and versus organ (BM, spleen) weight (not shown). In essence, males have a 
transiently enlarged response however still resolve the inflammation at the same rate and 
time as female mice. The reasons for this are unclear both from the literature and this study. It 
would be fair to speculate that more peritoneal macrophages, with greater phagocytic and 
ROS-producing capabilities (Scotland et al., 2011) are able to clear the zymosan quicker, 
thereby less neutrophils and monocytes are required to help, meaning fewer are recruited. On 
the other hand male neutrophils and monocytes appear efficacious enough to remove the 
inflammagen but just require a greater workforce to do so. Of note, as the inflammation 
appears to resolve on a similar time scale between male and female mice, it would suggest the 
lifespan and clearance of the neutrophils is not different between the sexes. Therefore, it does 
not appear that male mice are unable to deal with the infection, however it is plausible that if 
given a stronger inflammagen the dimorphisms in the inflammatory response may become 
more prominent and begin to affect the outcome of the animal. Also not to be overlooked in 
the resolution of the peritonitis is the influence of the spleen. In female mice neutrophils 
accumulate in the spleen. The outcome of this clear dimorphism is one that should not be 
ignored. Whilst it is difficult to draw the functional consequence of this phenomenon from the 
data obtained in this study, it could be that at this early 3h time point after inflammation, 
activated neutrophils home to the female spleen and induce the adaptive immune response, 
thereby promoting the dampening of responses and resolution, something that does not occur 
in the male.  
An obvious factor that has not been discussed thus far is the influence of sex hormones on the 
inflammatory response to zymosan. Despite being considered, female mice in the study were 
not selected at specific times in their oestrous cycle (referred to as menstrual cycle in humans). 
The murine oestrous cycle occurs every 4-5days (Caligioni, 2009). It was therefore reasoned 
that due to large n numbers over a period of 2 years, all stages of the cycle should be 
represented in this study. During certain phases of the murine oestrous cycle, i.e. pre-
ovulation, plasma 17β-oestradiol is high and may be further protective in inflammation 
(Caligioni, 2009), however the experiments in this thesis are sure to fall over all phases of the 
cycle yet still produce damped inflammatory responses versus males during zymosan 
peritonitis. Therefore, when designing human studies whereby oestrogens may influence the 
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results, it is essential to choose the correct phase of the menstrual cycle, make records of such 
phases, and interpret results accordingly to obtain the correct model. Alternatively, larger 
cohorts must be used representing all phases of the longer, 28-day, human female menstrual 
cycle to abolish any skewing of results due to varying hormonal levels.  
Differences such as those in the menstrual cycle and spleen structure between mice and 
humans raised the perpetually important question: Are mice a good model? Although there 
are obvious distinct differences between humans and mice, 99% of murine genes have human 
analogues (Gunter et al., 2002). Basic science studies such as those in this thesis would be 
unable to be conducted in humans, and therefore mice do resemble the next best feasible 
model. This thesis uses zymosan peritonitis as a model of acute inflammation to investigate 
sex-differences. To replicate a real human situation is only possible up to a point in murine 
models, with humans subjected to vast amounts of environmental factors that cannot be 
replicated in mice and which will be sure to influence disease progression. Indeed, few humans 
develop infectious peritonitis, however humans are susceptible to acute infections and these 
are reported to exhibit a sex disparity. What the use of mice in this study has facilitated is 
identification of sex-differences in specific compartments that can then be translated into 
more targeted, specific, and therefore less invasive and costly, studies in humans. If the 
hypothesis has foundations and the model is appropriate, mice can indeed represent a good 
model for basic science. Their relevance to other human-specific disease models is however 
outside the scope of this thesis.  
These findings could have important implications with respect to human health and disease. 
Firstly, the spleen is a poorly explored organ in inflammatory conditions. Further research into 
its role in human disease may present it as a candidate for therapeutic intervention, using both 
antagonists to dampen an overwhelming leukocyte recruitment response, and agonists to 
improve such a response as may be desirable in immunocompromised patients. Secondly, as 
sexual dimorphisms exist in both the prevalence and severity of many immune related 
conditions, the spleen could prove a novel therapeutic target for personalised medicines. 
Should sexual dimorphisms in the spleen leukocyte pool and spleen leukocyte trafficking be 
unveiled in humans also, targeting these for disease prevention and treatment, respectively, is 
likely to prove beneficial.  
These data also have highly important implications for basic research. Few labs consider the 
sex of animals when conducting experiments, and a huge number of scientific papers fail to 
disclose such information in the materials and methods. Whilst it is possible that many in vivo 
models show no sex-bias, the data from this thesis validates clearly that sex should be an 
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important consideration with regards to experimental design and data interpretation. In 
addition, it is well established that many immune system disorders have a sex bias in humans. 
It is therefore important to select the correct sex (or investigate both sexes), when developing 
in vivo models of such inflammatory conditions. This again highlights the importance of correct 
experimental design and the consideration of sex is likely to in fact reduce the number of 
animals used, in line with the National Centre for the 3Rs, as studies would have a greater 
chance of success and a lesser chance of failure. Furthermore, the use of a mixture of male and 
female animals in inflammatory models could essentially mask any differences and may 
provide an explanation for failed studies. Again, consideration and selection of the correct 
experimental model could save animals by improving a positive study outcome and therefore 
reduce the chances of having to repeat studies.     
 Elevated TLR2 and TLR4 expression on basal BM neutrophils in male mice 9.1.3.
Sex-differences in TLR expression have previously been identified in resident peritoneal 
macrophages (Scotland et al., 2011). To explore the extent of this male-female difference, this 
thesis comprehensively compared basal TLR expression of various leukocyte subsets in 
multiple leukocyte-containing compartments. The focus was placed on TLR2 and TLR4 as these 
receptors were identified both as sexually dimorphic on macrophages in the above mentioned 
study, and as therapeutic targets in inflammatory diseases with a leukocyte recruitment 
pathogenesis (Shimamoto et al., 2006; Arslan et al., 2010b). Whether such dimorphisms exist 
on other leukocytes and elsewhere in the body was assessed in this thesis. Male mouse BM 
neutrophils were significantly higher in cell surface TLR2 and TLR4 than neutrophils from 
female BM. This represents the first report of sex-differences in leukocytes TLRs in the BM. No 
sex-differences in TLR2 or TLR4 expression were observed on neutrophils from other sources, 
or on macrophages, classical monocytes, non-classical monocytes, B cells or T cells obtained 
from the blood, peritoneum, BM or spleen. Sex-difference in leukocyte TLR2 and TLR4 
expression at sites remote from the initial stimuli could suggest involvement of these 
receptors in the dimorphic inflammatory response. 
Blood neutrophils are known to express TLRs and respond to both TLR2 and TLR4 activators 
(Sabroe et al., 2003; Prince et al., 2011). Surprisingly, the expression of TLR2 and TLR4 protein 
on BM neutrophils is poorly documented with only one study to date showing protein in mice 
by Western blot (Zhang et al., 2005). Therefore, this thesis provides the first characterisation 
of cell-surface TLR2 and TLR4 protein on BM neutrophils, and furthermore is the first report of 
sex-differences in this expression. Sex-differences in BM neutrophil TLR2 and TLR4 expression 
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were initially hypothesised to influence the mobilisation of BM neutrophils and therefore the 
accumulation of these cells in the circulation and peritoneal cavity during zymosan peritonitis. 
Investigations into the BM however yielded similar mobilisation profiles in male and female 
mice, opposing a role for these receptors in release of BM stores. The purpose and function of 
TLRhigh BM neutrophils in male mice remains unclear. Various speculations into neutrophil 
subsets, maturation, and activation states could however be made. 
Neutrophils are produced and mature in the BM during the process of granulopoiesis, 
mediated by G-CSF (Kolaczkowska et al., 2013). It is likely that granulocytes develop expression 
of TLRs on their cell surface only towards the point of maturity, as only mature neutrophils 
would be fully equipped to clear PAMPs and DAMPs. This is, however, purely speculative as 
there is a little evidence in the literature detailing the time at which TLRs become expressed. 
Although it has not been studied, sex-differences in the rate at which granulopoiesis occurs 
and neutrophils mature may exist, therefore it is possible that the dimorphisms observed in 
BM neutrophil TLR expression are in fact a reflection of different states of maturity. By the 
same token, different TLR expression may also be the result of sex-differences in neutrophil 
senescence. Whilst one group reported that male neutrophils undergo more spontaneous 
apoptosis, this was not in the context of the BM, and neutrophils were aged for 24h only 
(Molloy et al., 2003). Therefore whether senescent neutrophils firstly express different levels 
of TLRs, and secondly, age and home back to the BM differently in males and females is 
currently unknown but may provide some explanations for the sex-differences observed.   
The existence of neutrophil subsets in the BM combined with differences in such subsets 
between the sexes may provide another explanation for the sex-differences in BM neutrophil 
TLR2 and TLR4 described in this thesis. Three subsets of circulating neutrophils, distinguishable 
by cytokine production, macrophage activation, and surface antigen expression have 
previously been described in mice (Tsuda et al., 2004). Subsets were also distinguishable by 
TLR5, TLR7, TLR8, and TLR9 expression however all 3 neutrophils also expressed mRNA for 
both TLR2 and TLR4. As the sex of the mice used in this study was not disclosed, it is possible 
that differences in TLR2 and TLR4 between the neutrophil subsets exist if sex is taken into 
consideration. Whether mature neutrophil subsets are present in the BM is not clear but may 
provide explanation for the sex-differences seen if such subsets themselves prove dimorphic. 
It is also possible that differences in the activation states of BM neutrophils occur between 
male and female mice. As TLR expression has been shown to alter in certain inflammatory 
conditions, it is possible that sex-differences in neutrophil activation status underlie 
differences in TLR2 and TLR4 expression. Under basal conditions in the BM, one of the most 
Chapter 9 
 
162 
 
sterile organs, this theory is least plausible. In reality, the consequences of the TLR2 and TLR4 
expression difference to the function of male and female BM neutrophils should first be 
assessed before dissecting the cause. Male mice express approximately 25-30% more TLR2 and 
TLR4 on BM neutrophils than female mice. If this is enough to influence inflammatory 
responses between the sexes must be determined. Surprisingly, despite this difference in the 
TLR expression in the BM, circulating and splenic neutrophils have similar expression in males 
and females. This specificity to the BM store of neutrophils suggests that TLRs may play role in 
the egress of the neutrophils into circulation, but also that sex-differences are likely to be a 
consequence of the above mentioned factors (i.e. maturation, senescence, subsets), rather 
than peripheral factors.     
 Stable TLR2 and TLR4 expression profile of leukocyte subsets in male and 9.1.4.
female mouse zymosan peritonitis  
The temporal expression profile of leukocyte TLR2 and TLR4 was assessed during the zymosan 
peritonitis model of acute inflammation in male and female mice. The expression of these 
receptors was studied on blood, peritoneal, BM, and splenic neutrophils, classical monocytes, 
non-classical monocytes, B cells, and T cells. Overall, little change in receptor expression was 
evident on any of the leukocyte subsets throughout the inflammation. Modulation of TLR 
expression has however previously been reported in a number of inflammatory disease (Härter 
et al., 2004; Ashida et al., 2005; Kashiwagi et al., 2012). Changes in TLR expression has 
therefore been implicated as a compounding factor in the pathogenesis of certain 
inflammatory conditions, with increased TLR expression proposed to exaggerate the 
inflammation (Arslan et al., 2010a; Reilly et al., 2013).  
Although the data in this thesis present some small modulations of TLRs, e.g. increased blood 
neutrophil TLR4 and cavity neutrophil TLR2 and TLR4 at 24h, the relative expression levels, 
particularly on neutrophils, remained low. Once activated and signalling cascades are initiated, 
the functional consequence of a cell possessing marginally more TLRs is questionable. Whether 
these small but significant TLR upregulations in fact effect neutrophil function would need to 
be tested, however overall TLR2 or TLR4 expression remained stable during the peritonitis. 
Low expression of TLR2 and TLR4 on certain leukocyte subsets, including neutrophils was 
consistent in this study. The use of TLR antibodies may account for the low RFIs and expression 
levels obtained as they are renowned for being poor. This also provides explanation for the 
lack of TLR protein expression data, compared to the abundance of functional TLR data in the 
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literature. Antibody quality therefore continues to be a challenge in the quantification of 
proteins.  
Eritoran, a synthetic TLR4 antagonist, and OPN-305, a fully humanised monoclonal antibody 
targeting TLR2, have reached clinical trials for conditions with leukocyte recruitment 
underlying their pathogenesis (sepsis and renal transplant (renal I/R), respectively) (Tidswell et 
al., 2010; Reilly et al., 2013). Eritoran, after proving beneficial in pre-clinical and Phase II 
clinical trials, failed in a Phase III trial of severe sepsis (Opal et al., 2013). The mechanisms by 
which both molecules work are not completely clear, and whether such molecules are 
targeting leukocyte, endothelial, or tissue TLRs is also unknown. It is likely such drugs elicit 
their beneficial effects via blockade of leukocyte or even EC TLRs, preventing activation of 
these cells and thereby limiting leukocyte transendothelial migration and recruitment, and 
their damaging potential.  
As previously discussed in this thesis, sex imbalances are evident in the prevalence of 
inflammatory disorders where aberrant leukocyte recruitment underlies the pathogenesis. 
Sex-differences in leukocyte TLR expression have previously been proposed to underlie the 
dimorphisms seen in these inflammatory conditions (Scotland et al., 2011). As already alluded 
to, there is also evidence of modulation of TLR expression in inflammation. It could be 
hypothesised that men and women may differentially modulate expression of TLRs and in 
doing so affect the extent of the inflammatory reaction. The results in this thesis demonstrate 
that men and women have similar leukocyte TLR2 and TLR4 expression throughout zymosan 
peritonitis, and despite some small modulations in receptor expression, this was evident in 
both sexes. Overall this study provides evidence against ‘personalised’ TLR-targeting medicines 
and supports the equal treatment of male and female patients with TLR2- and TLR4-targetting 
therapies.  
 Future directions 9.2.
 Validation of TLR expression and cytokine environment data 9.2.1.
The data demonstrate that expression of TLR2 and TLR4 were overall similar on leukocyte 
subsets from male and female mice under both basal and inflamed conditions. In contrast, in a 
number of conditions sex-differences were evident either significantly or with a trend. 
Previous studies have shown female murine resident peritoneal leukocytes have more TLR2, 
TLR3 and TLR4 mRNA compared to males (Scotland et al., 2011). It would therefore be useful 
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to validate the data in this thesis using qPCR. Such experiments will also leave scope to 
investigate the expression of the other TLRs. Evaluation of TLR message may also yield 
information on the life span and cycling of TLRs to and from the membrane, and may provide 
potential indications for mechanisms of the trends in expression changes observed. Similarly, 
to further our understanding of the cycling of TLRs, cells could be permeabilised prior to 
antibody labelling and analysed by flow cytometry for both cell surface and intracellular TLR2 
and TLR4. Of note, whilst TLR localisation could also be investigated by confocal microscopy, 
TLR antibodies were found not to be amenable to such a technique as demonstrated in 
Appendix 5. 
Proteome Profiler™ arrays revealed no differences in the expression of cytokines and 
chemokines in the peritoneal cavity or spleen of male and female mice. Limitations of this 
technique however mean it is not fully quantitative. It would therefore be beneficial to repeat 
these experiments using either ELISA or a LI-COR system to detect an infrared dye as a 
quantitative alternative to HRP chemiluminescence. Problems with signal saturation would 
also be avoided by using these techniques. 
 Investigation into the mechanisms of sex-differences in basal splenic leukocyte 9.2.2.
subset numbers 
The data show clearly that male mice have significantly larger stores of neutrophils and 
monocyte subsets in their spleens compared to aged-matched females. Investigations into 
both the splenic chemokine environments and splenic leukocyte chemokine receptors yielded 
similar results from male and female mice. Sectioning of the LysM-eGFP and CX3CR1
+/gfp 
spleens and analysis by confocal microscopy may provide some insight into differential 
localisation of neutrophils and monocytes, respectively, in the spleens of male and female 
mice. This may also provide indications to the potential functions of these cells in the spleen. 
In reality however, it is unlikely that one molecule or receptor will be responsible for such 
difference. To begin dissecting the precise mechanisms by which the sex-difference in splenic 
leukocyte numbers occur, it would first be useful to assess whether it is inherent properties 
and characteristics of the leukocyte, or whether it is the properties and environment of the 
body and spleen which are different between males and females and underpinning this 
observation. Future studies should address these questions using leukocyte transfer 
experiments. Analysis of the accumulation of transferred labelled male and female donor 
leukocytes in the spleens of male and female recipients will shed light on this question. 
Equivalent splenic accumulation of male and female transferred leukocytes would suggest it is 
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properties of the spleen itself that affects the size of the leukocyte pool. Conversely, differing 
numbers of male and female transferred leukocytes homing to the spleen would suggest the 
phenotypes of these cells are heterogeneous.  
Appendix 6 shows preliminary leukocyte transfer studies that begin to address this future 
work. Should the trends demonstrated in Appendix 5 prevail, it is likely that differences 
between the male and female leukocytes underlie dimorphisms in basal spleen number. To 
further investigate the differences between male and female leukocyte subsets, splenic 
neutrophils and monocyte subsets could be isolated and subjected to gene expression and 
proteomic studies. By these means, genes that are differentially expressed in male and female 
neutrophils and monocytes can be identified and selected for further investigation. 
 Validation of the role of the spleen in sex-differences in neutrophil and 9.2.3.
classical monocyte trafficking in zymosan peritonitis 
This study demonstrates that with regards to the murine spleen, zymosan peritonitis induces 
the homing of female neutrophils and mobilisation of male classical monocytes. The overall 
result of such trafficking is likely to represent explanation for the elevation of neutrophils and 
classical monocytes in the male mouse circulation. Evaluating the leukocyte trafficking 
responses in male and female splenectomised mice during zymosan peritonitis would validate 
the role of the spleen in this inflammatory reaction. The removal of the spleen would result in 
an elimination of the site of proposed neutrophil homing in female mice, whilst also 
eliminating the likely source of the additional classical monocytes released in male mice. It 
would be hypothesised that sex-differences seen with regards to circulating and recruited 
neutrophils and classical monocytes during early zymosan peritonitis would be no longer 
evident in splenectomised mice.  
 Investigation into the role of ovarian sex hormones in the dampened female 9.2.4.
responses during zymosan peritonitis 
The influence of hormones has not been studied in this comprehensive analysis of sex-
differences in the trafficking of leukocyte subsets in acute inflammation. Previous studies 
report that in response to bacterial peritonitis, greater leukocyte recruitment is evident in 
ovariectomised (OVX) female mice with 2-fold reduction in serum 17β-oestradiol versus sham 
controls (Scotland et al., 2011). Future experiments could use OVX mice to assess the influence 
of ovarian sex hormones on the sexually dimorphic observations in the study (i.e. 
accumulation of neutrophils and classical monocytes in the blood and tissue, and the basal 
Chapter 9 
 
166 
 
splenic leukocyte numbers). Furthermore, microarray analysis of male and female neutrophils 
and monocyte subsets treated with or without 17β-oestradiol ex vivo would improve our 
understand of the regulatory effects sex hormones have on immune cells, and identify 
candidate genes for activation or blockade in future leukocyte trafficking experiments.  
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 Concluding remarks  9.3.
This study has demonstrated for the first time a role for the murine spleen in sexually 
dimorphic responses to acute inflammation. It was found that the resting male spleen 
contained a significantly greater pool of neutrophils, classical monocytes, and non-classical 
monocytes than that of the female. During early zymosan peritonitis, male mice accumulated 
more neutrophils and classical monocytes in their circulation, and furthermore had greater 
recruitment of both cell types to the peritoneal cavity. These were in parallel with a differential 
leukocyte trafficking about the spleen between the sexes with male mice releasing splenic 
classical monocytes, and neutrophils homing to the female spleen. Similar TLR expression 
between the sexes and during the inflammation was observed, suggesting differences in TLRs 
do not underlie the dimorphisms reported.  
Collectively these findings demonstrate that sex-differences in the inflammatory response 
exist, and highlight the importance of considering sex in study design, inflammatory model 
selection, and data interpretation. These findings also propose the spleen as a key orchestrator 
in the dimorphic inflammatory response in mice. This suggests the spleen as a potentially 
novel therapeutic target for inflammatory diseases with leukocyte recruitment as a contributor 
to the pathogenesis. Should the mechanisms of differential trafficking in males and females be 
defined in future studies, the spleen represents an exciting novel target for personalised, sex-
specific medicine development.  
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Appendices 
Appendix 1 
 
 
 
  
Appendix 1. Assessment of the leukocyte recruitment profile of CX3CR1
+/gfp mice.  Male and 
female C57BL/6 (WT) and CX3CR1
+/gfp mice were treated with or without zymosan (1mg, i.p.) 
for 3h. Leukocytes were isolated from the (A) blood and (B) peritoneal cavity of mice and 
counted. Differences in total leukocytes at each time point were compared between both 
genotypes of mice by Student’s t-test. Data is displayed at mean ± SEM of at least 7 mice. 
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Appendix 2 
  
Appendix 2. Characterisation of TLR antibodies. Concentration-response graphs of ex-vivo 
labelling of murine peritoneal lavage macrophages. (A) Anti-TLR2 antibodies clone 6C2 (grey) 
and T2.5 (green) and (B) anti-TLR4 antibodies clone UT41 (grey) and MTS510 (blue). TLR 
expression was measured as relative fluorescence intensity (RFI) to an isotype control 
antibody. 
Appendix 
170 
 
Appendix 3 
  
Appendix 3. Recruited neutrophil and classical monocyte correlation. Male (blue) and female 
(pink) mice were treated with zymosan (1mg, i.p.) for 3h to induce peritonitis. Correlation of 
the number of neutrophils and classical monocytes recruited to the cavity by 3h. n=11.  
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Appendix 4 
 
 
 
 
 
 
  
Appendix 4. Proteome Profiler™ array reference spots. Duplicate reference control spots from 
Proteome Profiler™ mouse cytokine and chemokine arrays. Spots are in triplicate per 
membrane. Shown are from representative membranes of each condition. Male and female 
membranes were always exposed for equal times.    
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Appendix 5 
Study rationale:  Some studies have demonstrated the expression of TLR4 protein in primary 
ECs by Western blot, however there is currently no clear evidence for the presence of the 
receptor on whole tissue blood vessels. Detection of EC TLR4, and evidence of modulation in 
inflammation may provide a link to aberrant leukocyte recruitment in inflammatory diseases. 
Aim: Investigate the expression of TLR4 in the murine microvasculature in basal and inflamed 
conditions.  
Experimental approach: Mice were treated ± intrascrotal (i.s.) TNF (300ng) or LPS (300ng) for 
4h, or were exposed to 30min ischaemia of the cremaster circulation with 2h reperfusion (I/R). 
Cremasters were dissected, fixed, permeabilised and stained with fluorescently labelled 
antibodies to VE-Cadherin and TLR4 (clone MTS510). Whole mount tissues were imaged for 
TLR4 expression using the Zeiss LSM 5 Pascal laser-scanning microscope with a 63x objective. 
Other techniques for employed for EC TLR4 analysis included cell culture and Western blot. 
Results: Anti-TLR4 antibody labelled infiltrating leukocytes in mouse cremasters stimulated 
with TNF, LPS, or I/R injury, however was unable to detect TLR4 on the vasculature.  
Conclusions: MTS510 anti-TLR4 detected leukocyte, but not vascular TLR4. A detailed 
description of this work is however beyond the scope of this Thesis.    
Appendix 5. Staining of mouse cremaster muscle with anti-TLR4 antibody. Male mice were 
(A) naïve, or treated with (B) TNF or (C) LPS (300ng, i.s., 4h), or (D) were exposed to 30min 
cremaster ischaemia followed by 2h reperfusion. Cremasters were then excised, fixed, 
permeabilised and stained with Alexa Fluor® 555 conjugated anti-TLR4 (red), and Alexa 
Fluor®488 or 647 conjugated anti-VE-Cadherin. Scale bars, 20µm.  
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Appendix 6 
  
Appendix 6. Trafficking of donor transfer leukocytes to recipient spleens. Leukocytes were 
isolated from the BM of donor male and female C57BL/6 mice and cells were labelled ex vivo 
with CellTracker™ Orange and CellTracker™ Violet dyes (2µM, Life Technologies), respectively. 
10x106 labelled donor leukocytes (5x106 male + 5x106 female) were transferred (i.v.) into 
recipient male or female mice. After 4h recipient mice were culled by Schedule 1 (cervical 
dislocation) and spleen leukocytes harvested. Leukocytes were counted on a hemocytometer 
and labelled with fluorescently conjugated antibodies to CD115 and Gr1. Samples were 
analysed by flow cytometry. (A) Donor male cells in the recipient spleen were identified as 
CellTracker™ Orange+ and donor female cells as CellTracker™ Violet+. (B) Presence of donor 
neutrophils were identified by subsequent gating on Gr1high cells. (C) Presence of donor classical 
monocytes were identified by subsequent gating on CD115+Gr1+ cells. Data are mean ± SEM, 
n=7/6/6/5. Differences in the accumulation of donor leukocyte subsets in recipient spleens 
were determined by 1-way ANOVA with Bonferroni’s post-test for multiple comparisons. 
Significance was indicated by * (p<0.05).   
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